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DIFFERENTIAL REGULATION OF SYNAPTIC PLASTICITY, MOOD AND 
REWARD BEHAVIOR BY CIRCADIAN GENES 
Puja K. Parekh, Ph.D. 
University of Pittsburgh, 2017 
Endogenously generated circadian rhythms allow living organisms to entrain to photic and non- 
photic cues in a changing environment. The master pacemaker region, the suprachiasmatic nucleus 
(SCN) coordinates the activity of several sub-oscillators throughout the brain and periphery to 
produce daily variation in physiology and activity patterns. However, SCN-autonomous rhythms 
also exist in mesocorticolimbic brain regions. The disruption of these rhythms at the molecular 
level can have dire consequences for physical and mental health. Clinical and preclinical studies 
provide a strong link between circadian gene perturbations and the development and progression 
of mood and substance abuse disorders including bipolar disorder (BD) and co-morbid addiction. 
While much is known about the inner workings of the SCN clock, the specific underlying 
mechanisms governing the regulation of mood and reward-related behavior by extra-SCN clock 
proteins are yet to be fully elucidated. 
Molecular rhythms are maintained by transcription factors, CLOCK and NPAS2, which 
are homologous in structure and function but differentially expressed throughout the brain. Genetic 
variants of both have been found to associate with neuropsychiatric illnesses in human populations. 
The expression profiles and uniquely regulated gene targets of these proteins however, may 
contribute to differences in their ability to modulate behavior. The work presented here focuses on 
how disruptions in CLOCK and NPAS2 alter mesolimbic excitatory neurotransmission and their 
effects on mood and reward-related behavior. We find that a mutation in CLOCK, which produces 
a dominant negative protein, and a behavioral phenotype in mice closely resembling human mania, 
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leads to a reduction in excitatory neurotransmission in the nucleus accumbens (NAc) a region 
critical for sensorimotor and limbic integration. These mice have also been characterized to be 
hyperhedonic with increased reward sensitivity. In contrast, a disruption in NPAS2 by viral- 
mediated knockdown, increases NAc excitatory synaptic transmission and incidentally decreases 
reward sensitivity in a cell-type specific manner. Electrophysiological, molecular, biochemical and 
behavioral studies contained within this dissertation aim to uncover the differential regulation of 
behavior by these core circadian proteins. The understanding of these mechanisms may help to 
inform targeted therapeutic strategies against BD and other disorders for which there is a strong 
circadian component. 
vi 
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PREFACE 
The past several years have marked a tremendous period of growth for me, intellectually, 
personally and professionally. With it have come the inevitable growing pains, the challenges 
faced with any undertaking of significant worth. However, the ultimate satisfaction of growth that 
can only be appreciated when taking stock is valuable beyond measure. For the opportunity to 
explore my interests, learn a considerable amount about the natural world and put an inquisitive 
mind to practice, I would like to express my gratitude to several individuals and organizations. 
Foremost are my mentors, Dr. Colleen McClung and Dr. Yanhua Huang, who have guided me 
through the technical aspects of the studies I describe in this dissertation, but who have also both 
taught me a great deal about how to approach the profession of a scientist, with its unique demands 
and responsibilities. Colleen has given me the freedom to ask questions and seek answers in my 
own style, forcing me to define what that style should be as I move forward in my career. Yanhua 
has given me unrestricted access to resources, undoubtedly the most valuable of which has been 
her expertise and sharp, analytical mind. I admire, respect, and hope to emulate both of my 
exemplary mentors. Additionally, I would like to thank both current and former members of my 
committee and especially my Chair, Dr. Bita Moghaddam. The valuable input from these 
individuals has enriched my learning experience and helped to focus my studies. For continued 
support and unparalleled training, I am proud to belong to the CNUP graduate program, the CNBC 
joint certificate program and the TNP. These organizations truly embody the spirit of the 
collaborative, innovative and thriving neuroscience community in Pittsburgh with their emphasis 
on fostering the potential of trainees. Lastly, I am indebted to countless peers whose camaraderie 
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and generosity have made a lasting impression on me. Sharing in our frustrations and fears has 
lessened their burden and likewise celebrating our accomplishments together has enhanced their 
meaning. As I look forward, I am comforted to know that my scientific colleagues will be the 
brilliant and unique individuals I have had the privilege to befriend here. 
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1.0 INTRODUCTION: THE MAMMALIAN CIRCADIAN CLOCK 
The rotation of the Earth on its axis creates a periodic shifting of light conditions, which has 
necessitated the evolution of a biological system to allow organisms to adaptively entrain to daily 
and seasonal cues. Circadian rhythms serve this purpose and are indispensible for maintaining 
proper physiological and behavioral responses to ensure survival (Milhiet et al, 2014). Biological 
rhythms are an ancient and highly conserved phenomenon and were first described in plants 
(Bunning, 1935; Chandrashekaran, 1998). Since then, countless species of invertebrate and 
vertebrate animals have been subjects of chronobiological studies. Mammals possess specialized 
melanopsin-containing retinal structures termed intrinsically photosensitive retinal ganglion cells 
(ipRGCs), which transmit light information from the environment via the retinohypothalamic tract 
to the master pacemaker region in the brain called the suprachiasmatic nucleus (SCN) (Hattar et 
al, 2006; Panda et al, 2003; Schmidt et al, 2011). The SCN, found in the anterior hypothalamus, 
is a highly coupled network of oscillators whose output synchronizes and coordinates the rhythmic 
activity of a number of subsidiary or “slave” oscillators throughout the brain and in peripheral 
tissues (Li et al, 2012; Quintero et al, 2003). In this way, daily molecular rhythms and activity 
patterns are set. While light is the most potent entraining cue or “zeitgeber,” from the German 
word “time keeper,” non-photic zeitgebers such as the availability of food or drugs of abuse can 
also act as signals around which animals consolidate their activity (Damiola et al, 2000). 
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At the molecular level, rhythms in gene and protein expression and activity exist in almost 
all cells in the body. Current estimates suggest that roughly 43% of the genome is rhythmic, the 
actual value may be higher as we continue to uncover cellular events under circadian or diurnal 
regulation (Zhang et al, 2014). The molecular basis of rhythm generation in mammals is a complex 
hierarchical series of interlocked transcriptional-translational feedback loops (TTFLs) with added 
regulatory control via kinase-dependent mechanisms (figure 1). Many homologous components of 
the molecular clock can be found in species as varied as Neurospora crassa, Drosophila 
melanogaster, rodents and humans (Mackey, 2007). Within the primary loop of the mammalian 
clock are the positive effectors, CLOCK (circadian locomotor output cycles kaput) and BMAL1 
(brain and muscle ARNT-like protein 1). 
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Figure 1. A series of transcriptional and translational feedback loops comprise the core molecular clock in 
mammals. At the heart of the clock are the transcription factors, CLOCK (or NPAS2) and BMAL1 which 
heterodimerize in the nucleus and bind to Enhancer Box (E-box) sequences in many genes to regulate their 
transcription. Targets include the Per and Cry genes. Over the course of 24 hours, PER and CRY proteins dimerize 
and shuttle back into the nucleus where CRY directly inhibits the CLOCK/NPAS2-BMAL1 complex, forming a 
negative feedback mechanism. Additionally, CLOCK/NPAS2 and BMAL1 also regulate the expression of nuclear 
hormone receptors, Rev-erbα and Rorα, which can repress or activate Bmal1 transcription. Other regulatory proteins 
act on the clock through phosphorylation, including Casein kinase 1 proteins and ubiquitination by Glycogen synthase 
kinase beta. Intracellular calcium signaling cascades can also act to regulate the activity of core circadian proteins 
through kinase-dependent pathways. CCGs – Clock controlled genes; P – phosphorylation; U – ubiquitination. From 
(Parekh et al., 2015). 
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These are bHLH-PAS domain-containing transcription factors that heterodimerize within the 
cytoplasm, enter the nucleus and bind to the canonical E-box sequence (CACGTG) in the promoter 
regions of Period (Per1, Per2 and Per3) and Cryptochrome (Cry1, and Cry2) genes. Together, 
these genes make up the negative limb of the core feedback loop. In the cytoplasm, CRY and PER 
proteins form hetero- and homodimers, translocate to the nucleus and inhibit the activity of 
CLOCK/NPAS2-BMAL1 (Ko and Takahashi, 2006; Lowrey and Takahashi, 2011; McDearmon 
et al, 2006; Meijer and Schwartz, 2003). Per and Cry transcript and protein levels decline over 
time as their degradation is induced by casein kinase 1δ (CK1δ) and CK1ε phosphorylation 
activity. This leads to a disinhibition of the CLOCK/NPAS2-BMAL1 complex, resetting the cycle. 
Ubiquitination by glycogen synthase kinase beta (GSK3β), a serine/threonine protein kinase, also 
plays a role in regulating the inhibition of the complex by PER/CRY. The timing of accumulation 
and degradation of these circadian proteins is critical to maintaining the period and amplitude of 
rhythms (Lee and Kim, 2014; Lee et al, 2011). Bmal1 expression is further regulated by a second, 
stabilizing loop feedback mechanism involving genes that encode the retinoic-acid-related orphan 
nuclear receptors REV-ERBα and RORα, which bind the ROR element in the Bmal1 promoter. 
ROR and REV-ERB proteins activate and repress expression of Bmal1, respectively, maintaining 
its robust rhythm in vivo (Preitner et al, 2002; Ripperger and Albrecht, 2012). 
The transcriptional activity of the CLOCK/NPAS2-BMAL1 heterodimer is conferred by 
CLOCK’s role as a histone acetyl transferase (HAT) (Doi et al, 2006). CLOCK HAT-dependent 
acetylation of histone H3 promotes transcription allowing for the “opening” of chromatin that is 
normally tightly condensed. This posttranslational modification of chromatin state provides access 
to the transcriptional machinery and thus the ability for the heterodimer to activate or repress 
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downstream genes involved in maintaining rhythms or other “clock-controlled genes” (CCGs) 
(Hardin and Yu, 2006). Importantly, the many CCGs that are targets of circadian transcriptional 
activation or repression are found in various regions throughout the central nervous system and 
periphery. A similar E-box-mediated transcriptional mechanism governs the regulation of these 
genes as well. Some of these genes have direct relevance in pathways important for normal and 
abnormal mood and reward-related behaviors in animals (McClung, 2007; Parekh and McClung, 
2015). 
1.1 CIRCADIAN RHYTHMS IN PSYCHIATRIC ILLNESS 
The de-synchronization of circadian rhythms appears to be both a symptom and a precipitating 
feature of some neuropsychiatric conditions. Normal “phase shifting” of the endogenous clock in 
response to changing environmental stimuli is an adaptive mechanism that allows organisms to 
flexibly entrain to new conditions. However, phase shifting processes can be inappropriately 
activated in a modern industrialized society where light availability is constant (Karatsoreos, 
2014). Dim light at night for instance, can offset normal circadian organization and contribute to 
depressed mood and reduced cognitive performance (Bedrosian and Nelson, 2013; Dunn et al, 
2010). Furthermore, scheduled activity that is misaligned with internal time such as trans- 
meridian travel or shift work can exacerbate the negative effects of circadian disruption (Cho et 
al, 2000; Katz et al, 2001; Scott et al, 1997). The “social jet lag hypothesis” suggests that the 
weekly disturbances in sleep-wake rhythms imposed by work or school obligations, particularly 
in adolescence, correlate with affective and substance abuse disorders (Hagenauer and Lee, 2012; 
Wittmann et al, 2006).  Consequently, sleep problems can cause individuals  to  self- 
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medicate through drug or alcohol abuse or to become depressed (Hasler and Clark, 2013; Hasler 
et al, 2015). Seasonal Affective Disorder (SAD), a condition in which individuals exhibit 
symptoms of depression during winter months occurs at a higher rate in populations living in 
temperate climates with seasonal variation in daylight hours (Lam and Levitan, 2000; 
Magnusson and Boivin, 2003). Compellingly, genome wide association studies (GWAS) link 
polymorphisms and other mutations in core circadian genes with predisposition towards SAD, 
major depression (MDD), addiction disorders and bipolar disorder (BD) which is characterized 
by spontaneous mood cycling through depressive, euthymic and manic phases (Benedetti et al, 
2008; Kovanen et al, 2013; Soria et al, 2010; Kovanen et al, 2010; Mansour et al, 2009). 
McCarthy and Welsh provide a detailed description of known circadian gene variants in humans 
associated with mood disorders (figure 3). Almost all core circadian genes are represented 
(McCarthy and Welsh, 2012; McCarthy et al, 2012). A genetic basis for chronotype (preference 
for morning or evening consolidation of activity) in humans has been suggested by a number of 
studies (Carpen et al, 2005, 2006; Katzenberg et al, 1998). Chronotype plays a role in mood and 
addiction disorders where “eveningness” is characteristic of bipolar patients many of whom 
display co-morbid substance abuse problems (Broms et al, 2014; Etain et al, 2014; Konttinen et 
al, 2014; Zhang et al, 2015). 
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Circadian rhythms in the use and sensitivity to several different classes of drugs have been 
observed as well (Broms et al, 2011; Danel et al, 2003; Gallerani et al, 2001; Kosobud et al, 
2007). Circadian gene variants and chronotype can also correlate with an abnormal response to 
reward (Hasler et al, 2012). A particular single nucleotide polymorphism (SNP) in the human 
Period gene, for instance, disrupts prefrontal reward responsivity and cortico-striatal activation 
following a rewarding stimulus (Forbes et al, 2012). These and other findings suggest an 
important role for circadian misalignment in the pathophysiology of mood and substance abuse 
disorders. 
Figure 2. Variants of core circadian genes strongly associate with mood disorders in humans. An enrichment of 
mood disorder associations among core clock genes indicates that Arntl (BMAL1), Clock, Cry1, Npas2, Nr1d1 (REV- 
ERBα), Per3 and Rorβ in particular are associated with aspects of bipolar disorder, onset of the disease, comorbidity 
with other psychiatric conditions or responsiveness to the main-line therapeutic agent, lithium. From (McCarthy and 
Welsh, 2012). 
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1.1.1 Central pathways involved in mood and reward regulation 
Decades of preclinical and clinical investigations into the mechanisms of neuropsychiatric illness 
highlight the central role of proper signaling in several key brain regions to maintain biochemical 
and neurophysiological balance within circuits. Reward circuitry is directly impinged upon by 
drugs of abuse and is also the main site of dysregulation in some mood disorders including BD 
(van Enkhuizen et al, 2015; Russo and Nestler, 2013). In the traditional view of the reward system, 
projections between certain regions are highlighted as critical to the expression and maintenance 
of proper reward sensitivity and behavioral response. Among these are dopaminergic (DA) and 
GABAergic (gamma-aminobutyric acid) projections from the ventral tegmental area (VTA) and 
substantia nigra (SN) to the nucleus accumbens (NAc) and dorsal striatum (Str) respectively 
(Koob and Volkow, 2010; Russo and Nestler, 2013). Dopamine, a monoaminergic 
neurotransmitter, is a highly complex signaling molecule, however, a key feature of the midbrain 
DA system is to confer incentive salience to environmental stimuli and promote motivational or 
goal-directed action. Its function in reinforcement learning forms the basis for a model to explain 
the unique value of drugs of abuse over natural reinforcers (Berridge and Robinson, 1998; Nestler, 
2005; Schultz, 2006; Schultz et al, 1997). Rapid pharmacokinetic effects of drugs on dopamine 
release may promote over-learning on drug-related stimuli or cues (Hyman, 2005). The VTA also 
sends afferent inputs to the prefrontal cortex (PFC), a major site of executive function and 
cognitive control over behavior, and in humans, abnormal dopaminergic signaling within the PFC 
has been correlated with a drug-addicted state (Ballard et al, 2011; Juarez and Han, 2016). 
The NAc is considered to be an integrator of sensorimotor and limbic information to gate 
emotional responses and drive appetitive and aversive behaviors (Goto and Grace, 2008; Richard 
et al, 2013). Its extensive afferent and efferent connections serve to underscore this function. 
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Chiefly, the NAc receives glutamatergic inputs from the PFC, amygdala (Amy) and hippocampus 
(Hipp) and provides GABAergic input to the VTA as well as the ventral pallidum (VP) (Britt et 
al, 2012; Tye, 2012). GABAergic medium spiny projection neurons (MSNs) serve as the output 
cells and make up approximately 90-95% of the NAc. Smaller populations of cholinergic and 
parvalbumin interneurons regulate the activity of the MSNs (Kauer and Malenka, 2007). Two 
major subclasses of MSNs predominantly express either dopamine 1-like (D1) or 2-like (D2) 
receptors (Le Moine and Bloch, 1995). These G-protein coupled receptors (GPCRs) differ in their 
intracellular signaling mechanisms in response to dopamine, effects on intrinsic excitability and 
synaptic transmission of MSNs, peptide expression and projection pathways (Lu et al, 1998). 
Generally, D1-containing MSNs belong to the striatonigral direct pathway while D2 MSNs 
comprise the striatopallidal indirect pathway. Activation of these distinct pathways has been shown 
to produce divergent effects on reward related behavior with direct pathway stimulation promoting 
reward value and seeking and indirect pathway activation attenuating reward-related behavioral 
responses (Baik, 2013; Gerfen et al, 1990; Kravitz et al, 2013; Smith et al, 2013). 
While direct projection targets of the SCN, including the medial pre-optic area (mPOA) 
and dorsomedial hypothalamic nucleus (DmH) are not central to the reward circuitry, they may 
modulate it through indirect neural connections (Mendoza and Challet, 2014). Orexinergic 
neurons in the DmH for instance encode information about arousal, energy balance and reward 
and project to the VTA (Aston-Jones et al, 2001, 2009). The dorsal raphe nuclei of the midbrain 
receive direct light input from the circadian visual system and also indirect input from the SCN 
and are the primary regions containing serotonin (5-HT) neurons in the brain (Ciarleglio et al, 
2011; Morin, 2013). Serotonergic neurotransmission is involved in the regulation of mood and a 
widely utilized class  of  antidepressants  targets  the  5-HT  re-uptake  mechanism (SSRIs) 
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(Anguelova et al, 2003; Lucas et al, 2007). Interestingly, this system is affected by photoperiod, 
where day length during development can alter firing properties of 5-HT neurons as well as 
extracellular levels of the neurotransmitter and norepinephrine. These light-induced changes 
further affect anxiety and depressive-like behavior (Green et al, 2015). The lateral habenula (LHb) 
in the midbrain also receives direct SCN input and has been shown to be an important inhibitor of 
DAergic activity in the VTA, thus exerting a more robust influence over mood and reward 
regulation (Bourdy and Barrot, 2012; Lecca et al, 2012). Each of these critical extra-SCN brain 
regions maintains rhythms and expresses circadian genes and proteins with clock and non-clock 
regulatory functions (Parekh and McClung, 2016). They therefore control mood and reward 
behavior through both circuit-level and molecular mechanisms. 
 
1.1.2 Bipolar disorder and the clock 
 
 
Mental illness and affective disorders in particular are a leading cause of disability worldwide 
according to the World Health Organization. The Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5) defines bipolar I disorder as being characterized by at least one 
manic episode with ‘…abnormally and persistently elevated, expansive or irritable mood and 
abnormally and persistently increased activity or energy…” Manic episodes also present with 
certain hallmarks including a decreased need for sleep and increased goal-directed activity and 
high-risk behaviors. Individuals can experience major depressive episodes preceding or following 
manic episodes with periods of euthymic or normal mood in between (figure 3). The severity of 
mood disturbance is sufficient to produce marked impairments in individuals’ social or 
occupational functioning. The prevalence of the disorder among adults in the U.S. is estimated to 
be approximately 2.5% of the population and co-morbidity with other conditions including anxiety 
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and substance abuse disorders is common (DSM-V). Sleep disturbances as well as the general 
cyclic nature of mood states characterizing BD have led researchers to speculate about circadian 
abnormalities underlying the illness (McClung, 2013; Melo et al, 2016; Mendlewicz, 2009). 
Symptoms can be tied to seasonal variation and shifts in mood state can be precipitated by erratic 
changes in daily activity schedules (McClung, 2013). The mood-stabilizing effects of tightly 
regulating sleep/wake schedules further underscore the importance of the clock in BD (Wirz- 
Justice et al, 2005). Social Rhythm Therapy and chronotherapeutics represent novel strategies to 
combat rhythm misalignment in patients and lessen the severity of symptoms (Coogan and Thome, 
2011; Dallaspezia et al, 2015; Haynes et al, 2016; Henriksen et al, 2016). Additionally, traditional 
mood stabilizers such as the antipsychotic compounds, lithium and valproate, have been shown to 
increase circadian period in rodents and humans and to change expression profiles of circadian 
genes (Landgraf et al, 2016; Milhiet et al, 2014). Together, these abnormalities may serve as trait 
markers of susceptibility for BD. 
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Figure 3. Hallmarks of bipolar I disorder. Distinct phases illness episodes in BD must meet DSM-V criteria and be 
characterized by a number of symptoms that distinguish the disease from others such as generalized anxiety, unipolar 
depression, or pharmacological features of drug abuse. A manic episode persisting for at least one week followed by 
euthymic or dysthymic states, hypomania or mixed states must occur for a BD diagnosis. From Stahl’s Essential 
Psychopharmacology, 4thed. 
 
 
Numerous human genetic studies have identified positive associations between core 
circadian genes including Clock, Npas2, Bmal1, and Per3 with BD (Milhiet et al, 2014). A 
particular single-nucleotide polymorphism (SNP) in the 3’UTR of Clock (3111 T to C) is 
associated with a higher rate of bipolar episodes, as well as sleep disruption in bipolar patients 
(Benedetti et al, 2003, 2007). Recent work from our lab provides further evidence of functional 
consequences of the 3111T/C SNP. CLOCK-deficient mouse embryonic fibroblasts (MEFs) 
transfected with the human mutant construct showed altered expression, function and stability of 
Clock transcript (Ozburn et al, 2016). Additionally, haplotypes and SNPs in Bmal1 have been 
found to significantly associate with BD (Mansour et al, 2006). These and other studies suggest a 
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strong implication of the molecular clock in the underlying mechanisms contributing to the 
development and progression of BD. 
 
1.1.3 Circadian rhythms in addiction 
 
 
Addiction is a widespread public health issue with social and economic ramifications. Koob and 
Volkow (2010) review decades of clinical and pre-clinical studies showing that discrete aspects of 
mesocorticolimbic circuitry are engaged during binge drug use, withdrawal/negative affect, and 
relapse, encompassing all stages of the addiction cycle (Koob and Volkow, 2010). Drugs of abuse 
including alcohol, cocaine, methamphetamine, and opioids act directly on the dopamine system 
and other signaling pathways to promote seeking behavior. Generally, these substances elicit their 
effects by increasing dopamine release from the VTA to its target regions (Kauer and Malenka, 
2007). Drugs of abuse can alter rhythmicity of core clock genes and the activity of these genes can 
in turn affect the expression of proteins important for plasticity suggesting a bidirectional 
relationship between the circadian and reward systems (Falcon et al, 2013; Lynch et al, 2008; 
Ozburn et al, 2015). 
Addictive drugs are able to serve as zeitgebers and can reliably entrain anticipatory activity 
rhythms in animals when given regularly. This locomotor activity has been likened to the seeking 
behavior characteristic of drug addiction. For example, daily methamphetamine injections have 
been shown to entrain animals and induce anticipatory locomotor activity to the time of injection 
(Kosobud et al, 1998). Ethanol, cocaine, and nicotine are all able to induce this anticipatory 
behavior and alter behavioral rhythms (Gillman et al, 2010; Kosobud et al, 2007; White et al, 
2000). Diurnal variations in amphetamine-induced locomotor activity, conditioned place 
preference for amphetamine, and the expression of TH mRNA in the VTA and NAc have also 
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been observed (Webb et al, 2010). In rodents with SCN lesions methamphetamine in the drinking 
water restores activity rhythms in a robust manner (Masubuchi et al, 2000). Rewarding stimuli 
such as food or chocolate can entrain both behavioral and Per1 expression rhythms, which persist 
for several days in several brain regions (including dorsal medial hypothalamus, NAc, PFC, and 
the central amygdala) (Angeles-Castellanos et al, 2008). Therefore, both behavioral and 
molecular rhythms appear to be affected by rewarding stimuli, and especially potently by drugs of 
abuse. 
1.1.4 Circadian regulation of reward-related regions and dopaminergictransmission 
The role of circadian genes in the direct regulation of dopaminergic reward circuitry has been well 
established. Within mesolimbic nuclei, virtually all aspects of dopaminergic activity including 
neuronal firing patterns, neurotransmitter synthesis, release, degradation and postsynaptic actions 
are subject to circadian transcriptional influence and display diurnal variation (McClung, 2007). 
This regulation of signaling is important for reward-related behavior as all drugs of abuse exert 
their actions by impinging on dopaminergic circuitry and any disruption of this system may 
increase vulnerability to the rewarding properties of drugs (Kauer and Malenka, 2007). 
Additionally, diurnal variation in dopaminergic neuronal activity may underlie the diurnal 
variation in behavioral responses to drugs as previously described. While it has long been thought 
that VTA DA neurons do not have a diurnal rhythm in firing rate, a recent study suggests that this 
may not be the case as an intradiurnal rhythmic pattern of VTA DA neuronal activity has been 
measured in anesthetized rats (Domínguez-López et al, 2014). Furthermore, the rhythm in 
extracellular levels of DA appears to be governed by a rhythm in the expression and activity of the 
dopamine transporter (DAT) (Ferris et al, 2014). It is still unclear whether a strong link exists 
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between firing and extracellular release of DA however in behaving animals. More work is needed 
to concretely establish these mechanisms. 
Within the VTA, rhythms have been observed in the expression of DA receptors as well as 
tyrosine hydroxylase (TH) and monoamine oxidase (MAOA), the enzymes responsible for the 
synthesis and degradation of DA respectively (McClung et al, 2005; Hampp et al, 2008; McClung, 
2007; et al, 2007; Sleipness et al, 2008; Weber et al, 2004). There is also evidence to support the 
idea that these regulatory genes may be clock-controlled genes (CCGs), as they contain canonical 
E-box sites in their promoter regions and are bound by CLOCK and BMAL1 (Sleipness et al,
2007; Hampp et al, 2008). Moreover, diurnal variations in extracellular levels of the 
neurotransmitters, DA, glutamate and GABA have been described in the NAc (Castañeda et al, 
2004). Our lab has demonstrated that cholecystokinin (CCK), a peptide negatively associated with 
DA activity in vivo and implicated in anxiety and drug response, is also a direct gene target of 
CLOCK (Arey et al, 2014). In a recent study from our group, chromatin immunoprecipitation 
followed by deep sequencing (ChIP-seq) revealed a role for NPAS2 in directly regulating the 
expression of the dopamine D3 receptor subtype in the striatum of mice (Ozburn et al, 2015). This 
receptor is often found co-localized with D1Rs on striatal MSNs and is involved in mediating 
rewarding effects of cocaine (Sokoloff et al, 2001). 
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Figure 4. Elements of dopaminergic transmission are directly under circadian control. Within the VTA-NAc 
circuitry, clock genes regulate the transcription of several genes involved in the synthesis, uptake, transmission and 
degradation of dopamine, including tyrosine hydroxylase (TH), dopamine transporter (DAT), pre-synaptic dopamine 
type-2 receptor (D2R), dopamine type-3 receptor (D3R), monoamine oxidase A (MAOA), and cholecystokinin 
(CCK). Within the NAc, diurnal rhythms in levels of the neurotransmitters, dopamine, glutamate and GABA have 
been measured as well. The transcription of TH is repressed by the circadian transcription factor, CLOCK as well as 
the nuclear receptor, REV-ERBα, which bind to enhancer box (E-Box) and ROR response element (RRE) sites in the 
promoter region, respectively. From (Parekh and McClung, 2016). 
The lateral habenula (LHb) in the midbrain also receives direct SCN input and has been 
shown to be an important inhibitor of DAergic activity in the VTA, thus exerting a more robust 
influence over mood and reward regulation (Bourdy and Barrot, 2012; Guilding et al, 2010; Lecca 
et al, 2012). The neuronal activity of the LHb and medial habenula (MHb) shows rhythmic 
oscillation both in vitro and in vivo and firing rates of neurons in both of these regions are altered 
in response to retinal illumination in vivo. The LHb maintains endogenous molecular rhythms as 
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well with oscillations in Per2 gene and protein levels across the light/dark cycle. Temporal 
variation in electrophysiological properties in each of these neuronal populations is absent in mice 
lacking a functional intracellular molecular clock. These findings support the idea that intrinsic 
circadian signals can shape the contribution of habenular nuclei to affective and reward behavior 
(McCarthy and Welsh, 2012; Sakhi et al, 2014; Zhao and Rusak, 2005). Another reward-related 
region in the thalamus, the paraventricular nucleus (PVT), which sits at the midline and projects 
to many limbic structures including the NAc, also displays rhythms in activity. The PVT receives 
input from the SCN and the DmH and has been shown to play role in the anticipatory locomotor 
response to food. The firing rate of PVT neurons varies throughout the day with greatest activity 
seen during the animal’s active phase (Alamilla et al, 2015; Colavito et al, 2015; Kirouac, 2015; 
Kolaj et al, 2012). The influence of this small nucleus on reward sensitivity and drug seeking is 
beginning to be further elucidated (Dayas et al, 2008; Matzeu et al, 2014). Work from the Aston- 
Jones lab has provided insights into the circadian regulation of activity of noradrenergic neurons 
in the locus coeruleus (LC), a key mediator of wakefulness and behavioral arousal. Using single- 
unit recordings of LC neurons in anesthetized rats, they have demonstrated that the neurons fire 
significantly faster during the active phase compared with rest phases. Additionally, the diurnal 
rhythm of noradrenergic neuronal activity correlates with the rhythm of activation of DmH orexin 
neurons, which project preferentially to the LC (Gompf and Aston-Jones, 2008; González and 
Aston-Jones, 2006). These findings suggest that important aspects of neuronal activity throughout 
the brain are under circadian influence and that the rhythmic activity of mood and reward-related 
regions may be relevant for behavioral outcomes. 
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1.2 ANIMAL MODELS OF NEUROPSYCHIATRIC ILLNESS 
 
 
 
The value of animal models to understand mechanisms underlying disorders of the central nervous 
system cannot be overstated. From early plant and invertebrate models we have pieced together 
the mechanisms of the interlocked feedback loops behind circadian rhythm generation and 
maintenance (Mackey, 2007). Additionally, self-report measures in humans have been reliable in 
understanding how natural zeitgebers influence individual phase of entrainment or chronotype, a 
factor that has been linked to mood states and reward response (Horne and Ostberg, 1976). 
Technological advances can extend the functionality of questionnaire-based self-report 
measurements. The use of a smartphone app to monitor daily eating patterns in humans, for 
instance, has revealed a largely erratic rhythm, deviating from the commonly reported “3 meals a 
day” structure (Gill and Panda, 2015). This information has relevance for individual metabolic 
health and epidemiological issues regarding obesity. Furthermore, cells derived from human 
psychiatric patients have been a fruitful model of molecular changes in SCN and SCN-independent 
clocks. Reporters of rhythmic clock gene expression in patients’ cells show correlations with 
severity of  alcohol use  disorders and  predict lithium sensitivity in BD   (McCarthy et al, 2013a, 
2013b). Blood biomarkers, inducible pluripotent stem cells (iPSCs) and skin fibroblasts have all 
yielded a wealth of information about cellular abnormalities in disease state suggesting diagnostic 
potential (McCarthy and Welsh, 2012). 
Rodent models, however, are particularly useful in providing clues about how the 
biological clock system interacts with neurobiological systems relevant for psychiatric illness. 
Basic evidence for a role of the SCN clock in mood comes from lesion studies demonstrating an 
anti-depressant effect of bilateral SCN lesions in rats (Tataroglu et al, 2004). In an attempt to 
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model zeitgeber effects on behavior in rodents, a number of studies have utilized circadian 
misalignment paradigms. Long and short photoperiods, or light phases produce desynchrony of 
internal clocks to various degrees of severity (Craig and McDonald, 2008; Johnson et al, 2003). 
Chronic constant light or darkness can both lead to depression and anxiety-like behavior with 
constant light also dramatically dampening circadian patterns in the hormones, melatonin and 
corticosterone (Tapia-Osorio et al, 2013). Recently, a depressive-like phenotype including 
anhedonia, a loss of interest in once pleasurable activity, and sexual dysfunction has been 
described in rats undergoing exposure to a 22-hr light/dark cycle (LD22). This forced desynchrony 
of the central clock also altered levels and turnover of monoamines in the PFC (Ben-Hamo et al, 
2016). These findings expand upon earlier results indicating monoamine content and metabolism 
in the hippocampus and amygdala of mice are disrupted by constantly shifting light-dark cycles 
(Moriya et al, 2015). Other theories have been put forth suggesting that internal desynchronization 
or bifurcation of SCN rhythms in mammals might underlie rapid cycling manic-depressive 
disorders or mania (Kripke et al, 2015). Together, these and other important findings point to the 
variety of valuable techniques to probe the influence of the circadian system on affective and 
reward-related behavior. 
Building upon information gained from more crude lesion studies, Landgraf and colleagues 
have more recently shown that direct disruption of SCN circadian rhythms by viral-mediated 
knockdown of the core circadian gene, Bmal1, produces a behavioral phenotype including 
helplessness, behavioral despair and anxiety-like behavior (Landgraf et al, 2016). Rapid progress 
in forward genetic approaches has revolutionized the study of gene and environment contributions 
and interactions in disease susceptibility and progression. Sophisticated and precise mutations in 
clock genes allow for the systematic characterization of their roles in regulatingbehavior. 
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1.2.1    Genetic models of bipolar mania 
 
 
Several models of mania have been described to elucidate the pathophysiology of bipolar mania; 
Logan and McClung (2016) thoroughly review and evaluate these. Many of these models utilize 
genetically modified mice to target particular genes, proteins or pathways known to be important 
for mood and reward regulation. As with all animal models, it is not possible to capture the full 
spectrum of a complex human disorder in any one manipulation. However, aspects of these models 
represent face, construct or predictive validity (Logan and McClung, 2016). While the DSM-V 
distinguishes a manic episode from the behavioral effects of psychostimulant drug exposure, 
amphetamine-induced hyperactivity has long been considered a model of mania because of its 
responsiveness to acute anti-psychotic treatment (Gould et al, 2001; Young et al, 2011). 
Additionally, amphetamine produces reliable alterations in mesolimbic dopamine circuitry that 
resemble those seen in BD patients, particularly an elevation of extracellular dopamine (Cousins 
et al, 2009). 
One widely used mutant model of mania is the dopamine transporter knockdown mouse 
(DAT-KD). Neuroimaging evidence suggests altered DA neurotransmission in un-medicated BD 
patients may be a result of lowered DAT expression in the SN (Pinsonneault et al, 2011) and 
reduced DAT availability in striatal regions (Anand et al, 2011). The human Behavioral Pattern 
Monitor (BPM) is used to characterize hyperactivity and increased exploration in BD patients and 
has been modified by Young and colleagues to assess manic-like behavior in mice. They have 
found that DAT-KD mice show a similar BPM profile as well as high-reward risk-preference 
consistent with BD (Gould et al, 2001; Young et al, 2011b). Impulsivity as measured by the Iowa 
Gambling Task (IGT) is another hallmark of BD sufferers and a feature shared by DAT-KD mice 
performing a rodent version of the assay (van Enkhuizen et al, 2013). Therefore, findings using 
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this model suggest that impaired function of the dopamine transporter may lead to a 
hyperdopaminergic state that negatively impacts decision making and promotes risky, goal- 
directed and impulsive actions. 
 
Polymorphisms in the circadian gene, Clock, have been associated with manic features in 
BD (Benedetti et al, 2003; Serretti et al, 2003) and perhaps the most well characterized genetic 
mouse model of mania is the ClockΔ19 mutant mouse. A single nucleotide transversion leads to 
an excision of exon 19 in the Clock gene of these mice, producing a dominant negative protein that 
is capable of dimerization with BMAL1 and E-box binding but dysfunctional in transcriptional 
activity (King et al, 1997). Aspects of circadian rhythm disruption in mutants are similar to those 
seen in BD patients including reduced circadian amplitude and delayed phase (Rock et al, 2014; 
Vitaterna et al, 2006) as well as sleep disturbances (Naylor et al, 2000). In measures of affective 
behavior, Clock mutants exhibit increased locomotor activity in response to novelty, reduced 
anxiety-like and depression-like behavior, and increased intracranial self-stimulation (ICSS) at a 
lower threshold (Easton et al, 2003; McClung et al, 2005; Roybal et al, 2007). 
Clock can act as a negative regulator of drug reward. Our group has identified a key role 
for the Clock gene in mediating the effects of drugs of abuse. ClockΔ19 mice exhibit increased 
cocaine conditioned place preference (CPP), a measure of reward sensitivity, compared with 
wildtype (WT) littermates (McClung et al, 2005). Ozburn and colleagues further examined 
whether results from the conditioned reward study were relevant to cocaine intake using a 
clinically relevant operant intravenous cocaine self-administration paradigm (IVSA). They found 
that WT mice exhibit a diurnal variation in acquisition and maintenance of drug intake that is 
absent in ClockΔ19 mice. A greater percentage of Clock mutant mice acquired cocaine self- 
administration, regardless of time of day tested. Furthermore, mutant mice self-administered more 
cocaine than WT mice (Ozburn et al, 2012). Using fixed ratio (to assess sensitivity to reinforcing 
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properties of cocaine) and progressive ratio (to assess motivation for cocaine) schedules of 
reinforcement dose-response paradigms, they also found that cocaine is a more efficacious 
reinforcer in ClockΔ19 mice compared with WT littermates. Importantly, ClockΔ19 mice 
exhibited similar learning and readily acquired food self-administration (Ozburn et al, 2012). 
Clock∆19 mutants also show enhanced preference for the rewarding aspects of ethanol and sucrose 
and have an increase in dopaminergic activity in the VTA, which is normalized by chronic lithium 
treatment (McClung et al, 2005; Coque et al, 2011; Ozburn et al, 2013). Many of the mutant 
behavioral and physiological phenotypes are rescued by expressing functional CLOCK in the VTA 
or are recapitulated by reducing Clock expression in the VTA of WT mice via RNA interference, 
however this leads to a mixed-manic state (Mukherjee et al, 2010; Roybal et al, 2007). The key 
manic-like characteristics of Clock∆19 mutants are compared with symptoms of human bipolar 
mania in Table 1. 
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Table 1. The Clock∆19 mutant mouse as a model of bipolar mania. The behavioral phenotype of Clock∆19 mice 
closely resembles characteristics of human mania. 
 
 
 
 
Subcortical, striato-thalamic and prefrontal circuit dysfunction has also been described in 
BD (Strakowski et al, 2005). Imaging studies of BD patients have revealed a functional imbalance 
between hyperactive limbic areas and hypoactive cognitive areas, circuitry that is also important 
for the processing of rewarding stimuli (Lois et al, 2014; Edwards and Koob, 2010). The 
synchronization and coherence of neural activity across brain regions is thought to be important 
for normal anxiety-like behavior and cognitive functions (Dzirasa et al, 2010). In addition to 
abnormalities in dopaminergic signaling, ClockΔ19 mice also exhibit alterations in cortico-striatal 
signaling that are indicative of aberrant behavior. When exploring a novel environment, ClockΔ19 
mice, have been shown to have profound deficits in cross-frequency phase coupling of NAc delta 
(1-4Hz) and low gamma (30-55Hz) oscillations, which correlate with enhanced exploratory drive 
(Dzirasa et al, 2010). The entrainment of NAc neurons to afferent input has been theorized to 
 depend upon the balance of synaptic weights.  Shifting of these weights can influence behavior 
 
(Wolf et al, 2005). Dopamine is known to modulate glutamatergic signaling within the NAc, 
providing a possible mechanistic avenue through which cortical-striatal circuitry could be impaired 
in Clock mutants and manic patients. The specific mechanisms contributing to circadian regulation 
of synaptic dysfunction in mesocorticolimbic areas remain poorly understood. Therefore, it will 
be important to systematically interrogate these systems, making use of appropriatemodels. 
 
 
 
1.3 DISSERTATION AIMS 
 
 
Studies contained within this dissertation focus on NAc excitatory signaling as potentially critical 
for ClockΔ19 manic-like behavior, and additionally seek to uncover the role of NPAS2 in 
glutamatergic transmission in the NAc as it relates to reward behavior. The central hypothesis of 
this study is that disrupted AMPAR-mediated synaptic transmission at NAc MSNs underlies 
reward-related behavioral abnormalities in Clock∆19 mice. Additionally, we hypothesize that 
NPAS2 regulates excitatory synaptic strength and reward sensitivity through cell-type specific 
 
mechanisms in the NAc. We test these hypotheses through the following experimental aims: 
 
 
 
Aim 1: Identify baseline changes in glutamatergic synaptic strength and intrinsic excitability of 
MSNs in Clock∆19 mice and the diurnal profile of GluA1 expression in the NAc. 
Aim 2: Manipulate AMPAR-mediated signaling in the NAc of Clock∆19 mice and assess the 
impact on mood and reward-related behavior. 
Aim 3: Determine the cell-type specific effects of NPAS2 knockdown on glutamatergic synaptic 
strength in WT MSNs as well as the conditioned reward response. 
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2.0 ALTERED GLUA1 FUNCTION AND ACCUMBAL SYNAPTIC PLASTICITY IN 
THE CLOCK∆19 MODEL OF BIPOLAR MANIA 
 
 
 
Parekh PK, Becker-Krail D, Sundaravelu P, Ishigaki S, Okado H, Sobue G, Huang YH, and 
McClung CA. (Under revision for Biological Psychiatry) 
 
 
Disruptions in circadian rhythms are associated with an increased risk for bipolar disorder (BD). 
Moreover, studies show that the circadian protein CLOCK is involved in regulating 
monoaminergic systems and mood-related behavior. However the molecular and synaptic 
mechanisms underlying this relationship remain poorly understood. Using ex vivo whole cell patch 
clamp electrophysiology in Clock∆19 mutant and wildtype (WT) mice we characterized alterations 
in excitatory synaptic transmission, strength and intrinsic excitability of nucleus accumbens (NAc) 
neurons. We performed protein crosslinking and Western blot analysis to examine surface and 
intracellular levels and rhythm of the glutamate receptor subunit, GLUA1, in the NAc. Viral- 
mediated overexpression of GluA1 in the NAc and behavioral assays were also used. Compared 
with WT mice, Clock∆19 mice display reduced AMPAR-mediated excitatory synaptic responses 
at NAc medium spiny neurons (MSNs) across the light/dark cycle. These alterations are likely 
postsynaptic as presynaptic release of glutamate onto MSNs is unaltered in mutants. Additionally, 
NAc surface protein levels and the rhythm of GLUA1 are decreased in Clock∆19 mice diurnally, 
consistent with reduced functional synaptic response. Furthermore, we observed a significantly  
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hyperpolarized resting membrane potential of Clock∆19 MSNs suggesting lowered intrinsic 
excitability. Lastly, overexpression of functional GluA1 in the NAc of mutants was able to 
normalize increased exploratory drive and reward sensitivity behavior. Together, our findings 
demonstrate that NAc excitatory signaling via GLUA1 expression is integral to the effects of Clock 
gene disruption on “manic-like” behaviors. 
 
 
 
2.1 INTRODUCTION 
 
 
Recently, BD has been re-conceptualized by some as a synaptic disorder where the functions of 
various postsynaptic proteins are altered in prefrontal and striatal regions, potentially producing 
circuit-level consequences affecting normal mood and reward response (Meador-Woodruff et al, 
2001; De Bartolomeis et al, 2014). Additionally, mood-stabilizing agents exert some of their 
effects by acting directly on elements of synaptic activity including glutamatergic transmission 
(De Bartolomeis et al, 2014; Du et al, 2004). Clock∆19 mice are hyperdopaminergic, displaying 
elevated ventral tegmental area (VTA) dopamine neuron activity and dopamine synthesis in the 
nucleus accumbens (NAc) (McClung et al, 2005; Spencer et al, 2012; Coque et al, 2011). 
Dopamine reliably modulates the activity of glutamate at MSN synapses via G-protein coupled 
receptor signaling, having implications for substance abuse and mood disorders (Nicola et al, 
2000; Beurrier and Malenka, 2002; Russo and Nestler, 2013). Moreover, PET studies of un- 
medicated BD patients indicate significantly lower striatal dopamine transporter (DAT) 
availability suggesting abnormal DA transmission and reward processing in this region (Anand et 
al, 2011). Along with decreased DAT transcript and protein levels in BD post-mortem cortical 
tissue and the correlation between DAT gene polymorphisms with predisposition to BD, there is 
27  
strong evidence to support the role of dopamine homeostatic dysregulation in the disorder 
(Greenwood et al, 2006; Rao et al, 2012).  Dopamine receptor density changes are somewhat 
inconsistent however glutamatergic abnormalities are more clearly seen in BD patients. Findings 
have reported reduced levels of ionotropic glutamate receptor α-amino-3-hydroxy-5-methyl-4- 
isoxazoleproprionic acid (AMPAR) subunits in cortical areas of mood disorder subjects and 
reduced gene expression of the GluA1 subunit in striatal regions of BD patients (Beneyto and 
Meador-Woodruff, 2006). Additional proteins associated with the structural integrity of the post- 
synaptic density and proper trafficking of glutamate receptors to the membrane, including the 
scaffolding protein, PSD-95, and synapse-associated protein 102 (SAP102), have been found to 
be altered in post-mortem brains of BD patients (Sans et al, 2003; Kristiansen and Meador- 
Woodruff, 2005). These alterations may potentially lead to disruptions in excitatory signaling in 
mesocorticolimbic brain regions affecting mood and reward behavior. Additionally, 
polymorphisms in N-methyl-D-aspartate (NMDA) glutamate receptor genes correlate with 
susceptibility to BD (Mundo et al, 2003; Martucci et al, 2006). Given the importance of dopamine- 
glutamate interaction at postsynaptic sites for normal synaptic plasticity processes, it will be 
critical to follow up these findings with functional studies in disease models. 
The consequences of Clock disruption on network activity in mesocorticolimbic circuitry 
have been investigated in greater depth. In a previous study we reported reduced total NAc protein 
levels of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type glutamate 
receptor subunit, GLUA1, and phosphorylated GLUA1 (P-GLUA1 Ser845) as well as changes in 
MSN dendritic morphology in Clock∆19 mice. Furthermore, diminished cross-frequency phase 
coupling of neural oscillations within the NAc and coherence with cortico-limbic regions during 
exploration of a novel environment have also been described in mutants (Dzirasa et al, 2010). NAc 
phase coupling is dependent upon glutamatergic signaling and computational models suggest that 
28  
altered AMPAR and NMDAR function can shift synaptic weights, disrupting the ability of 
MSNs to entrain to afferent input (Wolf et al, 2005). It has been proposed that this imbalance 
within accumbal circuitry can alter functioning of downstream target regions within the networks 
that regulate goal-directed behavior (Dzirasa et al, 2010). Given the increased dopaminergic tone 
of Clock∆19 mice, we hypothesized that there would be adaptations in NAc microcircuitry 
indicative of plasticity. 
Here we sought to investigate the effects of Clock gene disruption on excitatory drive onto 
NAc MSNs as well as the expression and rhythm of accumbal GLUA1 protein and intrinsic 
excitability of MSNs. While rhythms in DA, glutamate and GABA neurotransmission have been 
demonstrated in the NAc (Castañeda et al, 2004), ex vivo electrophysiological studies of diurnal 
activity in excitatory synaptic function have largely been limited. We therefore conducted our 
physiological and biochemical measures across the light/dark cycle. Additionally, we examined 
whether manipulation of GluA1 in the NAc could normalize aspects of the “manic-like” behavioral 
profile in Clock∆19 mice. 
 
 
 
2.2 MATERIALS AND METHODS 
 
 
2.2.1 Animal use 
 
 
Clock∆19 mice were created by N-ethyl-N-nitrosurea (ENU) mutagenesis, resulting in a dominant- 
negative CLOCK protein deficient in transcriptional activity (King et al, 1997). Clock mutant 
(Clock/Clock) and wildtype (+/+) littermates on a BALB/cJ and C57BL/6J mixed background 
were bred from heterozygote (Clock∆19 /+) pairs and group housed. Animals used in this study 
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were maintained on a BALB/cJ background. Male and female mutant and WT mice (6-9wks) were 
used for electrophysiological experiments and male mice (8-12wks) were used for biochemical 
and behavioral experiments. The use of younger mice for ease of electrophysiological studies was 
justified, as hyperactivity in response to novelty, a key manic-like feature of Clock∆19 mice was 
apparent within this age range (data not shown). Mice were maintained on a 12:12h light/dark 
cycle (ZT 0 = lights on 7:00AM; ZT 12 = lights off 7:00PM) or a reverse 12h light cycle for dark 
phase experiments. For 24hr time-series experiments, mice were group housed in temperature- 
controlled, soundproof cabinets with light cycles precisely regulated. Food and water were 
available ad libitum. All animal use was conducted in accordance with the National Institute of 
Health guidelines for the care and use of laboratory animals and approved by the Institutional 
Animal Care and Use Committee of the University of Pittsburgh. 
2.2.2 NAc slice preparation 
Clock mutant and wildtype mice were anesthetized rapidly with isoflurane and decapitated. Brains 
were removed into ice-cold oxygenated (95% O2/5% CO2) modified aCSF containing (in mM): 
135 N-methyl-D-glucamine, 1 KCl, 1.2 KH2PO4, 1.5 MgCl2, 0.5 CaCl2, 70 choline bicarbonate, 
and 10 D-glucose; pH 7.4 adjusted with HCL. NAc-containing coronal slices (250µm) were 
sectioned with a vibratome (VT1200S; Leica, Wetzlar, Germany) and incubated for 30 minutes at 
37°C in oxygenated aCSF containing (in mM): 119 NaCl, 26 NaHCO3, 2.5 KCl, 1 NaH2PO4, 2.5 
CaCl2, 1.3 MgCl2, 11 D-glucose. Slices were kept at room temperature until recording then 
perfused with aCSF (30-32°C). 
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2.2.3 Whole-cell patch-clamp recordings 
 
 
Slices were viewed by differential interference contrast (DIC) optics (Leica) and accumbal regions 
were localized under low magnification. Recordings were made under visual guidance with 40x 
objective. Borosilicate glass pipettes (3-5MΩ) were filled with (in mM): 117 Cs-MeSO3, 20 
HEPES, 0.4 EGTA, 2.8 NaCl, 5 TEA-Cl, 2.5 Mg-ATP, 0.25 Na-GTP, 5 QX-314; pH 7.3 adjusted 
with CsOH. Cells were voltage clamped at -70mV. For miniature EPSC (mEPSC) and current 
clamp recordings, a solution containing (in mM): 119 K-MeSO4, 2 KCl, 1 MgCl2, 1 EGTA, 0.1 
CaCl2, 10 HEPES, 2 Mg-ATP, 0.4 Na-GTP; pH 7.3 adjusted with KOH, was used interchangeably 
with no measured differences. A constant-current isolated stimulator (DS3; Digitimer) was used 
to stimulate excitatory afferents with a monopolar electrode to record evoked currents (eEPSCs). 
Single or paired pulses were generated using Clampex software (Molecular Devices, Sunnyvale, 
CA). Stimulus intensity was adjusted to generate currents with amplitude between 50 and 500pA. 
Cells with run-up or run-down of more than 15% were excluded from analysis, as were 
electrophysiologically identified interneurons. Picrotoxin (50µM, Sigma Aldrich) was included in 
the external perfusion aCSF to block GABAA receptors. TTX (1µM, Tocris, Bristol, UK) was used 
for mEPSC recordings. For EPSC experiments, D-APV (50µM, R&D Systems, Minneapolis, MN) 
was bath applied to block NMDARs at +40mV. In some experiments, D-APV was not applied and 
the peak amplitude of AMPAR current was measured at -70mV and the NMDAR peak amplitude 
taken at 40mV, 35ms from the AMPAR peak. Series resistance for all recordings was monitored 
continuously. 
 
Cells with a change in series resistance beyond 20% were excluded from data analysis. 
 
Synaptic currents were recorded with a MultiClamp 700B amplifier (Molecular Devices). Signals 
 were filtered at 2.6-3 kHz and amplified 10 times, then digitized at 20 kHz with a Digidata 1322A 
analog-to-digital converter (Molecular Devices). Miniature current recordings were analyzed 
using pClamp10 software (Molecular Devices) over a period of approximately 2.5 min during 
which 250-2500 events were collected. AMPAR/NMDAR ratios were determined by taking the 
average peak amplitude of EPSCs at 40mV in the absence or presence of D-APV (30 sweeps each) 
or at -70mV. For paired pulse experiments, a set of two pulses were delivered with an inter-pulse 
interval of 50-200ms and a minimum of 30 sweeps were recorded with the pulses delivered every 
10 seconds. For current clamp recordings, the resting membrane potential was adjusted after 
stabilization to -70mV with minimal current injection. A current step protocol from -200pA to 
+400pA (50pA increment) was applied for at least 5 runs to record evoked action potentials. 
 
 
2.2.4 Surface GLUA1 detection 
 
 
Experiments were performed using a modified version of a published protocol (Boudreau et al, 
2012). Single NAc tissue punches were rapidly micro-dissected using a stainless-steel stylet (1mm 
diameter) from 1 mm-thick coronal sections obtained from a mouse brain matrix. Punched tissue 
was consistently chopped with a surgical scalpel. NAc tissue was not pooled between mice. One 
hemisphere of tissue was immersed in ice-cold artificial CSF (aCSF) containing 2 mM 
Bis(sulfosuccinimidyl) suberate (BS3) (Pierce, Waltham, MA) and incubated for 30 min at 4°C on 
a rotator. Tissue from the other hemisphere was incubated in aCSF alone. The cross-linking 
reaction was quenched with 100 mM glycine in aCSF for 10 min at 4°C on a rotator. Samples were 
centrifuged for 2 min at 4°C. Supernatants were discarded and pellets washed once with aCSF. 
Samples were re-centrifuged, supernatants were discarded, and pellets were sonicated in ice-cold 
lysis buffer [0.1% NP-40 buffer in Tris-EDTA, pH 7.4, containing 1× protease inhibitor mixture 
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(Sigma-Aldrich, St. Louis, MO), 5 mm NaF, and 1× phosphatase inhibitor mixture (Sigma- 
Aldrich)]. Protein concentration was determined by DC assay (Bio-Rad, Hercules, CA) and 20 μg 
of protein was loaded on a 4–15% gradient Tris-HCl gel (Bio-Rad) and run at 100 V in 1X TGS 
buffer (Bio-Rad). Proteins were transferred onto PVDF membranes for 1.5 hrs at 500mA constant 
current in cold 1X TG buffer (Bio-Rad). Membranes were re-wet and blocked for 4hrs in Odyssey 
Blocking Buffer (LI-COR Biosciences, Lincoln, NE). They were further processed for GLUA1 
immunoblot analysis and probed with anti-mouse GAPDH (37kDa; 1:10000, Santa Cruz 
Biotechnology, Dallas, TX) and anti-rabbit GluA1 (106kDa; 1:500, Pierce). Following overnight 
primary incubation at 4°C, blots were incubated in fluorescent secondary antibodies including goat 
anti-rabbit 800 and goat anti-mouse 680 (1:400, LI-COR Biosciences). Blots were imaged using 
the LI-COR Odyssey system. Intensity of protein bands was normalized to GAPDH and surface 
protein levels were determined as the subtraction of the intracellular band intensity from the total 
band intensity (in arbitrary units). The surface-intracellular ratio was calculated from the obtained 
values. Rhythms and acrophase measures of GLUA1 expression were determined by multiple 
harmonic regression using CircWave v1.4 software available from circwave.org. Curves were fit 
to 2 sine waves and the center of gravity of each fitted waveform was used to determine acrophase. 
2.2.5 Viral gene transfer and stereotaxic surgery 
Stereotaxic surgery was performed as previously described (Ozburn & Falcon et al., 2015). 
Bilateral stereotaxic injections of 0.5µL of purified high titer AAV9 encoding GFP driven by the 
human synapsin promoter (control virus) or AAV9-hsyn-GluA1 were delivered into the NAc (from 
Bregma; angle 10°: AP +1.5mm, Lat. +1.5mm, DV -4.4mm). The efficiency of GluA1 
overexpression was confirmed by real-time RT-PCR from infected NAc tissue. Mice recovered 
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for 3 weeks allowing for full expression of the virus before behavioral testing. Following 
behavioral testing, the placement of viral injections was verified using immunohistochemical 
methods as described in the supplement. Use of AAV-Clock-shRNA virus has been previously 
described (Mukherjee et al, 2010). 
2.2.6 Immunohistochemistry 
Mice were perfused with 1x phosphate-buffered saline (PBS) followed by 4% paraformaldehyde 
in PBS (pH 7.4). Brains were post-fixed then transferred to 30% sucrose solution. Sections (30µm) 
were taken and processed for GFP and DAPI. Briefly, floating sections were rinsed 3 x with PBS 
to remove fixative then blocked for one hour in PBS containing 0.2% Triton-X and 5% Normal 
Donkey Serum (Jackson ImmunoResearch, West Grove, PA). Sections were incubated overnight 
at room temperature with a rabbit anti-GFP primary antibody (1:20,000; Abcam, Cambridge, UK) 
on a rotary shaker. The following day, sections were rinsed 3 x with in PBS and incubated with 
donkey anti-rabbit conjugated to a 488nm fluorophore (1:400; Invitrogen, Carlsbad, CA) for two 
hours at room temperature on a rotary shaker. Following a final wash in PBS, sections were 
mounted and coverslipped with DAPI mounting medium (Vector Labs, Burlingame, CA) and 
imaged at 4x magnification on a fluorescent microscope (Olympus, Center Valley,PA). 
2.2.7 Animal behavior 
Animals habituated to testing rooms for at least 30 minutes prior to behavioral testing. Animals 
were tested early in the light phase between ZT0-ZT4. To test locomotor response to novelty, mice 
were placed inside automated locomotor activity chambers equipped with infrared photobeams 
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(San Diego Instruments, San Diego, CA) to measure activity. Data were collected continuously 
for 90 minutes and analyzed in 5-minute time bins. Elevated Plus Maze (EPM) was performed in 
a dimly lit room (~15 Lux at each open arm). Mice were placed in the center of the maze and both 
the number of entries into the open and closed arms and the total time spent in the open arms (in 
seconds) were manually recorded over a 10-minute period. A biased protocol was used to assess 
cocaine conditioned place preference (CPP). On the pre-test day, mice were allowed to explore all 
chambers of the place-conditioning apparatus for 20 minutes to determine inherent bias. On 
conditioning days 1 and 3, mice were given a saline injection (i.p.) paired with the preferred 
chamber of the apparatus, and on days 2 and 4, they received a cocaine injection (5mg/kg; i.p.) 
paired with the non-preferred chamber. Conditioning sessions lasted 20 minutes. Following 
conditioning, on day 6, mice were tested again for time spent on either side of the apparatus and 
the CPP score was calculated by subtracting the pre-conditioning time spent in the cocaine-paired 
side from the time spent in the cocaine-paired side on the test day. Data from mice that spent a 
majority of time in the center of the apparatus were eliminated fromanalysis. 
2.2.8 Real-time Polymerase Chain Reaction 
Primers used for qPCR: GluA1 Fwd: 5’ – ACCCTCCATGTGATCGAAATG-3’; GluA1 Rev: 5’- 
GGTTCTATTCTGGACGCTTGAG-3’; Gapdh Fwd: 5’-CTTTGTCAAGCTCATTTCCTGG-3’; 
Gapdh Rev: 5’-TCTTGCTCAGTGTCCTTGC-3’. Micro-dissected NAc tissue punches were 
homogenized both mechanically and by QIAshredder homogenization spin-column (Qiagen, 
Hilden, Germany). Total RNA was isolated using the RNeasy Plus Micro Kit (Qiagen) as per 
manufacturer guidelines. gDNA was eliminated with the provided gDNA Eliminator column. 
RNA concentration and quality was determined using NanoDrop 2000 UV-Vis spectrophotometer 
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(Thermo Fisher Scientific, Waltham, MA). cDNA was synthesized from 100ng total RNA using 
SuperScript VILO Master Mix (Invitrogen). Relative gene expression was measured by qPCR with 
1ng of cDNA mixed with Power SYBR Green PCR Master Mix (Thermo Fisher Scientific) and 
primers listed above. Reactions were run in duplicate in an Applied Biosystems 7900HT Fast Real- 
time PCR System (Applied Biosystems, Foster City, CA). Relative gene expression was calculated 
using the comparative Ct (2^∆∆Ct) method (Landgraf et al, 2014) and normalized to each sample’s 
corresponding Gapdh mRNA levels. 
2.2.9 Data analysis 
Electrophysiological, biochemical and behavioral experiments were conducted blind to genotype. 
Significant differences were determined by Student’s t-Test, one-way ANOVA or two-way 
ANOVA followed by Bonferroni post hoc tests. P<0.05 is considered significant for all analyses. 
All data are presented as mean ± SEM. 
2.3 RESULTS 
2.3.1 Clock∆19 mice have reduced AMPAR-mediated synaptic transmission and strength 
at NAc MSNs throughout the light/dark cycle 
Our results indicate that there is a significant reduction in glutamatergic synaptic transmission in 
Clock mutant MSNs compared with WT across the L/D cycle as indicated by reduced amplitude 
of AMPAR-mediated miniature  excitatory  postsynaptic  currents  (mEPSCs)  (F(1,76) = 16.43, 
36 
P=0.0001 genotype effect). We found a significant main effect of phase in mEPSC amplitude as 
well indicating that perhaps this particular measure has diurnal variability (F(1,76) = 6.615, 
P=0.0121 phase effect) (figure 5c). 
Figure 5. Clock∆19 mutation modifies MSN AMPAR-mediated synaptic transmission across the light/dark 
cycle. (A) Recording sites within the NAc from slices collected during light and dark phases (WT – black; Clock∆19 
– red; ZT = Zeitgeber time; CPu = caudate putamen; NAcc = NAc core; NAcSh = NAc shell). (B) Representative
traces of mEPSCs recorded at -70mV in the presence of 1uM TTX. (C) Summary of mEPSC amplitude of mutant and 
WT MSNs at both phases (n = cells/animals; all data in bar graphs are presented as mean ± SEM). (D) Plot of 
cumulative probability of all mEPSC amplitudes across phases. *P < 0.05; **P < 0.01; ***P < 0.001 in this and all 
subsequent figures. 
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Many studies have shown that signaling in core and shell sub-regions of the NAc can mediate 
affective valence and motivational behavior in a distinct manner (Faure et al, 2010; Meredith et 
al, 2008). However, when we further analyzed our mEPSC amplitude data by regional location no 
significant difference in NAc core versus shell neurons was observed during the light (F(1,37) = 
9.205, P=0.0044 genotype effect; F(1,37) = 0.0001, P=0.9910 region effect) or the dark (F(1,34) = 
6.715 P=0.0140 genotype effect; F(1,34)= 0.0491, P=0.8259 subregion effect) (figure 6a-b). 
 
 
 
 
 
 
Figure 6. Clock∆19 MSNs show reduced glutamatergic transmission in both core and shell subregions of the 
NAc. (A) Summary of mEPSC amplitude of WT and mutant NAc core and shell MSNs during the light phase. (B) 
Amplitude of mEPSCs in core and shell subregions during the dark phase. 
 
 
When calculating AMPAR/NMDAR ratio of evoked EPSCs, a measure of excitatory 
synaptic strength, there was a significant reduction in A/N of MSNs in Clock∆19 mutants 
consistent across the L/D cycle (F(1,44) = 11.53, P=0.0015 genotype effect; F(1,44) = 0.1237, 
P=0.7267 phase effect) (figure 7b) and no change in the decay kinetics of the evoked NMDA 
current indicating that subunit stoichiometry of these receptors was not altered in mutants (F(1,39) 
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= 0.1936, P=0.6624 genotype effect; F(1,39) = 2.013, P=0.1639 phase effect). Additionally, we 
failed to observe an effect of genotype or phase on the CV analysis of NMDAR EPSCs relative to 
AMPAR EPSCs, a measure directly correlated with the proportion of silent synapses, which lack 
functional AMPARs (F(1,29) = 0.0944, P=0.7609 genotype effect; F(1,29) = 0.4760, P=0.4957 phase 
effect) (figure 7c-f). This result indicates that the reduced functionality of AMPAR-mediated 
activity at mutant MSNs likely does not occur through a complete silencing of synapses. 
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Figure. 7. AMPAR-mediated synaptic strength of MSNs is reduced by the Clock∆19 mutation. (A) 
Representative traces of evoked AMPAR and NMDAR-mediated EPSCs at 40mV. (B) Ratio of the peak amplitude 
of the AMPAR EPSC to the NMDAR EPSC for each group of MSNs. (C) Representative traces of NMDAR-mediated 
EPSCs in the light phase (WT- black, Clock∆19 – red) and dark phase (WT- dark grey, Clock∆19 – light grey) MSNs. 
(D) Summary of NMDAR EPSC decay kinetics. (E) Sample plot of AMPAR EPSC amplitudes at -70mV and
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NMDAR EPSCs at 40mV from light phase WT and mutant MSNs. (F) Summary of ratio of 1/CV2 NMDAR EPSCs 
to 1/CV2 AMPAR EPSCs from mutant and WT MSNs during both phases. 
2.3.2 Presynaptic release of glutamate onto NAc MSNs is unaltered in Clock mutants 
throughout the light/dark cycle 
We further analyzed the frequency of mEPSCs as a measure of quantal release probability of 
glutamate at NAc MSNs in mutant and WT slices. Here, we found no significant difference 
between groups or by diurnal phase (F(1,72)= 0.06752, P=0.7957 genotype effect; F(1, 72)= 0.04288, 
P=0.8365 phase effect) (fig 8a-b). Another standard measure of transmitter release probability at 
excitatory synapses is the paired pulse ratio (PPR), which is comprised of the peak amplitude of 
the 2nd of a series of evoked EPSCs to the 1st. The PPR is inversely related to release probability. 
We determined the PPR at three different inter-pulse intervals and observed no significant 
difference between mutant and WT groups during either diurnal phase (F(3, 25)= 0.1803, P=0.9088 
genotype effect; F(3, 25)= 9.531, P=0.0003 interval effect) (figure 8c-d). These results indicate that 
synapse number or presynaptic release of glutamate onto MSNs remain unchanged with Clock 
gene disruption and wildtype animals do not show diurnal variability in these measures. 
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Figure 8. Clock∆19 mutation does not alter the presynaptic release of glutamate onto NAc MSNs. (A) Frequency 
of AMPAR mEPSCs recorded from mutant and WT MSNs at light and dark phases. (B) Cumulative probability of 
inter-event intervals (IEI) of all recorded mEPSCs. (C) Sample traces of pairs of evoked AMPAR EPSCs at -70mV at 
varying inter-stimulus intervals. (D) Paired-pulse ratio (PPR) calculated as peak amplitude of the second EPSC to the 
first plotted across inter-stimulus interval. 
2.3.3 Membrane levels and rhythm of GLUA1 protein are reduced in the NAc of 
Clock∆19 mice 
In order to investigate the molecular basis for the deficiency in excitatory drive onto MSNs seen 
in Clock mutant accumbens, we measured the protein expression of the AMPAR subunit, GLUA1, 
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across the light/dark cycle. Previously, we have shown reduced total and phosphorylated protein 
levels of this particular subunit in mutant NAc during the day (Dzirasa et al, 2010). These results 
indicate a potential deficiency in the translation or trafficking of AMPARs that may underlie 
microcircuit-level and physiological dysfunction. Here we used BS3 crosslinking to isolate 
membrane-bound and intracellular fractions of GLUA1. The inherent smearing of crosslinking to 
detect multi-protein complexes made it difficult to resolve a clear multimer band and we therefore 
quantified the reduction of the monomer instead to calculate the amount of surface expressed 
GLUA1-containing AMPA receptors. We found a significant reduction in the surface/intracellular 
(S/I) ratio of GLUA1 normalized to GAPDH at ZT6 and ZT18 in mutant NAc which corresponded 
closely with our recording times (F(1, 20) = 17.67, P=0.0004 genotype effect; F(1, 20) = 0.8999, 
P=0.3541 phase effect) (figure 9). These results suggest that reduction in CLOCK protein function 
may affect the ability of GLUA1-containing AMPARs to be inserted into the membrane for 
proper excitatory signaling and this deficit appears during both the light and dark phases. 
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Figure 9. The surface/intracellular ratio of GLUA1 expression is significantly reduced in Clock∆19 NAc 
during the light and dark phases. Crosslinked and non-crosslinked NAc tissue from mutant and WT animals 
allowed for the quantification of total and intracellular protein levels of GLUA1. Surface protein levels were 
inferred by the subtraction of intracellular protein from total protein. Clock∆19 mice have significantly reduced S/I 
ratio of GLUA1 compared with WT littermates at ZT6 and ZT18. Representative bands are shown below. Band 
intensity was normalized to GAPDH and presented as arbitrary units. 
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Furthermore, we tested for a rhythm in GLUA1 total protein and S/I ratio in WT and mutant 
NAc. Our measurements at 6 time points across 24 hours allowed us to apply multiple harmonic 
regression to detect a significant diurnal rhythm in WT GLUA1, with a bimodal pattern peaking 
at the midpoint of the light and dark cycles (P < 0.0001). A rhythm with similar pattern was also 
detected in the S/I ratio in WT NAc (P < 0.001). In mutant accumbens however, we were unable 
to curve fit the total and surface GLUA1 data indicating a lack of significant rhythm (figure 10a- 
b). Additionally, when we analyzed whether Clock mutants have a shift in the expression pattern 
of GLUA1, we found that indeed the acrophase, or estimation of circadian phase corresponding to 
the peak of the rhythm, was significantly advanced in mutants for both the total protein and S/I 
ratio (P < 0.05) (figure 10c). These results suggest that a biochemical basis contributing to 
excitatory drive onto MSNs is profoundly affected by a lack of proper CLOCK proteinfunction. 
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Figure 10. A diurnal rhythm in GLUA1 expression in the NAc is abolished in ClockΔ19 mice. (A) The diurnal 
rhythm of total protein levels of GLUA1 across 6 time points, normalized to GAPDH expression in mutant and WT 
NAc tissue. A significant curve fit was found in WT but not in mutant data (bars below represent light and dark 
phases). (B) Rhythmic profile of the GLUA1 S/I ratio in WT and mutant across the light/dark cycle showing a loss of 
significant rhythm in mutant NAc. (C) Acrophase of diurnal expression rhythms of total GLUA1 and S/I ratio in 
mutant and WT accumbens. Acrophase measures were derived from the center of gravity of the fitted harmonic curves 
(+SEM). n = 5-9 mice for allgroups. 
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2.3.4 Clock mutant MSNs display subtle alterations in intrinsic membrane properties 
 
 
The functional output of MSNs is dependent upon the integration of synaptic inputs and the 
membrane excitability inherent to the cells. In order to assess the effects of the Clock∆19 mutation 
on MSN functional output, we examined various parameters related to the intrinsic membrane 
excitability of these cells. We first measured the evoked firing rate of MSNs in response to current 
injection steps ranging from 100-400pA. While we did not observe a significant difference in spike 
number between genotypes, interestingly, we saw a robust difference in excitability at the different 
phases with a highly increased firing rate during the dark cycle (figure 11a-b). When collapsing 
across genotype we detected significant differences by phase and current injection (F(3, 39)= 48.87, 
P < 0.0001 phase effect; F(6, 234) = 699.8, P < 0.0001 current effect). Relatively few studies have 
conducted diurnal ex vivo measurements of neuronal activity in extra-SCN regions; therefore, the 
presence of a variable intrinsic excitability profile of NAc MSNs is noteworthy. A number of 
potential mechanisms could underlie this variability, including Clock-regulated fluctuations in the 
activity of potassium conductances responsible for MSN bi-stable excitability (Shen et al, 2004; 
Vilchis et al, 2000; Wickens and Wilson, 1998). 
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Figure 11. Excitability of MSNs is unaltered by Clock∆19 mutation however diurnal variation exists in 
evoked firing rates. (A) Representative traces of action potential firing in response to current injection from 
mutant and WT MSNs during the light phase. (B) Input-output curve of spikes with varying current steps during 
both phases in both groups. 
 
 
We further analyzed several intrinsic membrane properties of MSNs in mutant and WT 
slices across the light/dark cycle, including the resting membrane potential (RMP) at break-in, 
the rheobase or minimum current needed to elicit   action potential (AP) generation, and the    AP 
threshold (Table 2). In these measures, we saw a significantly lower RMP of Clock mutant MSNs 
compared with WT during the light phase (t(27) = 2.218, P = 0.0352) and the dark phase (t(14) = 
2.756, P = 0.0155). This suggests that mutant MSNs may rest at a more hyperpolarized 
membrane potential at baseline and require greater stimulation to enter the “up-state”. We did not 
find a significant difference in the rheobase during the light phase (t(27) = 0.4907, P = 0.6267) or 
dark phase (t(15) = 0.4971, P = 0.6264). AP threshold was similar during the light phase (t(17) = 
0.9113, P = 0.3794) however was lower in mutant MSNs during the dark phase (t(14) = 2.322, P = 
0.0358). Together, these results suggest that a reduction in CLOCK protein function 
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does not affect the intrinsic membrane excitability of MSNs, however a lowered resting 
membrane potential may indicate a more subtle effect on excitability. 
 
 
Table 2. Intrinsic membrane properties of Clock mutant and WT MSNs during light and dark phases. 
Additional properties of membrane excitability of MSNs were examined in Clock∆19 and WT cells including resting 
membrane potential at break-in, (RMP), rheobase and action potential (AP) threshold. 
 
 
 
 
 
 
 
 
 
 
2.3.5 Overexpression of GluA1 in the NAc normalizes “manic-like” behavior in Clock∆19 
mice 
 
Finally, we sought to determine whether up-regulation of functional GluA1 expression in 
Clock∆19 NAc could rescue their abnormal exploratory drive and reward sensitivity. We injected 
AAV9-hsyn-GluA1 or AAV9-hsyn-GFP bilaterally into the accumbens of adult male mutant and 
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WT mice and allowed 3 weeks for recovery and full expression. Our manipulation resulted in a 
roughly 3-fold increase in GluA1 transcript levels as determined by qPCR (figure 12a-c) and a 
potentiation of MSN excitatory synapses as measured by AMPAR/NMDAR ratio (P = 0.0036) 
(figure 12d-e). 
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Figure 12. Functional up-regulation of GluA1 in the NAc of Clock∆19 mice. (A) Timeline of experimental 
procedures testing the effect of AAV9-hsyn-GluA1 or AAV9-hsyn-GFP expression on exploratory drive and 
conditioned reward behavior. (B) Bilateral localization of viral injections to the NAc (left) and GFP expression (right). 
(C) Accumbal GluA1 transcript levels following viral overexpression compared with GFP expression in Clock
mutants. (D) Representative traces of AMPAR EPSCs (at -70mV) and NMDAR EPSCs (at 40mV) in GFP-expressing 
(black) and GluA1-overexpressing cells (red). (E) AMPAR/NMDAR ratio of evoked EPSCs from virally-infected 
cells. LV- lateral ventricle; AC – anterior commissure; NAcc – nucleus accumbens core; NAcSh – nucleus accumbens 
shell. 
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Similar to lithium treatment (Roybal et al, 2007) overexpression of GluA1 in Clock mutant mice 
did not alter the failure to habituate to a novel environment that was seen in GFP-expressing mutant 
mice. As expected, WT control groups showed faster locomotor habituation in this assay (F(17, 816) 
= 83.17, P < 0.0001 time effect; F(3, 48)= 3.522, P = 0.0218 treatment effect) (figure 13a). However, 
comparable to previous studies, we saw that mutant mice expressing GFP had a significantly 
higher proportion of open arm entries compared with WT GFP-expressing mice in the elevated 
plus maze (F(1, 54) = 6.427, P = 0.0142 genotype effect) and similar to lithium treatment, several 
weeks of NAc-specific GluA1 overexpression in mutants resulted in a significant reduction in open 
arm entries compared with GFP expression (F(1, 54) = 0.9928, P = 0.3235 treatment effect; F(1, 54) = 
6.009, P = 0.0175 interaction; Bonferroni’s multiple comparison’s test: *P < 0.05, ***P < 0.001). 
Open arm entries were normalized to total crosses in the apparatus (figure 13c). Additionally, total 
time spent in the open arms of the EPM was decreased to near WT levels with GluA1 up-regulation 
in mutant NAc (F(1, 54)= 1.498, P = 0.2262 treatment effect; F(1, 54)= 7.989, P = 0.0066 interaction; 
Bonferroni’s multiple comparison’s test: **P < 0.01, ***P < 0.001). As expected, GFP expressing 
mutant mice displayed increased time in the open arms compared with WT controls (F(1, 54)= 8.057, 
P = 0.0064 genotype effect) (figure 13b). 
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Figure 13. Overexpression of GluA1 in the accumbens of Clock∆19 mice reverses elevated exploratory drive 
behavior. (A) Locomotor activity in a novel environment of mutant and WT animals. (B) Total time spent in the open 
arms of the EPM during 10 min of testing. (C) Percent open arm entries in the EPM normalized to total crosses. 
 
 
 
 
To determine whether GLUA1-mediated signaling is important for the effects of Clock gene 
disruption on behavioral measures associated with cocaine reward sensitivity, we performed 
cocaine conditioned place preference (CPP) (figure 14a). Using a dose of 5mg/kg cocaine, which 
has been shown to increase preference in Clock mutant mice compared with WT littermates 
(McClung et al, 2005), we demonstrated a reliably elevated CPP score in GFP-expressing mutants 
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compared with WT controls (F(1, 53)= 2.514, P = 01188 genotype effect; F(1, 53)= 1.817, P = 01834 
treatment effect; F(1, 53) = 22.78, P < 0.0001 interaction; Bonferroni’s multiple comparison’s test: 
*P < 0.05, ***P < 0.001). GluA1 overexpression in Clock mutants was able to normalize 
conditioned place preference to WT levels. Interestingly, we also observed a marked increase in 
place preference in WT mice with GluA1 up-regulation (figure 14b). 
 
 
Figure 14. Cocaine sensitivity is normalized following GluA1 up-regulation in Clock∆19. (A) Schematic of 3- 
chambered CPP testing apparatus and timeline of conditioning experiment. (B) Cocaine CPP scores of all experimental 
groups following a biased conditioningparadigm. 
54  
2.4 DISCUSSION 
 
 
The current study demonstrates that a disruption in CLOCK protein function produces 
significantly reduced excitatory drive onto medium spiny neurons of the nucleus accumbens. We 
found that both the amplitude of AMPAR-mediated spontaneous currents as well as the ratio of 
AMPAR/NMDAR evoked currents was decreased across the day. This deficit in glutamatergic 
transmission does not appear to occur through silent synapse generation. Adaptations at mutant 
MSN excitatory synapses are likely postsynaptic as we found no alterations in presynaptic release 
properties. Additionally, the Clock mutation abolished a normal bimodal rhythm in GLUA1 
protein expression and advanced the acrophase of the rhythm. In a previous study we reported a 
significant decrease in both total and phosphorylated GLUA1 protein levels in mutant NAc during 
the day with no changes in the expression of GLUA2, GLUN1, GLUN2A or GLUN2B subunits 
(Dzirasa et al, 2010). These results were suggestive of a potential deficit in the translation or 
trafficking of GLUA1-containing AMPARs to NAc synapses. Here we demonstrate that indeed, 
membrane-bound GLUA1 levels are lowered by Clock mutation and this adaptation persists across 
light and dark phases. Therefore, this suggests that functional impairments in glutamatergic 
transmission and strength of mutant MSNs are a result of reduced synaptic GLUA1-containing 
AMPARs. Increased activity of VTA dopamine neurons and elevated extracellular dopamine 
levels are likely an indirect cause for these abnormalities in Clock∆19 accumbens neurons. The 
modulatory function of dopamine on NAc glutamatergic activity is characterized in studies in 
which drugs of abuse act to elevate dopamine levels. Chronic cocaine administration, for instance, 
leads to an up-regulation of surface expressed GLUA1 (Boudreau and Wolf, 2005; Conrad et al, 
2008; Lüscher and Malenka, 2011). Importantly, the plastic changes induced by chronic cocaine 
are not recapitulated in our model of hyperdopaminergia, implying that the effects we observe are 
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likely a compensatory response to a state in which dopaminergic activity is continually elevated. 
Additionally, the manner in which cocaine and dopamine influence both synaptic and intrinsic 
properties of MSN activity through differential signaling mechanisms has been empirically and 
theoretically examined (Moyer et al, 2007; Mu et al, 2010). Modulatory effects of dopamine are 
thought to differ based upon the specific dopamine receptor expression of MSNs. One limitation 
of our study is that we were unable to determine the cellular identity of MSNs in Clock mutant 
slices. We have previously reported an imbalance in D1R and D2R-mediated signaling in the 
striatum of mutants whereby there is a shift towards increased expression and binding activity of 
D2Rs (Spencer et al, 2012). Therefore, it is possible that these changes are occurring more 
frequently in particular neuronal pathways (i.e. direct versus indirect). When we investigated the 
intrinsic excitability of mutant and WT MSNs we found that they had similar firing however MSN 
excitability was significantly elevated during the dark phase. Rhythmicity in a number of ionic 
mechanisms could underlie this interesting effect. Diurnal variations in resting membrane 
potential, calcium currents, potassium conductances and in vitro firing patterns have been reported 
in midline thalamic neurons. Activity of these neurons is also elevated during the night phase 
(Kolaj et al, 2012). 
As a critical site of integration of limbic and sensorimotor information for gating of salient 
stimuli, the accumbens is important for maintaining proper mood and reward responses. Clock∆19 
mice display abnormal anxiety and depressive-like behaviors and robustly elevated sensitivity to 
a variety of rewarding substances. Restoration of functional CLOCK in the VTA and treatment 
with dopamine depleting pharmacological agents are able to normalize many aspects of the mutant 
manic-like phenotype (Roybal et al, 2007; Sidor et al, 2015). Disruption of glutamate receptor 
expression in the striatum however,  has  also  been  linked  with  neuropsychiatric  illness and 
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increased dopaminergic transmission. Wiedholz and colleagues have characterized a number of 
impairments in GluA1 knockout mice relevant to symptoms of schizophrenia including 
hyperactivity and reduced striatal clearance of extracellular dopamine (Wiedholz et al, 2008). A 
number of other preclinical models describing perturbations in glutamatergic transmission have 
also been likened to features of clinical BD including GluN2A deletion and GluR6 subunit 
knockout (Boyce-Rustay and Holmes, 2006; Shaltiel et al, 2008). Here, we have demonstrated 
that restoring functional expression of GLUA1-containing AMPARs to the accumbens is sufficient 
to normalize the increased exploratory behavior in Clock mutants. It will be interesting in future 
studies to determine whether GLUA1 overexpression can normalize accumbal phase signaling 
deficits in mutants as well. Up-regulation of GLUA1 in the NAc also reduced cocaine reward 
sensitivity in mutants. Interestingly, we observed robust increase in preference in WT animals in 
which GLUA1 was overexpressed. This was a surprising result given that Bachtell and colleagues 
have demonstrated diminished sensitization and decreased cocaine seeking in extinction and 
reinstatement following overexpression of GluA1 in the accumbens of wildtype rats (Bachtell et 
al, 2008). However, the specific mode of up-regulation in these studies varied from our own, in 
which long-term overexpression may have altered accumbal network activity in a more 
pronounced manner. 
 
Interestingly, the physiological, behavioral and biochemical changes that we find in the 
nucleus accumbens of the Clock mutant mice do not seem to be due to direct transcriptional 
mechanisms in these neurons but rather are tied to dysfunctional circuit dynamics. We have 
previously reported that a viral-mediated knockdown of CLOCK in the NAc does not affect 
locomotor activity, anxiety-like behavior or cocaine CPP (Ozburn et al, 2015) and we find here 
that it does not alter the amplitude (F(2, 53) = 4.545, P = 0.0151 treatment effect, Bonferroni’s 
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multiple comparison’s test: *P < 0.05) and frequency of AMPAR-mediated mEPSCs in MSNs 
(F(2, 50)  = 0.7478, P = 0.4786 treatment effect) (figure 15a-b). 
 
 
 
 
 
 
Figure 15. Knockdown of Clock in the NAc of WT mice does not alter excitatory transmission. (A) Summary of 
mEPSC amplitude in MSNs expressing AAV-Clock-shRNA. Compared with WT and mutant MSNs (B) Frequency 
of mEPSCs from allgroups. 
 
 
 
 
Together, these results support a model whereby diminished CLOCK function increases 
dopaminergic activity and tone, altering excitatory drive onto MSNs, most likely as a 
compensatory mechanism. This may reduce the functional output of the accumbens in feedback 
dynamics onto the VTA or disinhibit other target regions leading to the elevation of mood, 
exploratory drive and reward-seeking behavior. 
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Figure 16. Proposed model of the effects of the Clock∆19 mutation on NAc MSN activity. CLOCK disruption 
leads to an elevation of dopamine synthesis and extracellular dopamine (DA) in the accumbens. Previous studies from 
our lab have revealed that Clock∆19 mice have altered striatal DA receptor expression and activity with a shift in the 
D1:D2 ratio favoring D2 signaling. We have now also demonstrated that GluA1-mediated AMPAR expression is 
reduced at MSN synapses, potentially affecting the output of these GABAergic neurons, which project back to the 
VTA as well as the ventral pallidum. Disinhibition of these targets may produce mood elevationand reward seeking. 
 
 
 
 
2.5 FUTURE DIRECTIONS 
 
 
While we have uncovered valuable information regarding specific deficits in nucleus accumbens 
excitatory signaling that may have important consequences for the functioning of this critical brain 
region in mania-like behavior, a few outstanding questions remain to be investigated further. 
Clock∆19 mutant mice represent a model of bipolar mania with face, construct and predictive 
validity and their circadian rhythm dysfunction resembles rhythm disturbances seen in bipolar 
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patients. This is further underscored by a recent discovery from our group that these mice undergo 
rapid diurnal mood cycling from a daytime manic-like state to a nighttime euthymic condition 
characterized by normal mood behavior (Sidor et al, 2015). Rhythms in the neural activity of VTA 
dopamine cells as well as the expression and promoter binding of tyrosine hydroxylase by CLOCK 
point to a strong basis for diurnal variability in reward-related mechanisms in the mesolimbic 
system, which are disrupted by a dysfunctional CLOCK. Importantly, reduction of dopamine 
synthesis by the TH inhibitor, AMPT, reversed manic-like behavior specifically in the daytime 
when DA activity was high in mutants (Sidor et al, 2015). Here we have found additional diurnal 
differences in glutamatergic receptor expression and function in the NAc of mutant animals and 
have shown that we can rescue behavior with a viral-mediated approach to restore glutamatergic 
function. However, we only conducted measurements of exploratory drive and reward sensitivity 
behavior during the light phase. Our results show that excitatory synaptic transmission at MSNs 
was similarly reduced during both diurnal phases in mutants, as was GluA1 surface protein 
expression and the resting membrane potential of MSNs. Therefore, it will be important to follow 
up our findings with behavioral measurements in the dark phase to try to better link these 
mechanistic changes. We are in the process of conducting these experiments and hope to provide 
a more comprehensive profile of the role of GluA1 in Clock∆19 manic-likebehavior. 
To understand the effects of CLOCK disruption on intrinsic excitability of MSNs, we 
measured a number of membrane properties and found that while the firing rate of MSNs was 
increased in the dark phase to a similar extent in both WT and mutants compared to the light phase, 
AP threshold was also slightly increased in mutant cells during the dark phase. In order to reconcile 
these results, it will be important to try to characterize the passive membrane properties of the 
neurons as well. An increase in input resistance or a change in the membrane capacitance could 
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explain the differential excitability of the neurons across the light/dark cycle. A decreased rheobase 
during the dark phase could be a result of increased input resistance. Because hyperpolarizing 
current steps were included in our current clamp protocol, input resistance can be calculated by 
measuring the amplitude of the membrane potential change from baseline divided by the absolute 
value of the current injection. Additionally, more subtle properties of the individual action 
potentials in the evoked spike trains could provide information about potential differences in ionic 
mechanisms underlying MSN excitability. Cocaine is known to decrease membrane excitability of 
NAc shell MSNs in part through the up-regulation of SK-type calcium-activated potassium 
channels (Mu et al, 2010). Measuring the medium and fast components of the after- 
hyperpolarization of spikes would enable us to determine whether these ion channels are 
differentially regulated in the hyperdopaminergic Clock mutants. 
Another important question that has arisen from our results is the extent to which GluA1 
overexpression affects synaptic transmission and strength in WT MSNs. We confirmed that the 
overexpression was able to potentiate excitatory synapses in Clock mutant MSNs suggesting that 
this is the mechanism by which it may restore normal behavior, however we did not perform the 
requisite measure in WTs. This would be especially important because an up-regulation of GluA1 
in WT NAc led to a pronounced increase in cocaine CPP compared with GFP expression. This 
was a surprising result as another study of GluA1 overexpression in the NAc of WT rats 
demonstrated a decrease in cocaine seeking, particularly during extinction and cocaine-induced 
reinstatement with no effect on acquisition of self-administration. The passive administration of 
cocaine in the CPP paradigm differs from the active motivation to self-administer, which is 
influenced by emotional factors as well as the pharmacological properties of the drug itself in 
promoting a behavioral reward response (Prus et al, 2009). A single manipulation is capable of 
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driving behavior in these two reward-related measures in opposing directions. NAc overexpression 
of the cAMP responsive element binding protein (CREB), for instance, reduces cocaine CPP but 
increases self-administration (Larson et al, 2011). It may be possible that while in mutant animals, 
GluA1 overexpression restores balance to MSN circuitry, an up-regulation of the protein in WT 
animals could further unbalance the circuit by elevating receptor expression to a non-physiological 
range. Furthermore, the specific complement of GluA1-containing AMPARs that are inserted into 
the membrane of MSN synapses following viral overexpression is unknown. AMPARs can exist 
as homomers of GluA1 subunits or heteromers with GluA1 and most commonly, GluA2 subunits. 
GluA2-lacking AMPARs have the unique property of being calcium-permeable (CP-AMPARs) 
and these particular receptors are dynamically altered during drug-induced synaptic plasticity in 
the accumbens (Conrad et al, 2008). We can test for the presence of GluA2-containing AMPARs 
by measuring evoked currents with local application of the CP-AMPAR selective antagonist, 
NASPM. If these receptors are present, a percentage of the synaptic response would be blocked 
by NASPM. Moreover, it is possible that the cocaine conditioning protocol, while acute (2 days 
of 5mg/kg i.p. injections), is able to alter CP-AMPAR expression in the accumbens of WT mice 
overexpressing GluA1. To test this, we could also record from infected MSNs after mice have 
been exposed to a similar cocaine regimen. 
Lastly, we hypothesize that the effects of the Clock∆19 mutation on glutamatergic function 
in the NAc are a compensatory mechanism indicative of homeostatic plasticity in response to a 
state of constitutively elevated dopaminergic tone. Given the increased levels of DA and DA 
metabolites measured in the NAc of Clock mutants and the fact that CLOCK knockdown in the 
NAc does not alter excitatory synaptic transmission or anxiety and reward-related behavior, we 
believe it is likely that the VTA-NAc projection is necessary for the physiological and behavioral 
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abnormalities seen in mutants. Because VTA DA projections also target the prefrontal cortex 
which sends a dense glutamatergic input the NAc, there is a possibility that activation of this circuit 
is preferentially contributing to manic-like behavior and plasticity at NAc MSNs. Optogenetic 
tools allow for the dissection of neural circuits thought to be involved in mood and reward 
processing in order to assess the exact contribution of each to behavior and physiology (Lenz et 
al, 2013). In order to definitively address the question of whether local transcriptional activity of 
CLOCK or indirect circuit-level alterations are more important for NAc plasticity, VTA terminals 
within the NAc could be selectively inhibited with opsins. Sidor and colleagues have demonstrated 
that chronic optic stimulation of VTA DA neurons produced a manic-like phenotype in TH::Cre 
mice that persisted for up to 2 weeks following the end of stimulation, we anticipate that chronic 
inhibition of the VTA-NAc pathway would reverse abnormal mood and reward behavior seen in 
mutants (Sidor et al, 2015). Optical inhibition has been shown to be capable of suppressing 
dopamine transients that result from actions at both DA cell bodies and terminals and which play 
a key role in the behavioral response to rewarding substances (McCutcheon et al, 2014). 
The results of our study are significant because they contribute to a growing body of new 
studies indicating the involvement of disrupted clock gene function in neuropsychiatric disorders 
including bipolar disorder. Our understanding of the consequences of defective clock genes on the 
synapse and circuit level within mesolimbic brain regions is quite limited. Continued research in 
this direction is therefore very important in order to establish causal mechanisms and inform 
therapeutic strategies. 
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3.0 CELL-TYPE SPECIFIC EFFECTS OF NPAS2 DISRUPTION ONACCUMBAL 
SYNAPTIC PLASTICITY AND COCAINE SENSITIVITY 
The core circadian gene, Npas2, has been associated with neuropsychiatric illnesses including 
bipolar disorder (BP) and is known to regulate the reward value of drugs of abuse. NPAS2 
expression is especially enriched in the forebrain including the nucleus accumbens (NAc), a region 
critical for reward processing and the generation of motivated behavior. Furthermore, its 
expression appears to be restricted primarily to D1R-containing “direct pathway” medium spiny 
neurons (MSNs). We have previously demonstrated that a down-regulation of NPAS2 in the NAc 
decreases the conditioned response to cocaine in mice. Here we sought to further investigate the 
underlying mechanisms of NPAS2 disruption on accumbal synaptic activity, structural plasticity 
and reward sensitivity in a cell-type specific manner. Viral-mediated knockdown of NPAS2 in the 
NAc resulted in an increase in excitatory drive onto MSNs. Preliminary results also suggest that 
NPAS2 reduction prevents the cocaine-induced up-regulation of spines on secondary dendrites of 
MSNs. Using Drd1a-tdTomato transgenic mice, we found that the synaptic adaptation was specific 
to D1 MSNs compared with D2 MSNs. Lastly, we validated and utilized a novel Cre-inducible 
shRNA virus for knockdown of NPAS2 specifically in D1 MSNs of Drd1a::Cre mice to 
demonstrate that direct pathway mechanisms are important for the effects of NPAS2 reduction on 
cocaine place preference. Together, our results suggest that NPAS2 plays a role in regulating D1 
MSN excitatory synapses and cocaine-reward related behavior. 
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3.1 INTRODUCTION 
Circadian rhythm disturbances have been linked to the development and progression of mood- 
related neuropsychiatric illnesses including bipolar disorder (BD) and major depressive disorder 
(MDD) (Edgar and McClung, 2013; Karatsoreos, 2014; McClung, 2013). Substance abuse is often
co-morbid with these diseases and presents a substantial societal and economic burden. Human 
genome-wide studies point to a strong association of circadian gene variants and single nucleotide 
polymorphisms (SNPs) with mood and addiction disorders (Logan et al, 2014; McCarthy and 
Welsh, 2012). Circadian gene perturbations can predispose individuals to substance abuse and 
addiction vulnerability can be further exacerbated by circadian rhythm disruption producing a 
negative bidirectional relationship (Parekh et al, 2015). At the molecular level, rhythms are 
maintained by a complex series of transcriptional-translational feedback loops with core and 
accessory elements (Ko and Takahashi, 2006; Mackey, 2007). The circadian bHLH-PAS domain 
transcription factor, NPAS2 (neuronal PAS domain protein 2), heterodimerizes with BMAL1 to 
regulate transcription of genes functioning both within and outside of the molecular clock (Zhou 
et al, 1997). Our group and others have identified direct clock-controlled genes involved in various 
aspects of dopaminergic transmission within the ventral tegmental area (VTA) to nucleus 
accumbens (NAc) circuitry, which is critical for reward processing (Arey et al, 2014; Hampp et 
al, 2008; Koob and Volkow, 2016; McClung et al, 2005; Ozburn et al, 2015). 
NPAS2 is structurally homologous to CLOCK with only a slight difference in the 
transactivational domain region (Reick et al, 2001). Within the suprachiasmatic nucleus (SCN), 
or master pacemaker region of the brain, NPAS2 is able to functionally compensate for CLOCK 
to maintain behavioral and physiological circadian rhythms (DeBruyne et al, 2007). Recent 
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evidence also demonstrates a role of NPAS2 in maintaining peripheral circadian oscillations in the 
absence of CLOCK (Landgraf et al, 2016). However, the expression profile of the two 
transcription factors within the brain varies, with CLOCK found more ubiquitously throughout 
and NPAS2 enriched in forebrain structures, particularly the NAc (Garcia et al, 2000). These 
varying patterns of expression may account for differences in the roles of the two proteins in 
behavioral regulation. NPAS2 has been shown to be critical for allowing mice to adaptively entrain 
to restricted feeding schedules and for maintaining feeding conditions (Dudley et al, 2003; Wu et 
al, 2010). NPAS2-deficient mice also exhibit deficits in the acquisition of cued and contextual fear 
memory (Garcia et al, 2000). Previous studies from our lab have uncovered opposing roles of 
CLOCK and NPAS2 in mediating drug reward sensitivity. Mice with a specific mutation in the 
Clock gene, Clock∆19 mice, display a robustly elevated behavioral response to cocaine measured 
by increased conditioned place preference (CPP), while Npas2 mutant mice show decreased 
preference at the same dose (McClung et al, 2005; Ozburn et al, 2015). Furthermore, viral- 
mediated shRNA knockdown of NPAS2 exclusively within the accumbens is able to reduce 
cocaine CPP highlighting its importance in this limbic region (Ozburn et al, 2015). Interestingly, 
knock down of CLOCK in the NAc had no effect on locomotor activity, exploratory drive or 
cocaine CPP (Ozburn et al, 2015). These studies serve to underscore the relevance of region- 
specific differences in the function of circadian proteins. They also highlight a unique role of 
accumbal NPAS2 in mediating reward. 
NAc medium spiny neurons (MSNs) receive glutamatergic input from a number of regions 
including the prefrontal cortex and amygdala as well as dopaminergic input from the VTA 
(Groenewegen et al, 1999). Addictive drugs, including cocaine, act to increase mesolimbic 
dopaminergic signaling, which can remodel NAc excitatory synapses  (Lüscher and  Malenka, 
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2011). The NAc consists predominantly of two main types of dopamine receptor subtype- 
containing MSNs D1+ and D2+ (Lu et al, 1998). Their projection pathways, further define these 
subpopulations with D1 MSNs comprising the “direct” pathway circuitry, promoting goal-directed 
behavior, and D2 MSNs the “indirect” pathway, generally inhibiting such behavior (Gerfen et al, 
1990; Lobo et al, 2010; Kravitz et al, 2013; Lee et al, 2016). Using fluorescence-activated cell 
sorting (FACS) and gene expression profiling, Ozburn and colleagues demonstrated that Npas2 is 
enriched in D1 MSNs of the striatum (Ozburn et al, 2015). Here we further determined how 
NPAS2 affects the expression of glutamatergic genes and excitatory synaptic transmission in the 
NAc. Additionally, using reporter mice, we investigated the effect of Npas2 disruption on 
excitatory drive onto D1 and D2 MSNs. Lastly, we’ve begun to explore the role of NPAS2 in 
structural plasticity of NAc MSNs in response to cocaine as well as reward sensitivity of mice with 
Npas2 knocked down specifically in D1 MSNs. 
3.2 MATERIALS AND METHODS 
3.2.1 Animal use. 
C57BL/6J (Jackson Laboratories) and heterozygous and homozygous Drd1a-tdTomato (Jackson 
Laboratories) mice were used for Npas2 knockdown and electrophysiological experiments. 
Recordings were made on mice aged 7-9wks. Adult Npas2 knockout mice were maintained on a 
C57BL/6J background backcrossed to N10. Homozygous animals and wildtype littermates were 
used for imaging experiments. Adult male Drd1a::Cre mice were used in cre-dependent knock- 
down and cocaine conditioned place preference experiments. Mice were maintained on a 12:12h 
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light/dark cycle (ZT 0 = lights on 7:00AM; ZT 12 = lights off 7:00PM). Food and water were 
available ad libitum. All animal use was conducted in accordance with the National Institute of 
Health guidelines for the care and use of laboratory animals and approved by the Institutional 
Animal Care and Use Committee of the University of Pittsburgh. 
3.2.2 Viral gene transfer and stereotaxic surgery. 
Stereotaxic surgery was performed as previously described (Ozburn et al, 2015). Bilateral 
stereotaxic injections of 1µL of purified high titer adeno-associated virus (AAV2) encoding Npas2 
shRNA or a scrambled sequence (control) tagged with GFP were delivered into the NAc (from 
Bregma; angle 10°: AP +1.5mm, Lat. +1.5mm, DV -4.4mm). Mice recovered for 3-4 weeks 
allowing for full expression of the virus prior to electrophysiological recording. A similar 
procedure was used to inject AAV2/2.H1lox.mCherry-ShRNA-Npas2 or AAV2-scramble virus 
for cocaine place preference testing. Following behavioral testing, the placement of viral injections 
was verified. Mice were perfused with ice-cold 1x phosphate-buffered saline (PBS) followed by 
4% paraformaldehyde in PBS (pH 7.4). Brains were post-fixed for at least 24 hours then transferred 
to a 30% sucrose solution. 30µm-thick tissue sections were mounted onto slides and coverslipped. 
mCherry signal was not enhanced with immunolabeling. Sections were imaged at 4x magnification 
using an Olympus fluorescence microscope. 
3.2.3 Quantitative real-time RT-PCR 
To measure the relative expression of glutamatergic genes from Npas2 shRNA and scrambled 
shRNA expressing mice, NAc tissue  collection,  RNA  extraction  and  cDNA  synthesis were 
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performed as described in (Ozburn et al, 2015). Following cDNA synthesis, quantitative real-time 
polymerase chain reaction (qPCR) was carried out. Primer sets used included: Gria1 Fwd: 5’- 
GTGAGCGTCGTCCTCTTC-3’, Gria1 Rev: 5’-GGTTGTCTGATCTCGTCCTT-3’; 
Gria2 Fwd: 5’-AGTGGGAGAAGTTTGTGTACC-3’, Gria2 Rev: 5’- 
TGATGCGTCTGAATTCCTGG-3’; Grin2a Fwd: 5’-GATTGACCTCGCTCTGCT-3’, Grin2a 
Rev: 5’-TCACCTCATTCTTCTCGTTG-3’; Grin2b Fwd: 5’-ACATGGCTGGAAGAGACG-3’, 
Grin2b          Rev:         5’-CATAGCCCGTAGAAGCAAA-3’;       Gapdh Fwd:         5’- 
CTTTGTCAAGCTCATTTCCTGG-3’;     Gapdh     Rev: 5’-TCTTGCTCAGTGTCCTTGC-3’. 
cDNA (1ng) was mixed with Power SYBR Green PCR Master Mix (Thermo Fisher Scientific) 
and primers listed above. Reactions were run in duplicate in an Applied Biosystems 7900HT Fast 
Real-time PCR System (Applied Biosystems, Foster City, CA). Relative gene expression was 
calculated using the comparative Ct (2^∆∆Ct) method (Landgraf et al, 2014) and normalized to 
each sample’s corresponding Gapdh mRNA levels. 
3.2.4 NAc slice preparation. 
C57BL/6J and Drd1a-tdTomato mice were anesthetized rapidly with isoflurane and decapitated. 
Brains were removed into ice-cold oxygenated (95% O2/5% CO2) modified aCSF containing (in 
mM): 135 N-methyl-D-glucamine, 1 KCl, 1.2 KH2PO4, 1.5 MgCl2, 0.5 CaCl2, 70 choline 
bicarbonate, and 10 D-glucose; pH 7.4 adjusted with HCL. NAc-containing coronal slices 
(200µm) were sectioned with a vibratome (VT1200S; Leica, Wetzlar, Germany) and incubated for 
30 minutes at 37°C in oxygenated aCSF containing (in mM): 119 NaCl, 26 NaHCO3, 2.5 KCl, 1 
NaH2PO4, 2.5 CaCl2, 1.3 MgCl2, 11 D-glucose. Slices were kept at room temperature until 
recording then perfused with aCSF (30-32°C). 
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3.2.5 Whole-cell patch clamp recording. 
Slices were viewed by differential interference contrast (DIC) optics (Leica) and accumbal regions 
were localized under low magnification. Recordings were made under visual guidance with 40x 
objective. GFP and tdTomato expressing cells were visualized using filters for 488nm and 546nm 
light respectively. Borosilicate glass pipettes (3-5MΩ) were filled with (in mM): 117 Cs-MeSO3, 
20 HEPES, 0.4 EGTA, 2.8 NaCl, 5 TEA-Cl, 2.5 Mg-ATP, 0.25 Na-GTP, 5 QX-314; pH 7.3 
adjusted with CsOH. For miniature EPSC (mEPSC) intracellular solution contained (in mM): 119 
K-MeSO4, 2 KCl, 1 MgCl2, 1 EGTA, 0.1 CaCl2, 10 HEPES, 2 Mg-ATP, 0.4 Na-GTP; pH 7.3
adjusted with KOH. Cells were voltage clamped at -70mV. A constant-current isolated stimulator 
(DS3; Digitimer) was used to stimulate excitatory afferents with a monopolar electrode to record 
evoked currents (EPSCs). Picrotoxin (50µM, Sigma Aldrich) was included in the external 
perfusion aCSF to block GABAA receptors. TTX (1µM, Tocris, Bristol, UK) was used for mEPSC 
recordings to block action potential generation. For EPSC experiments, D-APV (50µM, R&D 
Systems, Minneapolis, MN) was bath applied to block NMDARs at 40mV. In some experiments, 
D-APV was not applied and the peak amplitude of AMPAR current was measured at -70mV and
the NMDAR EPSC peak amplitude taken at 40mV, 35ms from the AMPAR EPSC peak. 
Series resistance for all recordings was monitored continuously. Cells with a change in 
series resistance beyond 20% were excluded from data analysis, as were electrophysiologically 
identified interneurons. Synaptic currents were recorded with a MultiClamp 700B amplifier 
(Molecular Devices, Sunnyvale, CA). Signals were filtered at 2.6-3 kHz and amplified 10 times, 
then digitized at 20 kHz with a Digidata 1322A analog-to-digital converter (Molecular Devices). 
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Miniature current recordings were analyzed using pClamp10 software (Molecular Devices) over a 
period of approximately 2.5 min during which 250-2500 events were collected. 
3.2.6 Dendritic spine labeling and imaging. 
NAc MSN dendritic spines were labeled, imaged and analyzed as previously described (Graziane 
et al, 2016). Mice having undergone chronic (7 days) cocaine (20mg/kg; i.p.) injections were 
sacrificed for dendritic labeling 24 hr following the last injection. Animals were transcardially 
perfused (15ml/min) with 0.1M sodium phosphate buffer (PB) followed by 1.5% 
paraformaldehyde (PFA) in 0.1M PB. Brains were removed in to 1.5% PFA and allowed to post- 
fix for 1hr at room temperature. 100um-thick coronal slices containing the NAc were prepared in 
room temperature 1x phosphate buffered saline (PBS) using a vibratome. Slices were mounted 
onto slides and kept wet with PBS. DiI crystals (Invitrogen, Carlsbad, CA) were applied to the 
accumbens area of slices with a fine brush controlled by a micromanipulator. Slides were kept at 
4°C for 36-48hrs to allow crystals to diffuse into tissue and stain cells. Labeled sections were 
further fixed with 4% PFA for 1hr at room temperature, washed 2-3x with 1x PBS and cover- 
slipped with aqueous medium prolong (Invitrogen). 
DiI was excited with a Helium/Neon 559nm laser and spines were imaged using an 
Olympus confocal microscope. MSNs were scanned with a 60x oil-immersion objective and 
individual secondary or tertiary dendrites were zoomed into and scanned at 0.44um steps along 
the z-axis to capture the full profile. A two-dimensional projection image used for analysis was 
obtained for each dendrite by stacking all of the planes. Spine density analysis was performed with 
ImageJ software (NIH). Dendritic segments of 20um length were analyzed at least 5um from a 
branch point and 8-10 dendrites were sampled from each animal with 4-5 animals/group. 
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3.2.7 Generation and validation of Cre-inducible viruses 
 
 
Cre-inducible shRNA expression for cell-type specific knockdown of NPAS2 was achieved using 
a modified construct with an H1 polIII promoter driving a loxP flanked STOP cassette and stuffer 
DNA preventing transcription of Npas2 shRNA or a scrambled, non-functional sequence. The 
AAV backbone has been described previously (Arango-Lievano et al, 2014). Recombination of 
the loxP elements in transgenic animals expressing Cre-recombinase under the Drd1a receptor 
promoter (Drd1a::Cre mice), allows for the removal of the stuffer DNA and the transcription of 
the shRNA to achieve knockdown. 
 
3.2.8 Cocaine conditioned place preference. 
 
 
Cocaine place preference was assessed using a biased conditioning protocol. On the pre-test day, 
mice were allowed to explore all chambers of the apparatus for 20 minutes to determine inherent 
bias. On conditioning days 1 and 3, mice were injected with saline (i.p.) and paired with the 
preferred chamber of the apparatus, and on days 2 and 4, they received a cocaine injection (5mg/kg; 
i.p.) paired with the non-preferred chamber. Conditioning sessions lasted 20 minutes. Following 
conditioning, on day 6, mice were tested again for time spent on either side of the apparatus and 
the CPP score was calculated by subtracting the pre-conditioning time spent in the cocaine-paired 
side from the time spent in the cocaine-paired side on the test day. Data from mice that spent a 
majority of time in the center of the apparatus were eliminated from analysis. Locomotor activity 
was detected by infrared beam breaks and recorded using Med-PC software (Med Associates, Inc., 
Fairfax, VT). 
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3.2.9 Data analysis. 
Electrophysiological, imaging, gene expression and behavioral experiments were conducted blind 
to genotype and/or treatment. Significant differences were determined by Student’s t-Test, or two- 
way ANOVA followed by Bonferroni post hoc tests. P<0.05 is considered significant for all 
analyses. All data are presented as mean ± SEM. 
3.3 RESULTS 
3.3.1 Knockdown of NPAS2 within the NAc leads to an increase inglutamatergic 
transmission at MSNs. 
Our lab has previously shown that a knockdown of NPAS2 in the accumbens produces a decrease 
in reward sensitivity as measured by conditioned place preference for cocaine (CPP) (Ozburn et 
al, 2015). Changes in cocaine CPP have been correlated with alterations in excitatory transmission 
at NAc MSNs including the amplitude of miniature excitatory post-synaptic currents (mEPSCs) 
and the ratio of evoked AMPAR- and NMDAR-mediated EPSCs (Grueter et al, 2013). Here we 
found that compared with a scrambled control virus, NPAS2 shRNA-infected MSNs showed an 
increase in the amplitude of mEPSCs (t(20) = 2.713, P = 0.0134) and a trend-level increase in 
frequency of events (t(20) = 2.016, P = 0.0574) (figure 17c,d). Additionally, when analyzing the 
ratio of the average peak amplitude of AMPAR-mediated evoked currents to that of NMDAR 
EPSCs (AMPAR/NMDAR), a measure of synaptic strength independent of stimulus intensity or 
synapse number, we found a trend towards an increase with NPAS2 knockdown (t(13) = 1.795, P = 
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0.0960) (figure 17f). These results suggest that NPAS2 positively regulates accumbal MSN 
excitatory postsynaptic transmission and potentially presynaptic release, mechanisms by which it 
may modulate reward sensitivity. 
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Figure 17. Knockdown of NPAS2 in the NAc leads to an increase in excitatory transmission onto MSNs. (A) 
Bilateral targeting of AAV2-shRNA-Npas2 or AAV2-shRNA-scrambled to the NAc (left) and localization of GFP- 
tagged shRNA (right). (B) Representative traces of mEPSCs sampled from scramble and shRNA infected MSNs. (C) 
Summary of mEPSC amplitude in  cells  from both  treatment  groups.  (D)  Summary of mEPSC frequency. (E) 
Representative traces of AMPAR and NMDAR EPSCs from scramble treated (black) and NPAS2 knockdown (red) 
MSNs. (F) AMPA/NMDA ratio of evoked responses from both groups. n = cells/animals and *P<0.05 for this and all 
subsequent figures. 
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3.3.2 Effects of NPAS2 reduction on NAc glutamatergic geneexpression. 
Circadian transcription factors including CLOCK and NPAS2 directly regulate the activity of 
genes with non-clock functions in distinct brain regions. Chromatin immunoprecipitation followed 
by deep sequencing (ChIP-Seq) performed in a previous study from our lab (Ozburn et al, 2015) 
revealed the binding targets of CLOCK and NPAS2 in the striatum. Several genes related to 
glutamatergic transmission were among them. We tested the effect of Npas2 shRNA treatment, 
compared with scrambled control, on NAc glutamatergic gene expression. We found that 
knockdown produced an increase in expression of the main AMPAR subunit gene, Gria1 (GluA1) 
(t(10) = 2.23, P = 0.050) with strong trend-level significance (figure 18a). Knockdown of NPAS2 
did not significantly alter the expression of the AMPAR subunit gene, Gria2 (GluA2) (t(10) = 1.22, 
P = 0.2502) or the NMDAR subunit genes Grin2a (GluN2a) (t(10)= 0.574, P = 0.5785) and Grin2b 
(GluN2b) (t(4.38) = 0.940, P = 0.3960; Welch’s correction) (figure 18b-d). These findings suggest 
that while NPAS2 reduction does not appear to significantly affect the expression of several key 
glutamatergic genes in the NAc, perhaps its role as a negative regulator of excitatory transmission 
in the NAc may be mediated in part through a subtle alteration in transcription of the major 
AMPAR subunit, GluA1. 
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Figure 18. Knockdown of NPAS2 in the NAc does not significantly change AMPAR and NMDAR subunit gene 
expression. A) A strong trend towards an increase in levels of the GluA1 subunit gene, Gria1, was seen following 
NPAS2 reduction in the NAc. B-D) Relative gene expression of other glutamate receptor subunits, Gria2, Grin2a and 
Grin2b were not significantly altered by NPAS2 knockdown in NAc tissue. n = 3-4 mice/group. 
3.3.3 Increased excitatory synaptic transmission following NPAS2 knockdown is specific 
to D1 MSNs 
Given the restricted expression of NPAS2 to D1-containing MSNs of the striatum (Ozburn et al, 
2015), we utilized Drd1a-tdTomato BAC transgenic mice to identify D1 and non-D1, putatively 
D2, neurons (Shuen et al, 2008) for targeted recordings following Npas2 shRNA or scramble 
treatment. Cells co-expressing tdTomato and GFP signals were considered virally infected D1 
neurons while those that only expressed GFP signal were considered infected D2 neurons (figure 
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19a). We again measured glutamatergic transmission by analyzing the amplitude and frequency of 
AMPAR-mediated mEPSCs. Two-way ANOVA revealed a significant main effect of cell type on 
mEPSC amplitude (F(1,43)= 5.394, P = 0.0250 cell type effect; F(1,43)= 1.705, P = 0.1986 treatment 
effect; F(1,43) = 3.657, P = 0.0625 interaction). Bonferroni’s post-hoc analyses confirmed that 
mEPSC amplitude was significantly increased in D1 MSNs following NPAS2 knockdown 
compared with scramble treatment (P < 0.05) (figure 19b). We also found that NPAS2 reduction 
had a significant cell-type specific effect on the frequency of mEPSCs (F(1,43) = 4.234, P = 0.0457 
cell type effect; F(1,43)= 0.1265, P = 0.7239 treatment effect; F(1,43)= 4.265, P = 0.0450 interaction) 
(figure 19c). 
Consistent with the increase in AMPAR-mediated synaptic transmission, excitatory 
synaptic strength was exclusively increased in NPAS2-deficient D1 MSNs as measured by 
AMPAR/NMDAR ratio (F(1,18) = 4.275, P = 0.0534 cell type effect; F(1,18) = 10.34, P = 0.0048 
treatment effect; F(1,18) = 10.76, P = 0.0042 interaction) (figure 19d,e). Together, our findings 
indicate a specific and robust regulation of glutamatergic signaling in the population of D1- 
containing MSNs where NPAS2 expression is especially enriched. 
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Figure 19. Increased excitatory synaptic transmission following NPAS2 knockdown is specific to D1-containing 
MSNs. A) Drd1a-tdTomato reporter mice were used to visualize D1 and D2 MSNs in NAc slices treated with either 
AAV-Npas2-shRNA or AAV-Scrambled-shRNA virus. B) Summary of mEPSC amplitude in D1 and D2 neurons 
infected with shRNA or control virus. C) Frequency of miniature events in both groups and cell types. D) 
Representative traces of AMPAR (-70mV) and NMDAR (40mV) EPSCs from control (black) and Npas2 shRNA 
(red) infected D1 cells. E) Summary of AMPAR/NMDAR ratio of evoked curents from all groups. ***P < 0.001. 
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3.3.4 The role of NPAS2 in cocaine-induced MSN dendritic spinealterations 
Cocaine’s addictive potential lies in its ability to be a powerful mediator of structural and 
functional plasticity within the brain’s reward circuitry. Several studies have demonstrated a 
dynamic increase in the density of spines on dendrites in the NAc shell following cocaine exposure 
(Gipson et al, 2014; Robinson and Kolb, 2004; Russo et al, 2010). Chronic cocaine administration 
(7d, 15mg/kg, i.p.) also results in a significant up-regulation of Npas2 expression in the NAc as 
well as increased promoter binding of the Per genes, with no effect on Clock or Bmal1 levels or 
activity (Falcon et al, 2013). Therefore, we sought to determine whether NPAS2 is important for 
the alterations in MSN spine density mediated by cocaine. NPAS2 knockout (KO) mice and WT 
littermates (n = 4-5 animals/group) were given 7 days of cocaine (20mg/kg, i.p.). 24 hours after 
their last injection, animals were sacrificed for DiI labeling of MSN dendrites (figure 20a). Our 
preliminary results indicate that cocaine-treated NPAS2 KO mice showed a reduction in spine 
density on secondary dendrites of NAc shell MSNs compared with WT animals, however the data 
did not reach statistical significance (t(7)= 2.221, P = 0.0618) (figure 20b). The results of this pilot 
study are encouraging however in suggesting that NPAS2 may play a role in structural plasticity 
in the NAc and help explain the robust effect of the transcription factor in regulating the 
conditioned response to cocaine (Ozburn et al, 2015). We are following up with saline controls 
and increased sample size for all groups. 
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Figure 20. NPAS2 may be important for cocaine-induced changes in MSN structural plasticity. A) DiI dye 
labeling of MSNs allowed for the visualization of individual spines along secondary dendrites. Spine density was 
measured on 20µm segments at least 5µm from branch points off of primary dendrites. B) Spines per micrometer of 
dendrite were calculated for WT and NPAS2 KO MSNs following chronic cocaine administration. n = 8-10 
dendrites/animal; 4-5 animals/group. 
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3.3.5 D1-MSN-specific NPAS2 knockdown in the NAc reduces cocaine reward sensitivity 
Cell-type specific molecular mechanisms regulating cocaine reward have not been extensively 
studied, however, there is evidence for differential actions of another transcription factor, ∆fosB, 
in accumbal reward-related behaviors. Over-expression of ∆fosB specifically in D1 but not D2 
MSNs promotes behavioral responses to cocaine as measured by cocaine conditioned place 
preference (CPP) and locomotor sensitization (Grueter et al, 2013). In the CPP paradigm the 
conditioned stimulus is experimenter administered and preference is driven by sensitivity to the 
rewarding value of the drug (Prus et al, 2009). Using a novel Cre-inducible shRNA virus modified 
to selectively knockdown NPAS2 in D1 MSNs of Drd1a::Cre mice (or scrambled control) (figure 
21a), we used a biased CPP protocol to assess reward sensitivity (figure 21b). We found that 
cocaine preference was significantly reduced in mice following NPAS2 KD compared with control 
treated animals (t(20) = 2.451, P = 0.0236). These results suggest that the decrease in preference 
previously seen with indiscriminate NPAS2 knockdown (Ozburn et al, 2015) in the NAc may be 
mediated in part through direct pathway mechanisms. 
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Figure 21. Viral-mediated knockdown of NPAS2 specifically in D1 MSNs reduces cocaine place preference. A) 
Schematic of Cre-inducible Npas2 or scrambled shRNA constructs for cell-type specific reduction of NPAS2. B) 
timeline of viral injections, conditioning paradigm and histological verification. C) Representative micrograph of 
mCherry expression indicating presence and location of Cre-inducible shRNA virus within the NAc (left) and 20x 
image of virus expression within NAc cells (right). D) CPP score (test – pre-test time) for scramble and shRNA treated 
Drd1a::Cre mice. AC – anteriorcommissure. 
83 
3.4 DISCUSSION 
The results of the current study provide preliminary evidence for the role of NPAS2 in regulating 
reward-related behavior potentially via synaptic mechanisms in accumbal D1 direct pathway 
circuitry. While circadian gene variants associate strongly with psychiatric illness including co- 
morbid substance abuse, few studies have explored the regulatory function of these genes in 
mesolimbic regions and even fewer in specific circuits. We found that non-selective knockdown 
of NPAS2 in the NAc produced an overall increase in mEPSC amplitude indicative of either a 
higher density or conductance of postsynaptic AMPA receptors at individual synapses. A trend 
towards an increase in AMPAR/NMDAR ratio in a small number of cells further supports an 
increase in excitatory drive onto MSNs as a result of NPAS2 reduction. A strong trend towards an 
increase in the frequency of miniature currents at MSNs was also observed following NPAS2 
knockdown compared with scrambled control. This implies a potential elevation in presynaptic 
release probability of glutamate at existing sites or an increase in the number of functional synaptic 
sites. 
We hypothesized that the transcription of glutamate receptor subunit genes could be 
regulated by NPAS2, as previous ChIP-seq analysis revealed binding of the transcription factor to 
several of these genes. Using cDNA prepared from NAc tissue expressing either Npas2 shRNA or 
control virus, we performed real-time quantitative PCR assays to measure transcript levels of the 
genes, Gria1, Gria2, Grin2a and Grin2b, which encode AMPA and NMDA receptor subunits 
respectively. We only detected a strong trend-level increase in mRNA expression of Gria1 
(GluA1) with NPAS2 knockdown. This, however, is a major subunit of AMPARs, which mediate 
fast excitatory neurotransmission. Adaptations in the expression or function of receptors 
containing this subunit most likely underlie the functional synaptic changes  observed  in   our 
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electrophysiological recordings. ChIP-Seq results indicate NPAS2 binding within the Gria1 gene, 
however direct transcriptional regulation of the gene by NPAS2 would have to be verified by 
identifying binding at a canonical or noncanonical E-box sequence within the promoter region. 
While not significant, a pattern of decrease in levels of Gria2 with NPAS2 knockdown could 
indicate lowered expression of GluA2-containing calcium-impermeable AMPARs, however, this 
would have to be further tested with pharmacological methods. Collection of the whole NAc for 
gene expression measurements may be problematic if, as it has been previously shown, Npas2 
expression is largely restricted to a particular population of NAc neurons. However, these 
preliminary results point to at least one transcriptional mechanism that could underlie the function 
of NPAS2 as a negative regulator of excitatory synaptic transmission in the NAc, and should be 
expanded upon further. 
In a previous study from our group, Drd1a-tdTomato mice were used to isolate D1 MSNs 
from other cells of the NAc (mostly D2+ MSNs) via fluorescence activated cell sorting (FACS) 
followed by qPCR. Npas2 expression was found to be elevated approximately 80-fold in this 
population (Ozburn et al, 2015). Therefore, we were interested to find whether potentiation of 
excitatory synaptic transmission as a result of NPAS2 reduction would be specific to D1 cells. 
Here we found that in fact, D1 MSNs showed increased AMPAR mEPSC amplitude and frequency 
relative to control virus expression and compared with D2 cells. Additionally, the 
AMPAR/NMDAR ratio was significantly elevated exclusively in D1 cells. In our previous 
experiment, we saw a trend-level increase in this measure in NPAS2-deficient MSNs, possibly 
because we were sampling both D1 and D2 cells indiscriminately for recording. These results 
suggest that perhaps NPAS2 exerts influence on excitatory synaptic transmission and reward 
behavior in the NAc through adaptations in D1R-containing MSNs. 
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The interaction of NPAS2, NAc neuronal activity and modulation by cocaine is of 
particular interest to us. Cocaine is a highly reinforcing psychostimulant drug that is capable of re- 
wiring reward circuitry through dynamic regulation of intracellular signaling and plasticity-related 
mechanisms in NAc neurons. Cocaine and other drugs of abuse also alter the expression of 
circadian genes in reward circuits (Falcon et al, 2009, 2013; Lynch et al, 2008). We therefore 
sought to address the question of whether NPAS2 is involved in cocaine-induced structural 
alterations on MSN dendritic spines. Chronic cocaine exposure followed by short or long 
withdrawal can up-regulate the number of spines on secondary and tertiary dendrites of NAc shell 
MSNs (Graziane et al, 2016). In a pilot study we exposed WT and NPAS2 KO mice to one week 
of a high dose (20mg/kg) of cocaine and labeled MSNs with a lipophilic dye that filled dendrites 
and spines for full visualization. Our analysis in a small group of animals revealed a strong trend 
towards reduced spine density in KO mice compared with WT mice following cocaine treatment. 
While we are in the process of repeating this experiment with saline controls, we find that spine 
density in cocaine treated WT mice, as we have measured, is similar to that reported (Graziane et 
al, 2016). These preliminary findings are supportive of our hypothesis that NPAS2 may mediate 
structural plasticity within NAc circuitry whereby, inhibition of NPAS2 function can occlude 
cocaine-induced spine changes on MSN dendrites. One possible mechanism that could underlie 
the action of NPAS2 is its potential association with the transcription factor, nuclear factor kappa 
B (NfκB), an important mediator of reward behavior in the NAc. NfκB signaling is increased in 
the accumbens after chronic cocaine and inhibition of NfκB specifically in the NAc reduces the 
conditioned response to cocaine. Furthermore, NfκB inhibition also prevents the increase in 
dendritic spines after chronic cocaine (Russo et al, 2009). The circadian paralog of NPAS2, 
CLOCK, has recently been shown to positively regulate NfκB-mediated transcription (Spengler et 
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al, 2012), therefore, it is possible that NPAS2 may associate in a similar manner with this important 
transcription factor to regulate reward-related mechanisms. 
Tools to genetically target specific cell-types within the brain help to elucidate molecular 
mechanisms contributing to abnormal reward behavior. In this study, we employed a novel viral- 
mediated approach to selectively knockdown NPAS2 in D1-MSNs of the NAc. The Cre-dependent 
AAV backbone has been described (Arango-Lievano et al, 2014) and we have modified it for our 
use. We found that reducing NPAS2 expression only in D1 neurons was sufficient to decrease the 
expression of cocaine CPP, similar to the effect seen with non-specific knockdown in the NAc as 
well as Npas2 mutation (Ozburn et al, 2015). Together, our results begin to shed light on molecular 
and cellular mechanisms underlying the regulation of reward byNPAS2. 
3.5 FUTURE DIRECTIONS 
The preliminary findings here are part of a more comprehensive study aimed at understanding how 
the forebrain-enriched circadian transcription factor, NPAS2, modulates NAc neuronal activity at 
baseline and in response to cocaine. We find quite striking cell-type specific adaptations in 
glutamatergic transmission as a result of NPAS2 disruption in drug naïve animals, however, it will 
be important to investigate these mechanisms in animals exposed to cocaine which has been shown 
to specifically increase expression of Npas2 in the NAc (Falcon et al, 2013). We plan to follow up 
our experiments by recording miniature and evoked EPSCs in virus expressing Drd1a-tdTomato 
following chronic or acute cocaine administration. These experiments could reveal differential 
actions of NPAS2 at baseline compared with when the circuit undergoes adaptation by cocaine. 
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D1 and D2 excitatory signaling is altered by cocaine in varying manners, therefore we may find 
that NPAS2 function is more critical in mediating cocaine’s effects in one pathway over the other. 
Identifying the direct transcriptional targets of NPAS2 in the NAc is of great interest to us 
as we explore mechanisms of its action in this brain region. ChIP-Seq analysis has yielded a list 
of all sequences bound by NPAS2 in the striatum across the light/dark cycle. For added specificity, 
we are currently optimizing a protocol for the isolation of Npas2-containing or deficient D1 and 
D2 MSNs using fluorescence activated cell sorting (FACS) (figure 22). RNA extracted from the 
collected cell populations will be used for sequencing. Comparing the results of ChIP-Seq with 
RNA-Seq will allow us to determine genes both bound and directly regulated by NPAS2 in D1 
MSNs of the NAc. 
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Figure 22. FACS-RNAseq for the identification of gene targets regulated by NPAS2 in D1 and D2 MSNs. A) 
Schematic diagram of the flow cytometry method to sort and isolate populations of cells from suspension by 
fluorescent signals. B) Results from a single sort of NAc tissue pooled from 3 Drd1a-tdTomato mice expressing Npas2 
shRNA. Cells are differentiated by signal intensity and gates are set for collection. Numbers of live cell events detected 
for each population are shown at the right. RNA can be extracted fromthesesamples. 
Drd1a-tdTomato mice expressing GFP-tagged Npas2 shRNA or scrambled control viruses 
will be sacrificed and tissue dissociated as described (Lobo et al, 2006). Cells in suspension will 
be sorted into GFP+, tdTomato +, GFP-/tdTomato-, and GFP+/tdTomato+ populations. Cells are 
sorted into Trizol LS and RNA can be extracted and purified from these samples for RNA- 
sequencing. We have been successful in isolating these groups of MSNs from pooled NAc tissue 
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and have begun to optimize RNA extraction to meet the concentration and purity standards for 
sequencing.  From samples containing ~2000- ~5000 dual-labeled cells, we are able to harvest 
~200ng of total RNA. We are confident that this method will allow us to determine genes that 
are directly regulated by NPAS2 and that may influence direct and indirect pathway activity. 
Additionally, we plan to sample at multiple time points to map our results onto the ChIP-Seq 
data we have previously obtained. It is likely that genes involved in synaptic plasticity and 
dopaminergic and glutamatergic signaling in the NAc may be under circadian regulation by 
NPAS2. We have previously identified the dopamine D3 receptor as a direct and unique binding 
target of NPAS2 in the striatum. Furthermore, we can investigate how NPAS2 transcriptional 
activity changes in D1 and D2 cells as a result of cocaine exposure. 
Cocaine induced up-regulation of dendritic spines in the NAc appears to be specific to D1 
MSNs (Lee et al, 2006). We have attempted to identify D1 MSNs with NPAS2 knocked down 
for DiI labeling in order to determine whether cocaine-induced structural plasticity is only 
blocked by NPAS2 disruption in D1 neurons, however, we have faced some technical 
challenges. We were unable to isolate cells that both expressed shRNA virus and were dye 
labeled for analysis due to the necessity of sparse dye application to prevent oversaturation. It is 
thought that the incubation of cocaine craving is in part mediated by the generation of silent 
synapses in the NAc (synapses which contain very few functional AMPARs) (Huang et al, 2009; 
Lee et al, 2013). Morphologically, stubby or thin immature spines are associated with silent 
synapses (Holtmaat and Svoboda, 2009). Our analysis of spine density can be extended to 
include a characterization of spine morphology. Graziane and colleagues classified four types of 
spines found on MSN dendrites following chronic cocaine or morphine administration. The 
density of thin and filopodia-like  spines  was  increased  after  cocaine  compared  with saline 
treatment (Graziane et al, 2016). Moreover, chronic cocaine selectively induced silent synapses in 
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D1 MSNs, which were measured using electrophysiological methods (Graziane et al, 2016; 
Huang et al, 2009). Turning to electrophysiological characterization of silent synapses in Drd1a- 
tdTomato mice expressing shRNA or scramble virus may be the preferred option for addressing 
the question of whether NPAS2 is important for cocaine-induced alterations of MSN dendritic 
spines in D1 neurons specifically. 
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4.0 GENERAL DISCUSSION 
Through these studies, we set out to better understand how circadian genes and proteins regulate 
neural activity and consequently mood and reward-related behavior in extra-SCN brain regions. 
In particular, we focused on the nucleus accumbens as a critical integrator of signals encoding 
sensorimotor, emotional and motivational information to generate goal-directed actions. This 
complex structure serves as a hub of connections between forebrain and limbic regions. Bipolar 
disorder and substance abuse disorders, which are often comorbid, are associated with aberrant 
activity within mesolimbic circuitry. Circadian rhythm disruption on a behavioral or molecular 
level can be one of many symptoms or causal factors in the development or progression of these 
disorders. Mapping the cascade of molecular, circuit-level and network-level consequences of 
psychiatric disease-relevant genetic abnormalities is an overarching goal of our work. The hope is 
to be able to understand the precise ways in which systems are perturbed in order to restore balance 
where possible. 
For our first study, we utilized a validated genetic mouse model of bipolar mania with a 
circadian gene disruption to study how CLOCK regulates excitatory synaptic activity of NAc 
MSNs. We performed measurements across the light/dark cycle in order to capture a more 
comprehensive profile of neural activity in this brain region which has not be previously 
interrogated. We expected however, that we might uncover diurnal differences in synaptic 
transmission, receptor expression, and/or intrinsic excitability, as it is evident that circadian 
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fluctuations exist in structural morphology and functional plasticity in other brain regions. These 
variations have been described in invertebrate and vertebrate synapses including the expression of 
hippocampal long-term potentiation (LTP) and changes in dendritic branching, spinogenesis and 
even the size and distribution of synaptic vesicles (Wardlaw et al, 2014; Perez-Cruz et al, 2010; 
Ikeda et al, 2015; Jasinska et al, 2015). Circadian or diurnal activity-dependence of synaptic 
protein expression has also been shown. In the hippocampus, striatum and cortex, levels of the 
synaptic protein, Shank3, are influenced by circadian/melatonin rhythms and wheel-running 
activity (Sarowar et al, 2016). Rhythms in circulating hormones can also modify synaptic 
connections in a dynamic manner. Liston and colleagues have demonstrated that endogenous 
glucocorticoid oscillations modulate postsynaptic dendritic spine formation in the mouse cortex 
associated with skill learning (Liston et al, 2013). Excessive or abnormally high levels of 
glucocorticoids eliminated learning associated new spines and disrupted memories, indicating that 
these mechanisms may be part of the pathophysiology of stress-related disorders. Therefore, it is 
important to continue to investigate and consider diurnal or circadian variation on aspects of 
physiology, behavior, therapeutic efficacy and the activation or inactivation ofcircuits. 
The importance of cell-type and brain region specificity is further underscored by our 
results. Previous work from our lab has extensively characterized the role of CLOCK in the VTA 
for regulating aspects of dopaminergic neuronal activity and transmission, however, local 
disruption of CLOCK in the NAc does not significantly affect behavior or, as we have 
demonstrated here, excitatory drive onto MSNs. In contrast, the homologous circadian 
transcription factor, NPAS2 appears to exert its influence on plasticity and behavior predominantly 
in the NAc where it is highly expressed and perhaps specifically in D1R-containing MSNs. While 
CLOCK and NPAS2 have been thought to have overlapping function in the brain due to their high 
structural and functional similarity, we have characterized important differences in how   they 
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regulate neural activity and mood and reward-related behavior. Our findings are summarized 
below. 
Figure 23. Summary of the differential roles of CLOCK and NPAS2 in the regulation of neural activity and 
behavior. Findings from the studies presented here along with previous work from our lab serve to provide a more 
comprehensive understanding of the functions of CLOCK and NPAS2 within mesolimbic circuitry. 
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APPENDIX A 
ANTI-MANIC EFFICACY OF A NOVEL KV3 POTASSIUM CHANNEL MODULATOR 
Parekh PK*, Sidor, MM*, Gillman A, Bettelini L, Arban R, Alvaro GS, Zambello E, Mutanelli C, 
Huang Y, Large CH, and McClung CA. (Under revision for Neuropsychopharmacology). 
* denotes equal contribution.
Kv3.1 and Kv3.2 voltage-gated potassium channels are expressed on parvalbumin-positive 
GABAergic interneurons in corticolimbic brain regions and contribute to high frequency neural 
firing. The channels are also expressed on GABAergic neurons of the basal ganglia, substantia 
nigra, and ventral tegmental area (VTA) where they regulate firing patterns critical for movement 
control, reward, and motivation. Modulation of Kv3.1 and Kv3.2 channels may therefore have 
potential in the treatment of disorders in which these systems have been implicated, such as bipolar 
disorder. Following the recent development of a potassium channel modulator, AUT1 - an 
imidazolidinedione compound which increases currents mediated by Kv3.1 and Kv3.2 channels in 
recombinant systems - we report that the compound is able to reverse “manic-like” behavior in 
two mouse models: amphetamine-induced hyperactivity and ClockΔ19 mutants. AUT1 completely 
prevented amphetamine-induced hyperactivity in a dose-dependent manner, similar to the atypical 
antipsychotic, clozapine. Similar efficacy was observed in Kv3.2 knockout mice. In contrast, 
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AUT1 was unable to prevent amphetamine-induced hyperactivity in mice lacking Kv3.1 channels. 
Notably, Kv3.1 null mice displayed baseline hyperlocomotion, greater exploratory drive, and 
antidepressant-like behavior. In ClockΔ19 mice, AUT1 reversed hyperactivity. Furthermore, 
AUT1 application modulated firing frequency and action potential properties of ClockΔ19 VTA 
dopamine neurons potentially through network effects. Kv3.1 protein levels in the VTA of 
ClockΔ19 mice were significantly increased, suggesting a possible compensation for the increased 
dopaminergic activity in this brain region. Taken together, these results suggest that the modulation 
of Kv3.1 channels may provide a novel approach to the treatment of bipolar-mania. 
 
 
 
A.1 INTRODUCTION 
 
 
Treatment of bipolar mania is currently based on a mixture of serendipitously discovered drugs, 
including the antipsychotic drug olanzapine, anticonvulsants such as valproate and lamotrigine, 
and lithium (Beaulieu and Caron, 2008; Geddes and Miklowitz, 2013; Tohen and Vieta, 2009). 
With the possible exception of lithium, these drugs primarily treat the symptoms and not 
necessarily the underlying disease pathology. Furthermore, many pharmacological treatment 
options in use today are associated with significant safety and tolerability issues that ultimately 
limit their utility. There is a desperate need for novel approaches that target the primary 
pathophysiological mechanisms thought to underlie bipolardisorder. 
Some, if not all, symptoms of bipolar mania may be caused by an imbalance in the reward 
and motor circuits of the mesolimbic system and basal ganglia (Caseras et al, 2013; Phillips and 
Swartz, 2014; Salvadore et al, 2010). Behavioral abnormalities similar to symptoms of bipolar 
mania can be induced in mice by interventions that alter activity of the nigrostriatal and mesolimbic 
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dopamine pathways. Two such approaches involve acute amphetamine administration (Lyon, 
1991; Martinowich et al, 2009) and genetic mutation of the Clock gene in mice (McClung  et al, 
2005; Mukherjee et al, 2010; Roybal et al, 2007b). Previous studies found that the Clock∆19 mice 
have an increase in dopamine cell firing and bursting in the ventral tegmental area (VTA), which 
appear to underlie many of their manic-like phenotypes, including hyperactivity (Coque et al, 
2011; McClung et al, 2005; Roybal et al, 2007b). Psychiatrists have used antipsychotic 
interventions to reduce the "over-activity" of the dopamine system by inhibiting post-synaptic 
dopamine receptors, but this approach necessarily leads to significant adverse effects. An 
alternative approach may be to consider the activity of GABAergic output neurons of the basal 
ganglia and mesolimbic system that control movement and reward. 
Kv3.1 channels have been implicated in the maintenance of high-frequency firing of 
GABA output neurons in the globus pallidus (Hernandez-Pineda et al, 1999) and substantia nigra 
(Ding et al, 2011), areas critical to maintaining inhibitory control over motor output. Although 
function of Kv3 channels in the mesolimbic system has not yet been demonstrated, distribution 
studies confirm the presence of Kv3.1 channels in the VTA and striatum (Lenz et al, 1994), so an 
analogous mechanism of control over reward and motivation could be proposed. Activation of 
Kv3.1 channels may help enhance the fast firing of GABAergic neurons in these systems to re- 
establish the balance of inhibitory control in patients with bipolar disorder without resorting to 
blockade of the dopamine system. To this end, we have investigated the efficacy of a novel class 
of drug that modulates Kv3.1 channels (Rosato-Siri et al, 2016) in two models of mania-like 
hyperactivity associated with imbalance of the mesolimbic system in mice: acute amphetamine 
treatment and the ClockΔ19 genetic mutation. 
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A.2 MATERIALS AND METHODS 
 
 
 
A.2.1 Animals. 
 
 
Male Clock∆19 mutant mice were created by N-ethyl-N-nitrosurea mutagenesis that produces a 
dominant-negative CLOCK protein defective in transcriptional activity (King et al, 1997) and were 
obtained from J. Takahashi (UT Southwestern). For all behavioral experiments using Clock∆19 
mutants, adult male mutants (Clock/Clock) were compared with wild-type (+/+) littermate controls 
(10-12wks), on a mixed BALBc x C57BL/6 background. Clock∆19 mice (4-6wks) were used for 
electrophysiological experiments. Kv3.1 null (Kv3.1 -/-) male mice (Ho et al, 1997) on a mixed 
C57BL/6 x 129 background were obtained from R. Joho (UT Southwestern) and het-het breeding 
was used to obtain both nulls and WT littermate controls; Kv3.2 null (Kv3.2 -/-) male mice were 
obtained from B. Rudy (New York University). CD1 outbred male mice (8-12wks) were purchased 
from Jackson labs. All mice were maintained on a 12/12-hr light dark cycle (lights on/off at 
7:00/19:00) with food and water provided ad libitum. Mice were housed 2-4 per cage. All animal 
use was conducted in accordance with the National Institute of Health guidelines and approved by 
the Institutional Animal Care and Use Committees of the University of Pittsburgh and UT 
Southwestern Medical Center. 
 
A.2.2 Drug Preparation. 
 
 
AUT1 (structure: (5R)-5-ethyl-3-(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)-2,4- 
imidazolidinedione; Autifony Therapeutics Limited, UK) was administered intraperitoneally (i.p.) 
or through oral gavage and prepared fresh in vehicle (AUT1-vehicle) consisting of 0.1% Tween20, 
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0.5% HPMC K15EP (Colorcon) and 12.5% Captisol in bacteriostatic saline. Freshly prepared 
AUT1 was administered 30 minutes prior to behavioral testing. D-amphetamine (2 mg/kg, i.p. or 
4 mg/kg, i.p.) and clozapine (3 mg/kg, i.p.) (Sigma, St. Louis, MO) were prepared fresh in saline. 
All drugs were dosed at 10ml/kg. Lithium chloride was dissolved in drinking water (600 mg/L) 
and made available for 10 days as published previously (Roybal et al, 2007a). This treatment has 
been shown to produce a stable serum concentration in the low therapeutic range for humans (0.41 
+ 0.06 mmol/L) with little to no adverse health consequence (Roybal et al, 2007a). 
 
 
 
A.2.3 Behavioral Assays. 
 
 
Mood-related behavioral assays were performed in a cohort of Kv3.1 null mice with at least one 
week between tests. Behavioral testing was conducted during the light cycle and mice were 
habituated to the environment for a minimum of 30 minutes. 
 
 
Locomotor Activity. Mice were individually placed in novel, unexplored automated locomotor 
activity chambers equipped with apparatus-embedded infrared photobeams (San Diego 
Instruments, San Diego, CA and Kinderscientific Smart Cage Rack System; field dimensions: 
9.5”x18.0”), which measured continuous horizontal locomotor activity for 60 min. Kv3.1 null 
mouse naïve locomotor behavior was assessed under red light conditions; all other locomotor 
behavior was measured under regular room lighting conditions. 
 
 
Elevated plus maze. The plus maze consisted of two plastic open arms perpendicular to two closed 
arms (arms: 30 x 5 cm). Mice were habituated to the testing room for 30 min and then placed into 
the center of the plus-maze facing a closed arm under dim lighting conditions. The time spent on 
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the closed and open arms, as well as the number of explorations of open and closed arms were 
determined by video tracking software, Ethovision 3.0 (Noldus, Leesburg, Virginia) over a 5- 
minute period. The apparatus was cleaned and dried between animals. 
 
 
Light/Dark Test. The dark/light apparatus consisted of a two-chambered box (25 cm x 26 cm for 
each side, Med Associates, St. Albans, Vermont). One side was kept dark while the light chamber 
had a fluorescent bulb placed horizontally across the top. Mice were initially habituated to the dark 
chamber for 2 min and then allowed free exploration of both light and dark chambers for an 
additional 10 minutes. The time spent in each chamber and total transitions were measured by Med 
Associates automated software. 
 
 
Forced Swim Test. Mice were tested in the one-day modified forced swim test. Mice were placed 
into a 4L Pyrex glass beaker filled with 3L of water (23-26 °C) where the time spent struggling 
during the last 4 minutes of a 6-minute test (first 2 minutes are habituation) was videotaped and 
later measured by a blinded observer. Immobility was defined as all cessation of movement except 
those required for flotation. 
 
A.2.4 VTA Slice preparation. 
 
 
Clock∆19 mutant mice were anesthetized rapidly with isoflurane inhalation and decapitated. 
Brains were removed into ice-cold oxygenated (95% O2/ 5% CO2) modified aCSF containing (in 
mM): 93 N-methyl-D-glucamine, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 D-Glucose, 
5 Sodium ascorbate, 2 Thiourea, 3 Sodium pyruvate, 10 MgSO4•7H2O, 0.5 CaCl2•2H2O; pH 7.3- 
 
7.4 adjusted with HCL; 300-310 mOsm.  VTA-containing horizontal slices (250µm) were 
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sectioned with a vibratome (VT1200S; Leica, Wetzlar, Germany) and incubated for 12 minutes at 
37°C in the same solution. Slices were then transferred to holding aCSF at room temperature until 
recording. Holding aCSF contained (in mM): 92 NaCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 
HEPES, 25 D-Glucose, 5 Sodium ascorbate, 2 Thiourea, 3 Sodium pyruvate, 2 MgSO4•7H2O, 2 
 
CaCl2•2H2O (pH 7.3-7.4; 300-310 mOsm). 
 
 
A.2.5   Whole-cell patch-clamp recordings. 
 
 
Slices were viewed by differential interference contrast (DIC) optics (Leica) and the VTA was 
localized medial to the optic tract. Recordings were made under visual guidance (40X objective). 
Slices were maintained at 30-32°C in oxygenated aCSF containing (in mM): 124 NaCl, 2.5 KCl, 
1.2 NaH2PO4, 24 NaHCO3, 5 HEPES, 13 D-Glucose, 2 MgSO4•7H2O, 2 CaCl2•2H2O (pH 7.3- 
7.4, 300-310 mOsm). Borosilicate glass pipettes (3-5MΩ) were filled with (in mM): 119 K- 
MeSO4, 2 KCl, 1 MgCl2, 1 EGTA, 0.1 CaCl2, 10 HEPES, 2 Mg-ATP, 0.4 Na-GTP (pH 7.3 adjusted 
with KOH; 285-295 mOsm). Giga-Ohm seal was achieved and spontaneous sodium currents 
recorded in cell-attached mode to differentiate dopamine and non-dopamine neurons (Johnson and 
North, 1992). Cells were voltage clamped at -65mV and a hyperpolarizing voltage step protocol 
was applied (0mV to -100mV) to detect the presence of “h” current for further identification of 
neurons (Margolis et al., 2006). For recordings, cells were current clamped and action potential 
(AP) firing was recorded in response to increasing current steps (-80pA to 200pA) in the presence 
of DMSO (0.1%) or 10µM AUT1 (dissolved in 0.1% DMSO; 30 + min. bath incubation), a dose 
previously confirmed to modulate Kv3.1 channels (Rosato-Siri et al., 2016). All recordings were 
made using a MultiClamp 700B amplifier (Molecular Devices, Sunnyvale, CA). Signals were 
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filtered at 2.6-3 kHz and amplified 10 times, then digitized at 20 kHz with a Digidata 1332A 
analog-to-digital converter (Molecular Devices). Spike counts were tallied manually to produce 
input-output relationships. Using pClamp 10 software (Molecular Devices). AP half-width and 
amplitude of the negative peak of the first derivative were determined for each of the middle 5 
APs in the train and averaged. Inter-event intervals were automatically determined and CV was 
calculated as the SD/mean. 
 
A.2.6 Immunohistochemistry. 
 
 
Free-floating tissue sections underwent antigen retrieval for 20 min at 80°C in 10 mM sodium 
citrate buffer pH 9 (pre-heated), followed by a 10 min cooling period at room temperature (RT) in 
the same buffer. Sections were permeabilized for 10 min at RT in 0.1 M phosphate buffered saline 
(PBS) + 0.1% Triton X-100, then washed (3 x 5 min) in 0.1 M PBS, and incubated for 60 min in 
0.1 M PBS + 1% H2O2 (30%) at RT. Sections were blocked with 1% blocking buffer (Component 
D, supplied by tyramide signal amplification kit) for 60 min at RT and then incubated at 4 °C for 
48 hours with rabbit anti-Kv3.1b (Sigma #P9732) diluted 1:500 in 1% blocking buffer. Following 
primary antibody incubation, sections were washed with 0.1 M PBS (3 x 5 min washes) and 
incubated at RT with a goat anti-rabbit HRP conjugated antibody prepared in 1% blocking buffer, 
followed by 3 x 10 min washes with 0.1 M PBS. For amplification of signal, sections were 
incubated for 10 min in freshly prepared tyramide working solution, consisting of diluted tyramide 
stock solution (1:100) in amplification buffer. Sections were washed for 3 x 10 min with 0.1 M 
PBS and mounted with Vectashield mounting medium for fluorescence (Vector Laboratories, 
Burlingame, CA). 
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A.2.7 Western Blotting. 
 
 
SDS-PAGE and Western blots: Mice were placed in a plexiglass restrainer and euthanized by 
microwave irradiation aimed at the head (5 kW, 1.2 s, Murimachi Kikai Co., Ltd. Tokyo, Japan). 
Both ventral tegmental (VTA) and nucleus accumbens (NAc) tissue was dissected from 1-2 mm 
slices with a 16-gauge tissue punch and immediately frozen on dry ice for later use. For protein 
extraction, tissue samples were homogenized by sonication on wet ice in a buffer containing 320 
mM sucrose, 5 mM HEPES, phosphatase inhibitor cocktail I and II (Sigma, St. Louis, MO), 
protease inhibitor (Sigma, St. Louis, MO), 5% SDS, and 50 mM NaF. Protein homogenate was 
spun at 12,000 RPM for 10 min at 4 °C and the supernatant carefully removed. DC assays (Biorad, 
Hercules, CA) were performed to quantitate protein levels. Aliquots of sample were combined in 
Laemmli SDS sample buffer (Bio-World, Dublin, OH), and heated at 65 °C for 20 min. Samples 
were loaded (VTA: 20 µg total protein per lane; NAc: 40 ug total protein per lane) and run on a 
pre-cast 4-15% Tris-glycine (TG) extended gel (Biorad, Hercules, CA) at 100V for 95 min in 1 x 
TGS buffer (Biorad, Hercules, CA). Proteins were transferred overnight at 4 °C onto Immobilon 
PVDF membranes (Millipore, Bedford, MA) at 30V in 1 x TG buffer. Membranes were re-wet 
briefly in a series of methanol, MilliQ water and 1 x PBS and blocked in Odyssey Blocking Buffer 
(LI-COR Biosciences, Lincoln, NE) for 1 hr at room temperature (RT). Membranes were 
incubated for 24 hrs at RT with the primary antibody, mKv3.1b (1:100, Abcam, UK #ab84823) 
and mouse anti-GAPDH (1:50,000, Fitzgerald, Acton, MA) diluted in blocking buffer + 0.2% 
Tween20. The following day, blots were washed in 1 x PBS + 0.1% Tween20 and incubated for 
1 hour at RT with infrared (IR) Dye 680 conjugated goat anti-mouse antibody (1:5000, LI-COR 
Biosciences, Lincoln, NE) diluted in 0.2% Tween20 + 0.02% SDS. Blots were washed in 1 x PBS 
+ 0.1% Tween20 with a final wash in 1 x PBS. Blots were scanned using the Odyssey Infrared 
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Imaging System (LI-COR Biosciences, Lincoln, NE) interfaced to a PC running Odyssey 2.1 
software for quantification. To control for potential discrepancies in loading concentration, values 
are expressed as a ratio to the corresponding GAPDH integrated intensity. Values that were +/-1.5 
standard deviations from the group mean were excluded from analyses. 
 
A.2.8 Pharmacokinetics. 
 
 
Blood aliquots were collected into micronic tubes (70 uL blood + 130 uL water with HEPES 0.1N), 
vortexed and stored at 4°C prior to the assay. Samples were vortexed and centrifuged at 3000rpm 
for 10 mins and diluted into 96 well plates for the assay (80μL water + 100μL supernatant). Brains 
were homogenized with 4.3 vol. di MeOH 50% and collected into tubes (200μL). Homogenates 
were then vortexed and centrifuged at 3000rpm for 10 minutes and the aliquots of the supernatant 
transferred to 96 well plates. High performance liquid chromatographic (HPLC) assays using mass 
spectrometric detection (LC-MS/MS with UV) for the determination of AUT1 were developed 
and validated to identify the compound in brain and blood matrices. 
 
A.2.9 Statistical Analysis. 
 
 
Data were analyzed using an unpaired Student’s t-test while comparisons of three or more group 
means were conducted using an analysis of variance (ANOVA) followed by a Bonferroni or 
Dunnett post-hoc test for multiple comparisons. Analyses over time were conducted using a two- 
way repeated measures-ANOVA followed by a Bonferroni post-hoc test to control for multiple 
comparisons. In some instances, interactions that reached significance or trended towards 
significance were followed up with post-hoc student’s t-tests and are indicated in the figure 
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legends. Analyses were conducted using the GraphPad Prism 5 statistical software for Windows. 
Data are presented as mean ± standard error of the mean (SEM) with a two-tailed p-value ≤ 0.05 
considered statistically significant. 
 
 
 
A.3 RESULTS 
 
 
A.3.1 AUT1 attenuates amphetamine-induced hyperactivity: importance of Kv3.1 
channels. 
 
The efficacy of AUT1 was first assessed in the amphetamine-induced hyperactivity model in the 
outbred CD1 mouse strain (figure 23). AUT1, administered 30 min prior to a single dose of 
amphetamine, was effective in preventing amphetamine-induced hyperactivity in a dose- 
dependent manner (figure 23a,c). One-way ANOVA revealed a significant difference between pre- 
treatment groups (F5,57 = 2.96, p = 0.02) Both 30 mg/kg and 60 mg/kg doses were effective in 
attenuating hyperactivity, whereas no significant effect was found with a 10 mg/kg AUT1 dose. 
Significant group differences were found in locomotor activity during the 60 minutes following 
amphetamine injection (F5,54 = 13.17, p < 0.0001) (figure 23c). Importantly, the higher (60 mg/kg) 
AUT1 dose was as effective as clozapine, an antipsychotic with demonstrated anti-manic efficacy, 
at preventing hyperactivity. 
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Figure 24. A Kv3.1 channel modulator (AUT1) prevents amphetamine-induced hyperactivity. (A) CD1 mice 
were pre-treated with AUT1 (10 mg/kg, 30 mg/kg or 60 mg/kg) or AUT1-vehicle 30 minutes prior to a single injection 
of 2 mg/kg amphetamine (indicated by red arrow). Locomotor behavior was assessed both before (B) and after (C) 
amphetamine injection. Clozapine was administered as a positive control. (A) Time course of locomotor activity 
following AUT1 administration at T=0min and after amphetamine injection at T=30min. (B) There was a significant 
difference in locomotor activity across pretreatment groups, with a specific reduction in locomotor activity within the 
clozapine group prior to amphetamine injection. Note that two vehicle groups are depicted to dissociate groups that 
subsequently received a second dose of a vehicle (vehicle group 1: vehicle + vehicle) vs. a dose of amphetamine 
(vehicle group 2: vehicle + amph). Importantly, AUT1 had no effect on locomotor activity prior to amphetamine 
injection. (C) As expected, amphetamine injection resulted in a significant increase in activity in vehicle pre-treated 
CD1 mice and in mice that were pre-treated with a low dose of AUT1 (10 mg/kg). Locomotor activity following 
amphetamine injection was significantly lower in mice that were pretreated with higher doses of AUT1 (30 mg/kg 
and 60mg/kg) relative to vehicle pre-treated mice, i.e. locomotor activity following amphetamine injection in AUT1 
pre-treated mice was not significantly different than mice who did not receive amphetamine (saline injection). The 
highest dose of AUT1 was as effective as clozapine pre-treatment at preventing amphetamine-induced hyperactivity 
(clozapine vs. vehicle + amph). Vehicle group = AUT1-vehicle pretreatment + saline injection. Vehicle + amph = 
AUT1-vehicle  pre-treatment  +  amphetamine.  Treatment  group  vs.  vehicle  ***p<0.001;  treatment  group  vs. 
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amphetamine: ##p<0.01, ###p<0.001. Amph = amphetamine. Red arrow indicates time of amphetamine 
administration. n=10/group. 
 
 
Pharmacokinetic analyses were conducted to measure the systemic exposure and brain penetration 
of differing doses of AUT1 (10, 30 and 60 mg/kg) in male CD1 mice at 30 min (blood 
concentration) and 90 minutes (blood and brain concentration measured following locomotor 
testing) post-administration (Table 4). Overall, brain penetration was high and consistent among 
the doses. The mean brain-to-blood concentration ratio for AUT1 was ca. 1.6. Importantly, 
sufficient brain penetration was observed at all doses tested and was concurrent with behavioral 
effects seen during efficacy testing. 
 
 
Table 3. Bioavailability of AUT1 with oral administration. 
 
 
 
 
To test the specificity of this effect to Kv3.1 channels, separate cohorts of Kv3.1 null mice 
and their WT littermates were administered three different doses of AUT1 (or vehicle) 30 min 
prior to a single injection of amphetamine or vehicle (figure 24). Both WT and Kv3.1 null mice 
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exhibited the expected increase in locomotor activity following a single amphetamine injection 
(figure 24b). WT mice, however, that received AUT1 prior to amphetamine, exhibited attenuation 
in amphetamine-induced hyperactivity with the effects most notable at the 60 mg/kg and 100 
mg/kg doses. Two-way ANOVA revealed a significant main effect of treatment on locomotor 
activity (F4,67 = 22.37, p < 0.0001) and a genotype x treatment interaction (F4,67 = 2.28, p = 0.07) 
(figure 24b). 
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Figure 25. AUT1 does not attenuate amphetamine-induced hyperactivity in Kv3.1 null mice and these mice 
exhibit manic-related behaviors. (A) Cohorts of mice were pre-treated with AUT1 (30 mg/kg, 60 mg/kg or 100 
mg/kg, i.p.) or AUT-vehicle prior to amphetamine injection (4 mg/kg, i.p.) at T=30min. Bonferroni post-hoc analyses 
revealed that wild-type (WT) mice decreased locomotor activity in response to AUT administration in a dose- 
dependent manner relative to vehicle-treated WT mice. In Kv3.1 null mice, only AUT1 at the highest dose of 100 
mg/kg significantly reduced activity relative to vehicle treated Kv3.1 mice. Note that two vehicle groups are depicted 
to dissociate groups that subsequently received a second dose of a vehicle (vehicle group 1: vehicle + vehicle) vs. a 
dose of amphetamine (vehicle group 2: vehicle + amph). (B) Bonferroni post-hoc analyses revealed that amphetamine 
109  
injection lead to a significant increase in locomotor activity in both vehicle pre-treated WT and Kv3.1 null mice and 
in mice pre-treated with the lower 30 mg/kg dose of AUT1. AUT1 administered at 60 mg/kg and 100 mg/kg, however, 
prevented amphetamine-induced hyperactivity in WT mice, leading to a significant reduction in locomotor behavior 
relative to vehicle pre-treated mice administered amphetamine (WT AUT1 vs. amph). In contrast, AUT1 was not 
effective at preventing amphetamine-induced hyperactivity in Kv3.1 null mice, with significant increases in 
locomotion observed following amphetamine injection at 30 mg/kg (Kv3.1 AUT1 vs. vehicle) and 60 mg/kg but not 
at 100 mg/kg. AUT1 vs. vehicle: *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; AUT1 vs. vehicle + Amph: 
###p<0.001. Amph = amphetamine. n=6-10/group. (C) Kv3.1 null mice exhibited a significant increase in total 
locomotor activity over a 1-hour test in novel locomotor chambers. Anxiety-like behaviors were decreased in Kv3.1 
null mice as demonstrated by significant increases in (D) time spent exploring the open arms of the elevated plus maze 
(no difference in entries into open arm [E]) and in (F and G) time spent in, and transitions into, the light chamber of 
the light:dark test. (H) Furthermore, Kv3.1 mice exhibited a significant increase in time spent struggling in the forced 
swim test. WT vs. Kv3.1: *p<0.05, **p<0.01, ***p<0.001 n=8/genotype. 
 
 
At the highest dose of 100 mg/kg, AUT1 significantly decreased locomotor activity in both 
WT and Kv3.1 null mice prior to amphetamine injection, possibly indicating a non-specific 
sedative effect at this dose (figure 24a). AUT1, however, was not effective at reducing 
amphetamine-induced hyperactivity in mice lacking Kv3.1 channels, even at these high doses 
(figure 24b,), which argues against a purely sedative effect. This suggests that functional Kv3.1 
channels are required for the effects of AUT1 on amphetamine-induced hyperactivity. Notably, 
this was confirmed by repeating the experiment using Kv3.2 knock-out mice where AUT1 was as 
effective at preventing hyperactivity as in WT mice (F2,24 = 12.73, p = 0.0002) (figure 25). 
Collectively, this suggests that Kv3.1 channels (and not Kv3.2) are necessary for AUT1’s 
mechanism of action in this model. 
110  
 
 
Figure 26. AUT1 prevents amphetamine-induced hyperactivity in Kv3.2 KO mice. (A) Time course of locomotor 
activity in wild-type (WT) and Kv3.2 knock-out (KO) mice that received pre-treatment with AUT1 (60 mg/kg, p.o.) 
or vehicle at T=0min followed by an injection of amphetamine (2 mg/kg, i.p.) at T=30min (injection time indicated 
by red arrow). (B) There was no significant difference in locomotor activity following AUT1 administration prior to 
amphetamine injection. Note that two vehicle groups are depicted to dissociate groups that subsequently received a 
second dose of a vehicle (vehicle group 1: vehicle + vehicle) vs. a dose of amphetamine (vehicle group 2: vehicle + 
amph).  (C)  Two-way ANOVA revealed  a  significant  main effect  of treatment  on locomotor  activity following 
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amphetamine injection. Bonferroni post-hoc analyses confirmed that amphetamine led to a significant increase in 
activity in both WT and Kv3.2 vehicle pre-treated mice. AUT1 pre-treatment was effective at preventing 
amphetamine-induced hyperactivity in both WT and Kv3.2 mice, with no significant difference from vehicle pre- 
treated mice. Locomotor activity in AUT1 pre-treated mice was significantly lower than mice that received 
amphetamine injection alone. Treatment group vs. vehicle: *p<0.05; treatment group vs. amphetamine: #p<0.05. 
Amph = amphetamine. Red arrow indicates time of amphetamine administration. n=5/group. 
 
 
A.3.2 Kv3.1 null mice exhibit manic-likebehaviors. 
 
 
To further establish an association between Kv3.1 channels and mood-related behaviors, mice 
lacking Kv3.1 channels were tested in a behavioral battery to assess features of manic-like 
behavior including exploratory, anxiety- and depressive-like behaviors. Kv3.1 null mice exhibited 
a hyperactive phenotype during a 1-hr locomotor test (t12 = 3.55, p < 0.01) (figure 24c). Kv3.1 
null mice also exhibited an increase in exploration of the open arms of the elevated plus maze 
(figure 24d-e) and light chamber of the light-dark test (figure 24f-g), indicating an overall decrease 
in anxiety-like behaviors (time: t12 = 2.43, p = 0.032; transitions: t13 = 2.42, p = 0.031). In the 
forced swim test, Kv3.1 null mice exhibited antidepressant-like behavior as evidenced by 
increased time spent struggling relative to WT littermate controls (t14 = 5.11, p = 0.0002) (figure 
24h). 
 
A.3.3 Effects of AUT1 on hyperactivity in the ClockΔ19 mutant mouse model ofmania. 
 
 
The ability of AUT1 to attenuate hyperactivity was additionally tested in the well-validated 
ClockΔ19 mutant mouse model of mania (Roybal et al, 2007b). As expected, vehicle treated 
ClockΔ19 mice exhibited hyperactivity compared to WT littermate controls throughout the 
duration of locomotor testing (p < 0.01) (figure 26).  ClockΔ19 mutant mice that received acute 
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administration of AUT1, however, exhibited a reduction in locomotor activity at both a 30 mg/kg 
(F1,27 = 14.67, p = 0.0007, genotype effect; F1,27 = 6.11, p = 0.02, treatment effect) (figure 26a,b) 
and 60 mg/kg dose (figure 26c,d), with the higher 60 mg/kg dose completely reversing 
hyperactivity to WT levels with a significant main effect of treatment (F1,25 = 9.023, p = 0.006) 
and a trend for a main effect of genotype (F1,25 = 3.84, p = 0.062). Importantly, AUT1 did not 
impact locomotion in WT controls at these doses. 
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Figure 27. AUT1 reverses hyperactivity in the ClockΔ19 mutant mouse model of mania. (A, C) Time course of 
locomotor activity in wild-type (WT) and ClockΔ19 administered a (A, B) 30 mg/kg or (C, D) 60 mg/kg dose of AUT1 
or vehicle (AUT1-vehicle) at T=0min. (B). As expected, Bonferroni post-hoc analyses revealed that vehicle-treated 
ClockΔ19 mice exhibited a significant increase in locomotor activity relative to WT mice. ClockΔ19 mice 
administered 30 mg/kg AUT1 exhibited a significant reduction in locomotor activity compared with vehicle treatment. 
(D) The ability of AUT1 to reduce hyperactivity in ClockΔ19 mutants was additionally tested at a 60 mg/kg dose. 
Hyperactivity was seen in vehicle treated ClockΔ19 vs. WT and a complete reversal of this phenotype with 60 mg/kg 
AUT1 administration (ClockΔ19 AUT1 vs. vehicle). Genotype effects: *p<0.05, **p<0.01; treatment effects: 
#p<0.05, ##p<0.01. n=7-8/genotype. 
 
 
 
 
A.3.4 AUT1 differentially modulates ClockΔ19 VTA neuronalactivity. 
 
Given the effect of AUT1 in attenuating hyperactivity in ClockΔ19 mice, we focused on the VTA 
as a region of interest to further explore the underlying mechanism. In an ex vivo preparation, we 
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tested the ability of AUT1 to modulate firing and action potential (AP) properties of ClockΔ19 
dopamine and non-dopamine (putatively GABAergic) neurons (figure 27). The identity of cell 
types was confirmed by standard electrophysiological signatures including morphology, 
spontaneous firing rate and the presence of an HCN channel-mediated hyperpolarization-activated 
current (Ih) (figure 27a,b). As measured by whole-cell current clamp, AUT1 bath application 
(10µM) significantly decreased DA neuron AP firing compared with DMSO (0.1%) specifically 
at higher current injections (F(1,31)= 4.049, p = 0.0530 treatment effect; F(10, 310)= 392.5, p < 0.0001 
current effect; F(10, 310) = 2.994, p = 0.0013 interaction) (figure 27c). AUT1 appeared to increase 
the rate of firing in non-DA neurons, but this effect did not reach significance (F(1,10) = 0.5848, p 
= 0.4621 treatment effect; F(10, 100) = 179.3, p < 0.0001 current effect) (figure 27d). 
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Figure 28. The firing rate of ClockΔ19 VTA dopamine neurons is attenuated by AUT1. (A) Micrograph of VTA 
dopamine neurons in a brain slice from ClockΔ19 mutant mice. (B) DA neurons exhibit a characteristic Ih-mediated 
“sag” response to hyperpolarizing voltage steps and spontaneous activity in the range of 1-3Hz (left) while putative 
GABAergic neurons in the VTA lack Ihcurrent and fire at a rate higher than 20Hz (right). (C) AUT1 reduced the firing 
of DA neurons compared with DMSO specifically at higher current steps; n=14 DMSO, n=19 AUT1 (D) AUT1 
application did not significantly alter the firing of GABAergic cells in a small sample group; n=6 DMSO, n=6 AUT1. 
*p<0.05, **p<0.01. 
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Furthermore, we examined the effects of AUT1 application on several action potential properties 
of DA and non-DA neurons in ClockΔ19 VTA. We analyzed the half width, amplitude of the 
negative phase of the first derivative, coefficient of variation (CV) of the inter-event interval and 
amplitude of spikes at 100pA and 200pA current steps (figure 28a). Here we found that AP half 
width of ClockΔ19 mutant DA cells was significantly increased (F(1,27) = 6.306, p = 0.0183 
treatment effect; F(1,27)= 43.05, p < 0.0001 current effect) as was the CV (F(1, 26)= 7.520, p = 0.0109 
treatment effect; F(1,26) = 40.11, p < 0.0001 current effect). The first derivative was significantly 
reduced in the presence of AUT1 (F(1,27) = 6.602, p = 0.0160 treatment effect; F(1,27) = 46.98, p < 
0.0001 current effect). AP amplitude remained unchanged (F(1, 26) = 1.254, p = 0.2730 treatment 
effect; F(1, 26) = 66.24, p < 0.0001 current effect) (figure 28b-e). These data indicate that AUT1 
broadens individual APs, decreases the rate of repolarization and increases irregularity of APs 
within the spike train. 
When we recorded from putative GABAergic neurons, we did not find significant changes 
in AP half width (F(1,7) = 0.2994, p = 0.6013 treatment effect; F(1, 7) = 6.060, p = 0.0434 current 
effect), first derivative (F(1, 7)= 1.773, p = 0.2248 treatment effect; F(1,7)= 185.5, p < 0.0001 current 
effect) and amplitude (F(1, 7)= 0.3100, p = 0.5950 treatment effect; F(1, 7)= 23.30, p = 0.0019 current 
effect). However, AUT1 significantly decreased the CV at both current steps (F(1, 7) = 10.44, p = 
0.0144 treatment effect; F(1, 7) = 1.809, p = 0.2206 current effect) (figure 28f-i). Together, our 
results suggest that AUT1 may exert its effects on reducing ClockΔ19 hyperactivity through a 
subtle augmentation of GABAergic neuronal firing properties that may lead to an inhibition of DA 
neuronal firing and spike fidelity. 
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Figure 29. AUT1 modulates action potential properties of ClockΔ19 dopamine and GABAergic neurons. (A) 
Representative spike trains and individual action potentials from DMSO and AUT1 treated DA neurons. Middle APs 
were chosen for analysis of half width, first derivative negative phase amplitude, and spike amplitude. (B) Application 
of AUT1 increased the AP half width of DA neurons at 100pA and 200pA. (C) The first derivative of APs was 
significantly decreased by AUT1 at both 100pA and 200pA current steps. (D) AUT1 incubation increased the CV of 
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the inter-event interval. (E) Lastly, we did not identify an effect of AUT1 on the AP amplitude of DA neurons 
compared with DMSO. (F) Analysis of AP properties of GABAergic revealed no significant effect of AUT1 on AP 
half width. (G) Similarly, AUT1 incubation failed to alter the first derivative compared with DMSO. (H) ClockΔ19 
GABAergic neurons however responded to AUT1 application with a significant decrease in the CV of the inter-event 
interval at both current steps. (I) AP amplitude was unaffected by AUT1 incubation. *p<0.05, **p<0.01. 
 
 
 
 
A.3.5 Kv3.1 channels are targets of mood stabilizer treatment in ClockΔ19 mutantmice 
 
 
Immunohistochemistry confirmed the presence of Kv3.1b channels in various dopaminergic rich 
regions of the brain, including the caudate putamen (figure 29a), Islands of Calleja (figure 29b), 
VTA (figure 29c) and substantia nigra (figure 29d). Based on previous work demonstrating the 
importance of both the VTA and NAc to manic-related behaviors in ClockΔ19 mutant mice (Coque 
et al, 2011; Dzirasa et al, 2010; McClung et al, 2005; Mukherjee et al, 2010), we used Western 
blotting to quantitate levels of Kv3.1b protein (an alternative splice form of the Kv3.1 subunit) 
specifically in these mesolimbic brain regions. Analysis revealed an increase in Kv3.1b channel 
protein in the VTA of ClockΔ19 mutant mice compared to WT controls (p = 0.056) (figure 28e), 
with no differences in the NAc (figure 28f). Interestingly, lithium, which reverses manic-like 
behavior in ClockΔ19 mutant mice and restores normal dopaminergic activity (Roybal et al, 2007; 
Coque et al, 2011), also restored Kv3.1 protein to WT levels in the VTA (p < 0.05) with a trend 
for an interaction in the effect of lithium treatment on Kv3.1b protein in ClockΔ19 mice compared 
with WT littermate controls (F(1,18 )= 3.38, p = 0.08) (figure 29e). 
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Figure 30. Lithium restores abnormal Kv3.1b protein levels in a mouse model of mania. Kv3.1b immunopositive 
cells (green) were detected in various dopamine-rich areas of the brain including the (A) caudate putamen (CP), (B) 
Islands of Calleja, (C) ventral tegmental area (VTA), and (D) substantia nigra (SN). (E) Post-hoc analyses revealed 
an increase in Kv3.1b protein in the VTA of vehicle-treated ClockΔ19 mice that decreased to WT levels after 10 days 
of lithium treatment. (F) No significant genotype or treatment effects were found in the nucleus accumbens (NAc). 
ClockΔ19 water vs. lithium treatment: #p<0.05. n=5-6/genotype. 
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A.4 DISCUSSION 
 
 
The current study tested the efficacy of a novel modulator of Kv3-family voltage-gated potassium 
channels (AUT1) in two separate animal models associated with imbalance of the mesolimbic 
system: the amphetamine-induced hyperactivity model and the ClockΔ19 mutant mouse model of 
mania. Furthermore, Kv3.1 null mice were used to test for behavioral abnormalities in mice 
lacking Kv3.1 channels. Kv3.1 null mice were found to exhibit both increased exploratory drive 
and reduced depressive-like behaviors, combined with hyperactivity. A similar behavioral 
phenotype is present in the ClockΔ19 model of mania, though we have not yet determined if Kv3.1 
null mice share other features of mania including increases in the reward value for drugs of abuse, 
motivated behavior, and impulsivity. The current findings extend previous studies that have also 
shown similar behavioral abnormalities in Kv3.1 knockout mice, most notably hyperactivity 
(Espinosa et al, 2004; Joho et al, 2006). It should be noted that these mice also have highly 
disrupted daily activity rhythms (Kudo et al, 2011), with increased activity during the day (light 
cycle) and reduced sleep time, similar to that seen in ClockΔ19 mice and human manic patients 
(Espinosa et al, 2004; Joho et al, 2006; Naylor et al, 2000). 
In the amphetamine-induced hyperactivity model, we found that AUT1 successfully 
prevented hyperactivity in outbred mice. Importantly, AUT1 was unable to prevent amphetamine- 
induced hyperactivity in Kv3.1 null mice, demonstrating the importance of Kv3.1 channels to 
AUT1’s mechanism of action. Notably, this effect was specific to Kv3.1 channels, as AUT1 
successfully prevented hyperactivity in mice lacking Kv3.2 channels. Additionally, AUT1 also 
reversed hyperactivity in the ClockΔ19 mutant mouse model of mania, where we found 
background alterations in the expression of Kv3.1 channels in dopamine-rich mesolimbic regions. 
Specifically, Kv3.1b protein levels were increased in the VTA of ClockΔ19 mutant mice. Based 
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on the manic-like behavioral profile observed in mice lacking functional Kv3.1 channels, one 
might expect a decrease in Kv3 channels in the VTA of ClockΔ19 mutants. However, the increase 
might reflect a compensatory mechanism that attempts to normalize the increased VTA dopamine 
neural activity present in ClockΔ19 mutants (Coque et al, 2011; Roybal et al, 2007b). A similar 
compensatory effect has been proposed for the observed decrease in levels of glutamate-receptor 
1 (GLUA1) protein in the NAc of ClockΔ19 mutant mice (Dzirasa et al, 2010). It is also possible 
that these channels are not optimally functional in the Clock∆19 mice leading to an attempt at 
rescue through increased expression. Regardless of the directionality of the effect, the current 
results suggest an association between Kv3.1 channels and mania-related behaviors possibly 
through its action on dopaminergic neural activity. Indeed, given that previous studies have shown 
that Kv3.1 channels are present in dopaminergic-rich CNS regions and given that we found 
evidence of protein expression in various dopamine-rich areas, it is likely that Kv3.1 channels 
indirectly contribute to dopaminergic neural activity through modulation of GABAergic 
interneuron activity. With regards to the current findings, it should be noted that 30% of VTA 
neurons are GABAergic (Sesack and Grace, 2010). 
Rosato-Siri and colleagues have demonstrated AUT1-induced modulation of PV 
interneuron firing in the somatosensory cortex of mice when potassium channel activity is 
pharmacologically impaired (Rosato-Siri et al, 2016). Our results showed significant effects of 
AUT1 on the action potential characteristics of ClockΔ19 DA and putative GABAergic neurons 
in the VTA. The most robust effect of the drug was to reduce the CV of firing of GABAergic 
neurons. This effect may be associated with the reduced AP half-width and increased rate of 
repolarization that was observed following AUT1 application; these parameters showed only a 
trend towards reduction and increase, respectively.  However, AP half-width and rate of 
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repolarization prior to AUT1 application were already very short and fast, respectively, thus further 
positive modulation would be limited by other ion channels mechanisms. The combination of 
effects of AUT1 observed in GABAergic neurons is entirely consistent with Kv3.1 positive 
modulation. We suggest that observed effects of AUT1 on the AP characteristics of the recorded 
DA neurons may be secondary to alterations in the firing properties of the GABAergic neurons 
that synapse onto them. This would be consistent with the presence of Kv3.1 channels on 
GABAergic neurons, but not DA neurons (Kudo et al, 2011). However, we cannot exclude the 
possibility that the significant changes in DA cell AP characteristics seen with AUT1 might be due 
to action of the drug on other ion channels directly on the DA cells. 
Moreover, we found that the levels of Kv3.1 channel protein were normalized in the 
Clock∆19 mice in response to lithium, which is known to decrease dopaminergic activity in these 
animals (Coque et al, 2011). The decrease in Kv3.1 levels could occur as a response to 
normalization of dopamine levels, or it could be involved more directly in the actions of lithium 
on neural activity. A critical aspect of this study was the ability to compare concentrations of AUT1 
that were active in vivo with those concentrations that have been shown to modulate Kv3 channels. 
In vitro, concentrations in the range of 1–10 micromolar were found to modulate Kv3.1 and Kv3.2 
channels (Rosato-Siri et al, 2016). In the present study, we found that doses of 30 and 60 mg/kg 
of AUT1 produced significant effects on behavior in the mouse models tested. These oral doses 
were associated with free brain concentrations in the range of 1 – 2 micromolars over the time- 
course of behavioral testing. These concentrations are therefore consistent with effects mediated 
by Kv3 channels. 
A recent study confirmed the importance of Kv3.1 channels to additional psychiatric 
disorders. Kv3.1 channels were reduced in patients with schizophrenia and normalized with 
123 
antipsychotic treatment (Yanagi et al, 2014). Here, the authors focused on the importance of these 
channels located on cortical parvalbumin (PV) interneurons and the role of these neurons in 
maintenance of cortical gamma oscillations and synchrony (Sohal et al, 2009), which are disrupted 
in schizophrenia, bipolar disorder and in severe cases of unipolar depression (Uhlhaas et al, 2011). 
A direct role for Kv3.1 channels in the generation of thalamocortical gamma oscillations has been 
described in the Kv3.1 null mice (Joho et al, 1999), demonstrating a link between Kv3.1 channels 
and the maintenance of fast spiking neural activity required for gamma synchronization. Moreover, 
AUT1 was able to restore normal levels of activity of the PV-positive interneurons in the 
somatosensory cortex (Rosato-Siri et al, 2016). Thus, Kv3.1 channels may play a role in the 
development of different classes of psychiatric diseases. As novel medications for psychiatric 
diseases are greatly needed, we propose that compounds like AUT1, which directly target and 
modulate Kv3 channels, may be beneficial for the treatment of disorders associated with abnormal 
neural activity. In particular, this may prove to be a useful strategy for restoring dopaminergic 
function without the side effects associated with dopamine blockade. Further studies will be 
needed to understand the exact role these channels play in the development of psychiatric disease. 
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APPENDIX B 
REGULATION OF ANXIETY-LIKE BEHAVIOR AND GABAA RECEPTORS BY 
NPAS2 
Ozburn AR, Kern J, Parekh PK, Logan RW, Liu Z, Falcon E, Becker-Krail D, Purohit K, Edgar 
NM, Huang Y, and McClung CA. (Submitted to Biological Psychiatry) 
Abnormal circadian rhythms are strongly associated with several psychiatric disorders. NPAS2 is 
a core component of the molecular clock that acts as a transcription factor and is highly 
expressed in reward- and stress-related brain regions such as the nucleus accumbens (NAc). 
Variations in Npas2 are associated with seasonal affective disorder and major depressive 
disorder. However, the mechanisms by which NPAS2 is involved in mood-related behaviors is 
still unclear. We determined the effect of a chronic stress paradigm on NAc Npas2 expression, 
characterized the behavioral phenotype of mice with a null mutation in Npas2 and mice with 
reduced NAc Npas2 expression (via RNAi). Further, we identified and validated GABAA 
subunits as novel transcriptional targets of NPAS2, and assessed the effects of NAc Npas2 
knockdown on inhibitory neurotransmission. Chronic unpredictable mild stress significantly 
increased Npas2 expression in the NAc. Npas2 mutants exhibited decreased anxiety-like 
behaviors (in elevated plus maze, light/dark box, and open field assay) as compared 
with WT mice. NAc Npas2 knockdown was sufficient to reduce anxiety-like behaviors and alter 
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inhibitory neurotransmission (decrease mIPSC amplitude). Additionally, Npas2 mutants were 
resistant to the motor incoordinating effects of diazepam. Furthermore, we found that NPAS2 
binds to and regulates specific Gabra genes and Npas2 knockdown rendered MSNs insensitive to 
diazepam. We provide strong evidence that the circadian transcription factor, NPAS2, modulates 
anxiety-like behaviors and GABAA receptors using a combination of molecular and behavioral 
approaches. These findings suggest a mechanism by which stress increases NPAS2 dependent 
transcription of specific GABAA receptor subunits, thus altering the function of the receptors and 
ultimately inhibitoryneurotransmission. 
B.1 INTRODUCTION
Psychiatric disorders are among the most devastating diseases and rank among the top factors 
involved in loss of productivity, quality of life, and reduced life span. Clinical and pre-clinical 
studies provide strong evidence that circadian rhythms and the genes that make up the molecular 
clock play a key role in the expression of mood-related symptoms in psychiatric disorders 
(Karatsoreos, 2014; Landgraf et al, 2014; Logan et al, 2014; Falcon and McClung, 2009). In fact, 
nearly all psychiatric disorders involve some disruption to the normal sleep/wake cycle and this is 
often one of the criteria used for diagnosis (McClung, 2013). 
Circadian rhythms are regulated by a set of transcriptional/translational feedback loops that 
make up the molecular clock. The core feedback loop consists of transcription factors Circadian 
Locomotor Output Cycles Kaput (CLOCK), or Neuronal PAS Domain Protein 2 (NPAS2), and 
Brain and Muscle ARNT like Protein 1 (BMAL1) forming heterodimers, binding to E-box 
(CACGTG) sequences and positively regulating the transcription of Period (Per1, Per2, and Per3) 
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and Cryptochrome (Cry1 and Cry2) genes. PER and CRY proteins are phosphorylated by casein 
kinase epsilon 1 (CKE1), form homomers or heteromers, and translocate to the nucleus where they 
can inhibit CLOCK:BMAL1 or NPAS2:BMAL1- mediated transcription (Lowrey and Takahashi, 
2000; Mohawk and Takahashi, 2011; Wang et al, 2007). While the circadian genes that drive these 
molecular rhythms are found in the master pacemaker (the suprachiasmatic nucleus), elements of 
the molecular clock are expressed throughout the brain and periphery. 
Studies have revealed that circadian genes and rhythms significantly contribute to mood, 
anxiety and depression, as well as reward and motivation (Logan et al, 2014; McClung, 2013; 
Ozburn et al, 2012; Ozburn et al, 2015; Parekh et al, 2015; Spencer et al, 2013; Roybal et al, 2007; 
Ozburn et al, 2013). Abnormal rhythms are strongly associated with psychiatric diseases like 
seasonal affective disorder, bipolar disorder, major depression, and drug addiction (Hasler et al, 
2012; Li et al, 2013; McCarthy et al, 2013; McClung, 2011; Mukherjee et al, 2010; Salgado- 
Delgado et al, 2011). Increased agitation and anxiety are key symptoms commonly associated with 
these disorders, and are the focus of the studies presented here. Moreover, many of the therapies 
used to treat these disorders are known to modulate the circadian clock (Bunney and Bunney, 
2013). Additionally, single nucleotide polymorphisms (SNP) in a number of circadian genes have 
been associated with mood disorders (Benedetti et al, 2004; Desan et al, 2000; Kishi et al, 2008; 
Kripke et al, 2009; Lavebratt et al, 2010a-b; Nievergelt et al, 2006). SNPs in Npas2 are associated 
with seasonal affective disorder and major depressive disorder (Partonen et al, 2007; Soria et al, 
2010). However, the role of NPAS2 in these mood-related behaviors is unclear. 
Our present research focuses on identifying mechanisms by which the circadian gene, 
Npas2, regulates anxiety-like behaviors. Npas2 is highly expressed in reward- and stress-related 
brain regions such as the nucleus accumbens (NAc) (Garcia et al, 2000). The NAc, primarily 
composed of GABAergic medium spiny neurons (MSNs), is a significant point of convergence for 
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this circuitry where it receives dopaminergic input from the VTA, as well as glutamatergic inputs 
from a number of other brain regions (such as the pre-frontal cortex, amygdala, and hippocampus). 
Previously we found that NPAS2 expression in the NAc is localized specifically to dopamine 
receptor 1 (Drd1a) containing neurons of the so-called “direct” pathway (Ozburn et al, 2015). This 
circuit is thought to underlie positive or rewarding associations with salient events. We performed 
ChIP Seq (chromatin immunoprecipitation followed by deep sequencing) on striatal tissue to 
identify DNA sequences bound to NPAS2 and identified many novel gene targets, including 
GABAA alpha (1, 2, 3, 4 and 5), beta (1, 2, 3), gamma (1, 2,3), epsilon, and pi subunits (Ozburn et 
al, 2015). In the current studies, we determine how stress and anxiety alter Npas2 in the NAc and 
how Npas2 regulates anxiety-like behavior and inhibitory neurotransmission using a combination 
of qPCR, RNA interference, pharmacological, behavioral, and electrophysiological methods. We 
hypothesize that stress and anxiety alter NPAS2-dependent transcription of specific GABAergic 
subunits that selectively alter phasic inhibitory neurotransmission (perhaps specifically in Drd1a 
containing medium spiny neurons of the NAc). 
B.2 MATERIALS AND METHODS
B.2.1 Animal use. 
Npas2 (C57BL/6:129S6) mutant mice (Garcia et al, 2000) were tested as homozygotes. Wild type 
littermate controls were utilized as a control for this mutation. Male C57BL/6J mice (The Jackson 
Laboratory, Bar Harbor, Maine) were utilized for Npas2 knockdown, gene expression following 
unpredictable chronic mild stress, and ChIP studies. All mice were housed in a 12:12 light/dark 
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cycle (lights on at 7am, lights off at 7pm) with food and water ad libitum. All animal use was 
approved by the University of Texas Southwestern Medical Center, the University of Pittsburgh, 
and the Portland VA Medical Center Institutional Animal Care and Use Committees. 
B.2.2 Unpredictable Chronic Mild Stress (UCMS). 
Mice were group housed and exposed to six weeks of UCMS or control handling (N=36 mice per 
group). UCMS treated mice were subjected to a randomized schedule of 1-2 mild stressors per 
day, seven days per week. Stressors included forced bath (~4cm of water in a rat-sized cage for 15 
min), wet bedding, aversive smell (1h exposure to fox urine), dirty bedding (rotate mice into 
previously occupied “dirty” cages), tilt cages (45° tilt), restraint (50ml tube for 15 min), reduced 
cage space, no bedding, and bedding change (replaced soiled bedding with clean bedding). Two 
or three stressors were intermittently used simultaneously to contribute to the random nature of the 
paradigm. No light/dark manipulations were used. Fur rating and body weights were measured 
weekly to track the progression of the “UCMS syndrome”. Control animals were housed in the 
same room as the UCMS exposed animals and only handled for fur ratings and body weight 
measurements. To ensure UCMS treated mice exhibited increased anxiety-like behaviors 
associated with UCMS syndrome, mice were subjected to elevated plus maze and light/dark box 
testing (on two separate days) during the 5th week of UCMS, and thus did not receive randomized 
stressors on these days. Stressors were purposely conducted at random times throughout the day 
to avoid potential non-specific circadian effects of acute stressors. Immediately after 6 weeks of 
UCMS or control handling, mice were sacrificed by cervical dislocation and rapid decapitation 
every 4 hours over the next 24-hour period (6 time points). Whole brains were dissected and flash 
frozen on dry ice, sectioned on a cryostat at 200um, and NAc tissue was collected using a 1mm 
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core tissue puncher. 
 
B.2.3 Quantitative Real-time RT-PCR. 
 
 
For UCMS tissue: Total RNA was extracted using an RNeasy Micro Kit (Qiagen, Germantown, 
MD) and converted to cDNA using the Superscript III First Strand Synthesis Kit (Life 
Technologies, Grand Island, NY). cDNA was mixed with SYBR Green master mix (Applied 
Biosystems, ABI) and specific primers for Npas2 or Gapdh. Prior to the experiment primer sets 
were tested thoroughly to determine reaction efficiency, specificity, and the absence of primer- 
dimers [2]. Primer sequences for Npas2 were (forward) 5’-GACACTGGAGTCCAGACGCAA- 
3’ and (reverse) 5’-AATGTATACAGGGTGCGCCAAA-3’ and for Gapdh (forward) 5’- 
AACGACCCCTTCATTGAC-3’       and       (reverse)    5’-TCCACGACATACTCAGCAC-3’. 
Quantitative real-time RT-PCR reactions were assessed by SYBR green fluorescence signal 
(Power SYBR Green PCR Master Mix, Life Technologies) using a 7900HT Fast Real-Time PCR 
System (Applied Biosystems, Grand Island, NY). 
For Npas2 shRNA and Scramble shRNA transduced NAc tissue: Tissue was collected, 
RNA was isolated, and cDNA synthesis was performed as described (Ozburn et al, 2015). 
Following cDNA synthesis, multiplex polymerase chain reaction (PCR) was used to measure 
relative gene expression of multiple gamma-aminobutyric acid receptor (type A) subunits of 
interest (and housekeeping gene Gapdh) in the same sample. In brief, cDNA was mixed with 
SsoAdvanced™ Universal Probes Supermix (Bio-Rad Laboratories; Hercules, CA) and all five 
probes for genes of interest: Gapdh: Cy5.5 reporter, Cat# 10031237; Gabrg1: FAM reporter, Cat# 
10031228; Gabrg2: HEX reporter, Cat# 10031231; Gabra1: TEX 615, Cat# 10031234, and 
Gabra2: Cy5 reporter, Cat# 12001950. Reactions were carried out in a Bio-Rad CFX96 Touch™ 
Real-Time  PCR  Detection  System  using  the  Bio-Rad  CFX  Manager  3.1  software  (Bio-rad 
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Laboratories). Scan mode was set to ‘all channels’ to allow for detection of each of the five 
fluorophore reporters. For all reactions: Samples were run in duplicate and ΔCT values were 
determined by normalizing to the reference gene Gapdh. Relative expression values were 
calculated based on the following: ΔΔCT=(ΔCThighest value across groups – ΔCTsample) then relative 
expression ((2-ΔΔCT ample / 2-ΔΔCT ighest value across groups)*100) was calculated as described in (Landgraf 
et al, 2014). 
B.2.4 Behavioral Assays. 
Locomotor Response to Novelty: Mice were individually placed in a novel environment inside 
automated locomotor activity chambers equipped with infrared photobeams (San Diego 
Instruments, San Diego, CA) and measurements began immediately. Activity was continuously 
measured and the data was collected in 5-minute bins over a period of two hours. Distance traveled 
was measured. An initial exploratory bout of increased activity that decreases over the two-hour 
testing period is typically seen and represents habituation to the novel environment. 
Elevated Plus Maze: The maze consisted of two open arms and two arms with raised walls. The 
mice were placed into the center of the maze, and their movement and time spent in each arm was 
tracked using Noldus EthoVision video tracking software. Each test lasted ten minutes. Number 
of entries into the open and closed arms were measured, as well as time spent in the open arms. 
More time spent in the open arms, and more open arm entries are both indicative of reduced 
anxiety-like behavior. 
Light/Dark Box: A locomotor box was partitioned into a dark chamber and a light chamber. The 
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mice were placed into the dark chamber for 1min prior to beginning data collection. Recording 
began when the gates were opened and the number of beam breaks in both chambers were recorded 
over the course of 10 minutes. Latency to enter and time spent in the light side of the apparatus 
were measured. Reduced latency to enter the light portion of the apparatus indicates reduced 
anxiety-like behavior. 
Open Field: The open field arena consisted of a square plexiglass arena with a clear floor and solid 
black walls (61 x 61 cm). Mice were placed in the center of the open field and allowed to freely 
explore for 10 minutes. Anxiety-like behavior was assessed using the following: time spent in the 
center of the arena, distance traveled and velocity of movement in the center. Locomotor activity 
was measured by total distance traveled. Behaviors were recorded and scored using Ethovision 
XT. Increased time spent in the center and distance traveled in the center of the arena indicated 
reduced anxiety-like behavior. 
Accelerating Rotarod Assay: The rotarod test was performed to evaluate motor coordination. 
Npas2 knockout and WT mice (n=7/genotype) were placed on immobile cylinders, which ramped 
up from 0 to 45 rotations/min (IITC, USA). The timer was stopped when the mouse fell off the 
cylinder or did a whole turn with it. This procedure was repeated for four consecutive days. The 
first two days consisted of training on the accelerating rotarod. On the last two days, mice were 
injected with either saline or 3 mg/kg diazepam (in a counterbalanced manner) 30 minutes prior to 
rotarod testing. For each genotype, latency to fall was compared under diazepam and saline 
treatment conditions. A reduction in the latency to fall indicates sensitivity to the motor 
incoordinating effects of diazepam. 
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B.2.5 Stereotaxic surgery. 
Bilateral stereotaxic injections of 1 μl of purified high titer AAV2 encoding a scrambled sequence 
with no known target (scramble shRNA) or Npas2 shRNA was injected into the NAc (from 
bregma: angle 10°, AP +1.5 mm, Lat +1.5, DV -4.4). Mice recovered for 3-4 weeks in their home 
cage to allow for full viral expression before behavioral testing began. At the completion of 
behavioral testing, viral injection placement verification was carried out using 
immunohistochemical methods. 
B.2.6 Immunohistochemistry. 
Mice were deeply anesthetized with a mixture of ketamine (225mg/kg) and xylazine (22.5mg/kg) 
and transcardially perfused with phosphate buffered saline (PBS) and then 4% paraformaldehyde 
in PBS. The brains were incubated in 4% paraformaldehyde for 24 hours and then placed in 1X 
PBS-30% glycerol for an additional 24 hours. Tissue sections (30um) containing the NAc were 
obtained using a freezing microtome (Leica, Wetzlar, Germany). Immunofluorescence detection 
was carried out using a primary antibody for GFP (ab290, AbCam, Cambridge, MA) and a 
secondary anti-rabbit antibody conjugated with Alexa-488 (Molecular Probes, Carlsbad, CA) 
using standard procedures (Mukherjee et al., 2010, Ozburn et al., 2015). Brain sections were 
mounted onto glass slides using Vectashield mounting media with DAPI (H-1200, Vector Labs, 
Burlingame, CA) and observed with an epifluorescence microscope with a 10x objective. Data 
from mice were excluded from study if the viral infection spread was not localized to the NAc 
(with spillover to adjacent areas) or if there was a significantly disproportionate amount of 
infection between both hemispheres. 
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B.2.7 Chromatin Immunoprecipitation (ChIP). 
Chromatin immunoprecipitation was carried out as previously described (Ozburn et al, 2015). 
ChIP Seq was performed at 6 times of day and identified novel DNA binding targets of NPAS2. 
Here, we performed a separate ChIP experiment using an NPAS2 antibody (H20X, Santa Cruz 
Biotechnology, Santa Cruz, CA) to confirm findings that NPAS2 binds to several genes encoding 
subunits of the GABAA receptor. As a control, we also incubated samples with Anti-acetyl-Histone 
H3 (Upstate) or non-immune rabbit IgG (Upstate). PCR products were visualized and size verified 
using agarose gel electrophoresis. Primer sets used for PCR verification of ChIP Seq results 
include: Gabra1 Forward 5’ GCT CTA AAA GCT GGA GAG TAG CAC C, Reverse 5’ CCC 
AGT CCT TCT TTA TAG GCA CCG C; Gabra2 Forward 5’ TGG GAA GAT TGT AAC CCG 
TCC CCC, Reverse 5’ CCT GTC ATA GCC CTG TGA GCC ACC; Gabra4 Forward 5’ GCC 
CTG CTT CCA CAG CAA CAC AC, Reverse 5’ GCC AAA TAC CTG GCC TCA GCA GC; 
Gabra5 Forward 5’ CCC AGA CAA GCA AGG GCT GAC CC, Reverse 5’ AGC CCA AGG 
AGA GTC CAG ACT GAT T; Gabrb1 Forward 5’ ACT GCA CAG CAC AGT GAG AGA GAG 
T, Reverse 5’ ACA CAC ACA CTC ACA CAC ACA CAG A; Gabrb2 Forward 5’ ATC ACT 
GAC TGC TAG GAT GCG ACT, Reverse 5’ GAG TCC TAT TGC CCG ATG CAA GGC; 
Gabrb3 Forward 5’ GGG AGG AGA GTG TAT TGT CCT GGT, Reverse 5’ ACA GTG CTA 
ACG GAG CAG AGC CA; Gabre Forward 5’ GGG CTC TGA TTT CAT CTC TGG CTC, 
Reverse 5’ AAC CGG AGC CCC ATC CCC A; Gabrg1 (SET 1) Forward 5’ AAA AGG CAT 
GCA CAT GGT TGG GTG A, Reverse 5’ CCT CAG CTG CAT CCC TGA CCC TC; and Gabrg1 
(SET 2) Forward 5’ TCC CTC GGG AAC CCG ACT CTC A, Reverse 5’ TCA CAC CGG GTG 
GAT GCG GC. 
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B.2.8 NAc slice preparation and electrophysiological recordings. 
Three weeks after stereotaxic injection of AAV Npas2 or scramble shRNA into the NAc, mice 
were anesthetized with isoflurane and decapitated. Brains were removed into ice-cold oxygenated 
(95% O2/5% CO2) modified aCSF containing (in mM): 135 N-methyl-D-glucamine, 1 KCl, 1.2 
KH2PO4, 1.5 MgCl2, 0.5 CaCl2, 70 choline bicarbonate, and 10 D-glucose; pH 7.4 adjusted with 
HCL; pH 7.4 adjusted with HCl). Coronal slices (250 µm) containing the NAc were sectioned with 
a vibratome (VT1200S; Leica) and incubated for 30 minutes at 37°C in oxygenated aCSF 
containing (in mM): 119 NaCl, 26 NaHCO3, 2.5 KCl, 1 NaH2PO4, 2.5 CaCl2, 1.3 MgCl2, 11 D- 
glucose. Slices were kept at room temperature until recording at which point they were perfused 
with aCSF heated to 30-32°C. Whole-cell patch-clamp recordings of identified MSNs with viral 
expression (as indicated by GFP fluorescence) were made under visual guidance with 40x 
objective and DIC optics. Borosilicate glass pipettes (3-5 MΩ) were filled with (in mM): 15 Cs- 
MeSO3, 120 CsCl, 10 HEPES, 0.5 EGTA, 8 NaCl, 5 TEA-Cl, 2 Mg-ATP, 0.3 Na-GTP, 5 QX-314; 
290mOsm; pH 7.3 adjusted with CsOH. 
For miniature IPSC (mIPSC) and evoked IPSC experiments, D-APV (50 µM) and NBQX 
(5 µM) were included to block ionotropic glutamate receptors and TTX (1 µM) was used to prevent 
action potential generation in mIPSC recordings. Drugs were bath applied. Cells were voltage- 
clamped at -70 mV and held for at least 10 minutes prior to data collection. A constant-current 
isolated stimulator (DS3; Digitimer) was used to stimulate inhibitory afferents through a 
monopolar electrode at 0.1 Hz using 0.1 µs single pulses. After establishing a stable baseline of 
mIPSCs or IPSCs, 10 µM diazepam-containing aCSF was bath applied at a consistent flow rate 
over 10 minutes. Synaptic currents were recorded with a MultiClamp 700B amplifier (Molecular 
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Devices). Signals were filtered at 2.6-3 kHz and amplified 5-10 times, then digitized at 20 kHz 
with a Digidata 1322A analog-to-digital converter (Molecular Devices). Series resistance for all 
recordings was <20MΩ and was monitored continuously. Cells with a change in series resistance 
beyond 20% were excluded from data analysis. For mIPSC analysis, an event template was 
obtained by averaging at least 50 single events and used for template search with a threshold of 4. 
Events from each cell underwent visual inspections. Scoring was performed blind to treatment. 
The amplitude and frequency of miniature events were analyzed offline with Clampfit software 
(Molecular Devices). Peak amplitude of evoked IPSCs was measured and averaged across baseline 
and treatment conditions. All data is presented as Mean +/- S.E.M., with n representing the number 
of cells/animals. 
B.2.9 Data analysis. 
Two-way analysis of variance (ANOVA) was performed to analyze 1) Npas2 gene expression data 
after UCMS (treatment x time factors), 2) locomotor activity in response to a novel environment 
for NAc Npas2 shRNA and Scramble shRNA treated mice (viral treatment x time), and 3) 
electrophysiological measurements of mIPSC amplitude, mIPSC frequency, and IPSC decay time 
in NAc MSNs with Npas2 shRNA or Scramble shRNA treated mice (viral treatment x drug 
treatment). Student’s t-test (two tailed, unpaired) was performed to analyze data from anxiety-like 
behavioral testing (elevated plus maze, light/dark box, and open field assays) in WT or Npas2 
mutant mice, and NAc Npas2 shRNA or Scramble shRNA treated mice. Student’s t-test (two 
tailed, unpaired) was performed to analyze change in IPSC amplitude with diazepam treatment 
(percent change from baseline) in NAc Npas2 shRNA or Scramble shRNA treated mice. Data are 
presented as mean +/- SEM and p < 0.05 is considered statistically significant. 
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B.3 RESULTS
B.3.1 Npas2 expression is increased in the NAc in response to UCMS. 
We sought to determine whether expression of Npas2 changes in response to a paradigm known 
to alter mood-related behaviors, we employed a 6 week UCMS paradigm which in our hands 
reliably induces an increase in anxiety and depressive-like behavior (Logan et al, 2014). We found 
that UCMS resulted in a robust and significant increase in diurnal Npas2 expression in the NAc 
compared to control mice (figure 30; two way ANOVA, main effect of treatment group 
F(1,68)=163.45, p < 0001; main effect of time F(6,68)=2.94, p < 0.05), suggesting that NPAS2 
might be involved in the response to chronic stress. 
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Figure 31. Chronic unpredictable mild stress results in a robust and significant increase in diurnal NAc Npas2 
expression as compared with control mice. Two way ANOVA, main effect of treatment group F(1,68)=163.45, p < 
0001; main effect of time F(6,68)=2.94, p < 0.05). ZT=zeitgeber time, ZT0=lights on, ZT12=lights off. n=5- 
6/treatment/ZT. Bonferroni post-hoc * p < 0.05, ** p < 0.01, ***** p < 0.0001. 
B.3.2 Npas2 mutant mice have reduced anxiety-like behaviors and reduced sensitivity to 
diazepam. 
In order to determine if functional NPAS2 is important for anxiety-like behavior, we assayed 
Npas2 mutant mice and their wild-type littermates in a battery of behavioral tests. Compared with 
wild-type mice, Npas2 mutant mice exhibited reduced anxiety-like behavior as seen by the 
increased percent time spent in the open arms of the elevated plus maze (figure 31a, Student’s t- 
test, t=2.454, p < 0.05; with a trend for increased number of open arm entries, t=1.505, p=0.14), 
138 
reduced latency to explore the light side of the light/dark box (figure 31b, t=2.739, p < 0.05) and 
increased distance traveled in the center of the open field arena (figure 31c, t=2.822, p < 0.01). 
Additionally, we observed that WT, but not Npas2 mutant, mice are sensitive to the motor 
incoordinating effects of diazepam (3mg/kg; a GABAA receptor positive allosteric modulator) as 
determined by the rotorod test (Student’s t-test, WT saline vs diazepam t=3.134, p < 0.01; Npas2 
mutant saline vs diazepam t=0.3451, n/s). 
Figure 32. Npas2 mutant mice exhibit reduced anxiety-like behavior. A) Percent time spent in the open arms of 
the elevated plus maze (n=16-24/genotype; Student’s t-test, t=2.454, * p < 0.05). B) Latency to explore the light side 
of the light/dark box (n=16/genotype; Student’s t-test, t=2.739, * p < 0.05). C) Distance traveled in the center of the 
open field arena (n=12-25/genotype; Student’s t-test, t=2.822, * p < 0.05). D) Latency to fall on accelerating rotarod 
assay in response to saline or diazepam (n=7/treatment/genotype; Student’s t-test, WT saline vs diazepam t=3.134, ** 
p < 0.01; Npas2 mutant saline vs diazepam t=0.3451, n/s). 
B.3.3 NAc knockdown of Npas2 results in reduced anxiety-likebehaviors. 
Because Npas2 expression in the NAc is highly responsive to the anxiogenic paradigm, UCMS, 
and the NAc is an important site of neural integration for salient events, we determined if reducing 
Npas2 expression in the NAc via viral mediated RNAi (Npas2 knockdown) was sufficient for a 
reduction in anxiety-related behaviors.  We first assessed the effects of NAc specific Npas2 
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knockdown on locomotor response to a novel environment where analysis revealed a small, but 
significant treatment x time interaction (figure 32a, two-way ANOVA, F(23,805)=2.12, p < 0.01). 
As expected, there was a significant main effect of time (F(23,805)=63.61, p < 0.0001), indicative 
of locomotor habituation over the two hour testing period. These results reveal that NAc Npas2 
knockdown did not have the same effect over the times measured, suggestive of altered habituation 
over time. We note that the effect is modest, with increased exploration in response to the novel 
environment during the first 30 minutes of the assay, and reduced exploration in the last 10 minutes 
of the assay. NAc Npas2 shRNA treated mice exhibited reduced anxiety-like behavior (as 
compared with scramble shRNA treated mice) in several behavioral measures. Npas2 knockdown 
in the NAc resulted in a significant increase in the number of open arm entries (figure 32b, 
Student’s t-test, t=2.097, p < 0.05) in the elevated plus maze, with a trend towards a significant 
increase in time spent in the open arms (t=1.798, p = 0.08, data not shown). Npas2 knockdown in 
the NAc resulted in a reduced latency to explore the light side of the light/dark box (figure 32c, 
t=2.243, p < 0.05). The effects of NAc Npas2 knockdown were less robust on behaviors in the 
open field test. Npas2 knockdown resulted in a trend towards an increase in the distance traveled 
in the center of the open field arena that did not reach statistical significance (figure 32d, t=1.591, 
p = 0.12). 
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Figure 33. NAc Npas2 knockdown results in reduced anxiety-like behavior. A) locomotor response to a novel 
environment (two-way ANOVA, treatment x time interaction F(23,805)=2.12, p < 0.01; main effect of time 
(F(23,805)=63.61, p < 0.0001), B) number of open arm entries in elevated plus maze (Student’s t-test, t=2.097, p < 
0.05), C) latency to explore the light side of the light/dark box (Student’s t-test, t=2.243, p < 0.05), and D) amount of 
time spent in the center of the open field arena (Student’s t-test, t=1.591, p = 0.12). n=10-13/treatment. 
 
 
 
 
B.3.4 NPAS2 regulates expression of GABAA subunits. 
 
 
Altered GABAA subunit composition and possibly altered inhibitory synaptic transmission may 
occur with reductions in Npas2 because NPAS2 mutant mice have reduced diazepam sensitivity. 
NPAS2 is a transcription factor, and in a previous study we performed ChIP Seq on striatal tissue 
to identify DNA sequences bound to NPAS2 and identified many novel gene targets, including 
GABAA alpha (1, 2, 3, 4 and 5), beta (1, 2, 3), gamma (1, 2,3), epsilon, and pi subunits (Ozburn et 
al, 2015). Here we replicated these findings using ChIP followed by PCR, and we found that 
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indeed NPAS2 binds genes encoding the GABAA subunits alpha 1, 2, 4, and 5, beta 2 and 3, and 
gamma 1 (data not shown) 
We next wanted to determine whether NPAS2 mediates expression of GABAA subunits 
that mediate responses to diazepam, or that could indicate synaptic or extra-synaptic localization 
(Gabra1, Gabra2, Gabrg1, and Gabrg2). Following viral-mediated knockdown of Npas2 in the 
NAc, expression of GABAA subunits at two time points (ZT16 (lights off) and ZT4 (lights on)) 
were measured via qPCR. Interestingly, Npas2 knockdown significantly reduced Gabra1 
expression at both time points measured, suggesting NPAS2 mediates positive regulation of 
Gabra1 transcription (figure 33; two way ANOVA - main effect of knockdown, F((1,24)=4.81, p 
< 0.05). Gabra2 exhibited diurnal expression, but was not changed with knockdown (data not 
shown). Intriguingly, the effect of Npas2 knockdown on Gabrg1 expression had different effects 
depending on time of day, suggesting factors play a role in its transcriptional regulation (data not 
shown). Lastly, Gabrg2 expression was unaltered with Npas2 knockdown as expected since it was 
not identified via ChIP-Seq. We assayed for this gene to ascertain whether it exhibited diurnal 
variation, and to determine whether Npas2 knockdown resulted compensatory changes in 
expression of this subunit; data not shown). 
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Figure 34. Effect of Npas2 knockdown on diurnal expression of GABAa alpha 1 (Gabra1) subunit in the NAc. 
Two way ANOVA – significant knockdown x time of day (ZT) interaction, F(1,24)=4.81, p<0.05. 
B.3.5 Npas2 knockdown prevents diazepam-induced potentiation of IPSC amplitude in 
NAc MSNs 
In order to assess the effect of Npas2 knockdown on inhibitory synaptic activity of MSNs, we 
performed whole-cell patch-clamp recordings in NAc-containing brain slices. We recorded 
baseline inhibitory miniature currents (mIPSCs) from scramble shRNA and Npas2 shRNA 
infected cells to determine effects of knockdown on current amplitude and frequency (indicating 
alterations in postsynaptic and presynaptic mechanisms, respectively; representative trace shown 
in Figure 34a). Analysis of mIPSC amplitude revealed a significant main effect of viral treatment 
(figure 34b; two way ANOVA, F(1,46)=6.26, p<0.05) but no main effect of diazepam and no 
significant interaction. Analysis of mIPSC frequency revealed no significant shRNA treatment by 
diazepam interaction and no main effect of either shRNA or drug. These results suggest that Npas2 
knockdown in the NAc alters postsynaptic responses but not presynaptic release of GABA onto 
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MSNs (figure 34c). 
However, because we found that mice lacking a functional Npas2 gene display behavioral 
insensitivity to diazepam (figure 31d) and NPAS2 binds to genes encoding GABAA subunits 
important for pharmacological actions of diazepam, we tested whether this insensitivity could be 
identified at the cellular level. Therefore, we measured the peak amplitude of the evoked IPSC at 
baseline and following 10 minutes of diazepam bath application (10 µM) in both scramble shRNA 
and Npas2 shRNA treated MSNs. We found that diazepam application reliably increased the 
average IPSC peak amplitude in scramble control cells by approximately 20% while this increase 
in current amplitude was noticeably absent in Npas2 shRNA infected cells (figures 33d,e; 
Student’s t-test, t20=2.152, p < 0.05; n = 10 scrambled, n = 12 shRNA). Additionally, we measured 
the decay kinetics of IPSCs from both groups under baseline and diazepam conditions. We found 
that there is a significant main effect of diazepam to prolong the decay time of the GABAA 
receptor-mediated IPSCs (two way ANOVA, F(1,34)=4.90, p < 0.05). However, it does so to a 
similar extent in both scramble- and Npas2 shRNA treated cells (decay time constants for 
Scramble shRNA: baseline 13.8 +/- 1.7, diazepam 19.4 +/- 2.5; decay time constants for Npas2 
shRNA: baseline 16.8 +/- 3.4, diazepam 24.6 +/- 5.0; n = 10 baseline scrambled, n = 13 baseline 
shRNA, n = 7 diazepam scrambled, n = 12 diazepam shRNA), suggesting that the effects of Npas2 
knockdown are specific to the change in current amplitude bydiazepam. 
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Figure 35. Npas2 knockdown prevents diazepam-induced potentiation of IPSC amplitude in NAc MSNs. A) 
Representative traces of baseline mIPSCs from AAV-scramble shRNA and -Npas2 shRNA infected cells, B) mIPSC 
amplitude (two way ANOVA, F(1,46)=6.26, * p < 0.05), C) mIPSC frequency (n/s), D) peak amplitude of the evoked 
IPSC at baseline and following 10 minutes of diazepam bath application (10µM) in both scramble shRNA and Npas2 
shRNA treated MSNs (Student’s t-test, t=2.152, * p < 0.05), and E) representative traces of evoked IPSC at baseline 
and following 10 minutes of diazepam from AAV-scramble shRNA and -Npas2 shRNA infected cells. n = 
cells/animals. 
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B.4 DISCUSSION 
 
 
Circadian rhythms and the genes that make up the molecular clock play an important role in the 
expression of mood-related symptoms in psychiatric disorders. Here we link Npas2 to responses 
to stressful and anxiogenic stimuli, expression of anxiety-like behavior, regulation of specific 
GABAA subunit expression, and inhibitory neurotransmission in the nucleus accumbens in 
response to anxiolytic medication. 
Chronic unpredictable mild stress (UCMS) results in a robust increase in levels of Npas2 
expression in the NAc. To examine the effects of this stressful and anxiogenic paradigm on 
rhythmic circadian gene expression, tissue samples were collected over a 24 hour period. 
Individuals with mood disorders experience perturbations in a myriad of rhythmic processes, 
therefore, this result was surprising in that we had hypothesized that chronic stress would decrease 
or completely disrupt Npas2 gene expression rhythms. Interestingly, we found that UCMS 
treatment resulted in an approximate 4-hour phase delay in the peak expression of Npas2 and as 
indicated by the significant main effect of time which might contribute to the development of 
anxiety-like phenotype following UCMS. 
To determine if Npas2 is important for the expression of anxiety-like behaviors, we 
subjected mice lacking functional Npas2 to a battery of behavioral tests. Npas2 mutant mice 
exhibited decreased anxiety-like behaviors as compared with wild-type mice. Npas2 mutants 
exhibited an increased percent time in open arms of the elevated plus maze, reduced latency to 
explore the light side of the light/dark box, and an increase in the distance traveled in the center of 
the open field arena. Further, Npas2 mutant mice were resistant to the motor incoordinating effects 
of diazepam, suggesting these mice may have altered GABAA receptor subunit composition and 
reduced synaptic localization. This phenotype is the opposite of the Per1-/-/Per2-/- double mutant, 
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which exhibit increased anxiety-like behavior (Spencer et al, 2013). Because Per1 and Per2 
negatively regulate NPAS2/BMAL1 transcription, this further supports a role for NPAS2 in the 
regulation of anxiety-like behaviors. WT and Npas2 mutant mice were evaluated in tests of sucrose 
preference and locomotor response to novelty, with no differences observed (Ozburn et al, 2015). 
Although CLOCK and NPAS2 are homologous transcription factors, these mutants exhibit 
opposing reward-related phenotypes. Previously we found that Npas2 mutant mice exhibit reduced 
sensitivity to the rewarding effects of cocaine, whereas ClockΔ19 mutant mice exhibit increased 
sensitivity (Ozburn et al, 2015). Observed differences in sensitivity to the rewarding properties of 
cocaine in ClockΔ19 and Npas2 mutants are likely due to brain region (and cell-type) specific 
expression differences, as well as differences in transcriptional targets (Ozburn et al, 2012). For 
example, Npas2 is highly expressed in limbic and forebrain regions (Garcia et al, 2000). 
Furthermore, Npas2 expression has been shown to be specific to dopamine receptor 1 (D1) 
containing MSNs in the NAc, which are thought to underlie positive or rewarding associations 
with salient events (Ozburn et al, 2012). 
Selective knockdown of Npas2 in the NAc results in reduced anxiety-like behavior, similar 
to Npas2 mutant mice. AAV-mediated knockdown of Npas2 specifically in the NAc results in 
increased percent time in the open arms of the elevated plus maze, reduced latency to explore the 
light side of the light/dark box, and an increase in the velocity of movement in the center of the 
open field arena. NAc Npas2 knockdown also resulted in a small, but significant difference in 
locomotor response to novelty, where Npas2 shRNA treated mice exhibited an initial increased 
exploratory behavior that decreased more quickly (habituation) than scramble shRNA treated 
mice. Together, these findings suggest that knocking down NAc expression of Npas2 recapitulates 
the reduced anxiety-like behaviors seen in the Npas2 mutant mice. Previous reports, in conjunction 
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with the studies presented here, support a model whereby VTA Clock is important for negatively 
regulating reward and anxiety and NAc Npas2 is important for positively regulating reward and 
anxiety (Ozburn et al, 2012; Mukherjee et al, 2010; Coque et al, 2011; Sidor et al, 2015). 
We further examined genes that are under the transcriptional control of NPAS2 to 
identify a mechanism by which NPAS2 could positively regulate reward and anxiety. Using ChIP 
Seq, gene expression and behavioral assays, we found that the direct regulation of Dopamine 
receptor 3 (Drd3) by NPAS2 in the NAc is important for regulating reward (Ozburn et al, 2015. 
Genetic manipulation of Drd3 in mice has not yielded reports of consistent effects on anxiety-like 
behavior (Morago-Amaro et al, 2014; Steiner et al, 1997; Xing et al, 2013). These studies separate 
the role of NPAS2 regulation of Drd3 in reward from the role of NPAS2 in measures of anxiety- 
related behavior and suggest a separate mechanism by which these processes are regulated. Based 
on our current findings that Npas2 mutant mice are insensitive to diazepam, we explored the 
possibility that NPAS2 may act as a positive regulator for the transcription of GABAA subunits. 
We performed ChIP assays on striatal tissue to isolate DNA bound to NPAS2 and used this DNA 
as a template for PCR with primers targeting various GABAA subunit genes. We confirmed that 
NPAS2 binds genes encoding the GABAA subunits alpha 1, 2, 4, and 5, beta 2 and 3, and gamma 
1 and plays an important role in the positive regulation of the GABAA alpha 1 subunit. The binding 
site for diazepam requires the pentameric subunit composition of the GABAA receptor to contain 
two alpha subunits (1,2,3 or 5) in combination with two beta and one gamma subunit. Thus, the 
reduced sensitivity to diazepam in Npas2 mutant mice is likely mediated by a reduction in alpha 1 
subunit expression. GABAA alpha1 is thought to be important for the sedative effect of 
benzodiazepines, whereas alpha 2 and 3 confer the anxiolytic effects. This novel finding indicates 
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that chronic stress increases Npas2 and via NPAS2 mediated transcription of specific GABAA 
subunits, likely altering inhibitory neurotransmission in the NAc. 
Lastly, we tested the functional consequences of Npas2 knockdown on GABAergic 
neurotransmission in MSNs of the NAc using ex-vivo slice electrophysiology. We found that 
Npas2 shRNA infected cells had a reduction in mIPSC amplitude, but not frequency. This finding 
suggests that Npas2 knockdown may result in postsynaptic modification of MSNs resulting in 
decreased mIPSC amplitude, but does not affect presynaptic release of GABA onto MSNs. The 
lack of diazepam’s effect on this measure is not entirely surprising, as it is thought that the effects 
of diazepam are seen only with evoked IPSCs in this preparation. Further, we found that mice 
lacking Npas2 were insensitive to diazepam, and this insensitivity persists at the cellular level in 
Npas2 shRNA infected cells. Diazepam has been shown to potentiate GABAA-receptor mediated 
currents by binding specific subunit combinations of synaptic GABAA receptors and promoting 
the binding of GABA, which in turn increases total conductance of chloride. We found that 
diazepam application reliably increased the average IPSC peak amplitude in scramble control cells 
by approximately 20% while this increase in current amplitude was noticeably absent in Npas2 
shRNA infected cells. This result suggests that knockdown of Npas2 in NAc MSNs abolishes the 
cellular response to diazepam as measured by a change in inhibitory synaptic signaling. These 
results provide functional evidence for the regulation of GABAA receptor subunit expression by 
NPAS2. 
We propose that expression of the circadian transcription factor, Npas2, is important for 
stress responses and anxiety-related behaviors and regulates GABAergic inhibitory 
neurotransmission in MSNs of the NAc. Taken together, these findings support the existence of a 
homeostatic mechanism by which stress and anxiety increase NPAS2-dependent transcription of 
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specific GABAergic subunits that selectively alter phasic, synaptic inhibitory neurotransmission 
(perhaps specifically in Drd1a containing medium spiny neurons of the NAc). Future work will 
focus on testing the efficacy of pharmacotherapeutics (that target the molecular clock and/or its 
targets) in ameliorating these adaptations to improve our understanding of and treatments for 
anxiety-related disorders. 
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